{"companyName": "MyoKardia, Inc.", "reportNo1": {"reportType": "Form 4", "url": ["https://www.sec.gov/Archives/edgar/data/1413822/000089924318026330/xslF345X03/doc4.xml", "2018-10-05"], "content": {"nameOfOwner": "GIANAKAKOS ANASTASIOS", "position": "President and CEO", "dateOfReport": "2018-10-04", "transaction1": {"classOfStock": "Common Stock", "transactionDate": "2018-10-04", "amount": "3000", "price": "1.5068", "buyOrSell": "A", "ownershipAfterTransaction": "77949"}, "transaction2": {"classOfStock": "Common Stock", "transactionDate": "2018-10-04", "amount": "1200", "price": "57.0733", "buyOrSell": "D", "ownershipAfterTransaction": "76749"}, "transaction3": {"classOfStock": "Common Stock", "transactionDate": "2018-10-04", "amount": "700", "price": "58.1543", "buyOrSell": "D", "ownershipAfterTransaction": "76049"}, "transaction4": {"classOfStock": "Common Stock", "transactionDate": "2018-10-04", "amount": "1100", "price": "59.4379", "buyOrSell": "D", "ownershipAfterTransaction": "74949"}, "transaction5": {"classOfStock": "Stock Option (Right to Buy)", "transactionDate": "2018-10-04", "amount": "3000", "price": "0.00", "buyOrSell": "D", "ownershipAfterTransaction": "108254"}}, "dateOfReport": "2018-10-04", "htmlOfReport": " <!DOCTYPE html PUBLIC \"-//W3C//DTD HTML 4.01 Transitional//EN\" \"http://www.w3.org/TR/html4/loose.dtd\">\n\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<title>SEC FORM \n            4</title>\n<style type=\"text/css\">\n              .FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;}\n              .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;}\n              .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;}\n              .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;}\n              .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;}\n              .FormNumText {font-size: small; font-weight: bold; font-family: arial, helvetica, sans-serif;}\n              .FormAttention {font-size: medium; font-weight: bold; font-family: helvetica;}\n              .FormText {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left;}\n              .FormTextR {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right;}\n              .FormTextC {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center;}\n              .FormEMText {font-size: medium; font-style: italic; font-weight: normal; font-family: arial, helvetica, sans-serif;}\n              .FormULText {font-size: medium; text-decoration: underline; font-weight: normal; font-family: arial, helvetica, sans-serif;}\n              .SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: left;}\n              .SmallFormTextR {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: right;}\n              .SmallFormTextC {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: center;}\n              .MedSmallFormText {font-size: x-small; font-family: arial, helvetica, sans-serif; text-align: left;}\n              .FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold;}\n              .FormTitle1 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; border-top: black thick solid;}\n              .FormTitle2 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold;}\n              .FormTitle3 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; padding-top: 2em; padding-bottom: 1em;}\n              .SectionTitle {font-size: small; text-align: left; font-family: arial, helvetica, sans-serif; \n              \t\tfont-weight: bold; border-top: gray thin solid; border-bottom: gray thin solid;}\n              .FormName {font-size: large; font-family: arial, helvetica, sans-serif; font-weight: bold;}\n              .CheckBox {text-align: center; width: 5px; cell-spacing: 0; padding: 0 3 0 3; border-width: thin; border-style: solid;  border-color: black:}\n              body {background: white;}\n      </style>\n</head>\n<body>SEC Form 4 \n   <table border=\"0\" cellpadding=\"4\" cellspacing=\"0\" width=\"100%\">\n<tr>\n<td align=\"center\" class=\"FormName\" colspan=\"2\" valign=\"top\" width=\"20%\">FORM 4</td>\n<td align=\"center\" rowspan=\"2\" valign=\"middle\" width=\"60%\">\n<span class=\"FormTitle\">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span><br/><span class=\"MedSmallFormText\">Washington, D.C. 20549</span><br/><br/><span class=\"FormTitle\">STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP</span><br/><br/><span class=\"MedSmallFormText\">Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934</span><br/><span class=\"MedSmallFormText\">or Section 30(h) of the Investment Company Act of 1940</span>\n</td>\n<td align=\"center\" rowspan=\"2\" valign=\"top\" width=\"20%\"><table border=\"1\" summary=\"OMB Approval Status Box\" width=\"100%\">\n<tr><td class=\"FormTextC\">OMB APPROVAL</td></tr>\n<tr><td><table border=\"0\" summary=\"OMB Interior Box\" width=\"100%\">\n<tr>\n<td class=\"SmallFormText\" colspan=\"3\">OMB Number:</td>\n<td class=\"SmallFormTextR\">3235-0287</td>\n</tr>\n<tr><td class=\"SmallFormText\" colspan=\"4\">Estimated average burden</td></tr>\n<tr>\n<td class=\"SmallFormText\" colspan=\"3\">hours per response:</td>\n<td class=\"SmallFormTextR\">0.5</td>\n</tr>\n</table></td></tr>\n</table></td>\n</tr>\n<tr valign=\"middle\">\n<td><table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\"><tr><td>\u00a0\u00a0</td></tr></table></td>\n<td class=\"SmallFormText\">Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. \n         <i>See</i>\n\n         Instruction 1(b).</td>\n</tr>\n</table>\n<table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" width=\"100%\">\n<tr>\n<td rowspan=\"3\" valign=\"top\" width=\"35%\">\n<span class=\"MedSmallFormText\">1. Name and Address of Reporting Person<sup>*</sup></span><table border=\"0\" width=\"100%\"><tr><td><a ANASTASIOS</a></td></tr></table>\n<hr width=\"98%\"/>\n<table border=\"0\" width=\"100%\"><tr>\n<td class=\"MedSmallFormText\" width=\"33%\">(Last)</td>\n<td class=\"MedSmallFormText\" width=\"33%\">(First)</td>\n<td class=\"MedSmallFormText\" width=\"33%\">(Middle)</td>\n</tr></table>\n<table border=\"0\" width=\"100%\">\n<tr><td><span class=\"FormData\">C/O MYOKARDIA, INC.</span></td></tr>\n<tr><td><span class=\"FormData\">333 ALLERTON AVENUE</span></td></tr>\n</table>\n<hr width=\"98%\"/>\n<span class=\"MedSmallFormText\">(Street)</span><table border=\"0\" width=\"100%\"><tr>\n<td width=\"33%\"><span class=\"FormData\">SOUTH SAN FRANCISCO</span></td>\n<td width=\"33%\"><span class=\"FormData\">CA</span></td>\n<td width=\"33%\"><span class=\"FormData\">94080</span></td>\n</tr></table>\n<hr width=\"98%\"/>\n<table border=\"0\" width=\"100%\"><tr>\n<td class=\"MedSmallFormText\" width=\"33%\">(City)</td>\n<td class=\"MedSmallFormText\" width=\"33%\">(State)</td>\n<td class=\"MedSmallFormText\" width=\"33%\">(Zip)</td>\n</tr></table>\n</td>\n<td valign=\"top\" width=\"35%\">\n<span class=\"MedSmallFormText\">2. Issuer Name <b>and</b> Ticker or Trading Symbol\n      </span><br/><a Inc</a>\n     [ <span class=\"FormData\">MYOK</span> ]\n   </td>\n<td rowspan=\"2\" valign=\"top\">\n<span class=\"MedSmallFormText\">5. Relationship of Reporting Person(s) to Issuer\n      </span><br/><span class=\"MedSmallFormText\">(Check all applicable)</span><table border=\"0\" width=\"100%\">\n<tr>\n<td align=\"center\" width=\"15%\"><span class=\"FormData\">X</span></td>\n<td class=\"MedSmallFormText\" width=\"35%\">Director</td>\n<td align=\"center\" width=\"15%\"></td>\n<td class=\"MedSmallFormText\" width=\"35%\">10% Owner</td>\n</tr>\n<tr>\n<td align=\"center\"><span class=\"FormData\">X</span></td>\n<td class=\"MedSmallFormText\">Officer (give title below)</td>\n<td align=\"center\"></td>\n<td class=\"MedSmallFormText\">Other (specify below)</td>\n</tr>\n<tr><td align=\"center\" colspan=\"4\"><span class=\"FormData\">President and CEO</span></td></tr>\n</table>\n</td>\n</tr>\n<tr><td valign=\"top\">\n<span class=\"MedSmallFormText\">3. Date of Earliest Transaction\n         (Month/Day/Year)</span><br/><span class=\"FormData\">10/04/2018</span>\n</td></tr>\n<tr>\n<td valign=\"top\">\n<span class=\"MedSmallFormText\">4. If Amendment, Date of Original Filed\n         (Month/Day/Year)</span><br/>\n</td>\n<td valign=\"top\">\n<span class=\"MedSmallFormText\">6. Individual or Joint/Group Filing (Check Applicable Line)\n      </span><table border=\"0\" width=\"100%\">\n<tr>\n<td align=\"center\" width=\"15%\"><span class=\"FormData\">X</span></td>\n<td class=\"MedSmallFormText\" width=\"85%\">Form filed by One Reporting Person</td>\n</tr>\n<tr>\n<td align=\"center\" width=\"15%\"></td>\n<td class=\"MedSmallFormText\" width=\"85%\">Form filed by More than One Reporting Person</td>\n</tr>\n</table>\n</td>\n</tr>\n</table>\n<table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" width=\"100%\">\n<thead>\n<tr><th align=\"center\" class=\"FormTextC\" colspan=\"11\" valign=\"top\" width=\"100%\"><b>Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned</b></th></tr>\n<tr>\n<th align=\"left\" class=\"MedSmallFormText\" rowspan=\"2\" valign=\"top\" width=\"36%\">1. Title of Security (Instr. \n      3)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"6%\">2. Transaction Date\n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"5%\">2A. Deemed Execution Date, if any\n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"7%\">3. Transaction Code (Instr. \n      8)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"3\" valign=\"top\" width=\"19%\">4. Securities Acquired (A) or Disposed Of (D) (Instr. \n      3, 4 and 5)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"11%\">5. \n      Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. \n      3 and 4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"9%\">6. Ownership Form: Direct (D) or Indirect (I) (Instr. \n      4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"8%\">7. Nature of Indirect Beneficial Ownership (Instr. \n      4)\n   </th>\n</tr>\n<tr>\n<th align=\"center\" class=\"SmallFormText\" width=\"4%\">Code</th>\n<th align=\"center\" class=\"SmallFormText\" width=\"3%\">V</th>\n<th align=\"center\" class=\"SmallFormText\" width=\"8%\">Amount</th>\n<th align=\"center\" class=\"SmallFormText\" width=\"5%\">(A) or (D)</th>\n<th align=\"center\" class=\"SmallFormText\" width=\"6%\">Price</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"><span class=\"FormData\">10/04/2018</span></td>\n<td align=\"center\"><span class=\"FormData\"></span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">M</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">3,000</span></td>\n<td align=\"center\"><span class=\"FormData\">A</span></td>\n<td align=\"center\">\n<span class=\"FormText\">$</span><span class=\"FormData\">1.5068</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"><span class=\"FormData\">77,949</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"left\"></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"><span class=\"FormData\">10/04/2018</span></td>\n<td align=\"center\"><span class=\"FormData\"></span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">S</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">1,200</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"center\">\n<span class=\"FormText\">$</span><span class=\"FormData\">57.0733</span><span class=\"FootnoteData\"><sup>(2)</sup></span>\n</td>\n<td align=\"center\"><span class=\"FormData\">76,749</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"left\"></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"><span class=\"FormData\">10/04/2018</span></td>\n<td align=\"center\"><span class=\"FormData\"></span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">S</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">700</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"center\">\n<span class=\"FormText\">$</span><span class=\"FormData\">58.1543</span><span class=\"FootnoteData\"><sup>(3)</sup></span>\n</td>\n<td align=\"center\"><span class=\"FormData\">76,049</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"left\"></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"><span class=\"FormData\">10/04/2018</span></td>\n<td align=\"center\"><span class=\"FormData\"></span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">S</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">1,100</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"center\">\n<span class=\"FormText\">$</span><span class=\"FormData\">59.4379</span><span class=\"FootnoteData\"><sup>(4)</sup></span>\n</td>\n<td align=\"center\"><span class=\"FormData\">74,949</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"left\"></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">85,973</span></td>\n<td align=\"center\"><span class=\"FormData\">I</span></td>\n<td align=\"left\"><span class=\"FormData\">By Reporting Person's Trust 2</span></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">500,000</span></td>\n<td align=\"center\"><span class=\"FormData\">I</span></td>\n<td align=\"left\"><span class=\"FormData\">By Reporting Person's Trust 3</span></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">12,200</span></td>\n<td align=\"center\"><span class=\"FormData\">I</span></td>\n<td align=\"left\"><span class=\"FormData\">By Trust 1</span></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">12,200</span></td>\n<td align=\"center\"><span class=\"FormData\">I</span></td>\n<td align=\"left\"><span class=\"FormData\">By Trust 2</span></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">12,200</span></td>\n<td align=\"center\"><span class=\"FormData\">I</span></td>\n<td align=\"left\"><span class=\"FormData\">By Trust 3</span></td>\n</tr>\n</tbody>\n</table>\n<table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" width=\"100%\">\n<thead>\n<tr><th align=\"center\" class=\"FormTextC\" colspan=\"16\" valign=\"top\" width=\"100%\">\n<b>Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned</b><br/><b>(e.g., puts, calls, warrants, options, convertible securities)</b>\n</th></tr>\n<tr>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"13%\">1. Title of Derivative Security (Instr. \n      3)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"5%\">2. Conversion or Exercise Price of Derivative Security\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"5%\">3. Transaction Date\n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"5%\">3A. Deemed Execution Date, if any\n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"9%\">4. Transaction Code (Instr. \n      8)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"10%\">5. \n      Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. \n      3, 4 and 5)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"9%\">6. Date Exercisable and Expiration Date \n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"17%\">7. Title and Amount of Securities Underlying Derivative Security (Instr. \n      3 and 4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"6%\">8. Price of Derivative Security (Instr. \n      5)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"6%\">9. \n      Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. \n      4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"6%\">10. Ownership Form: Direct (D) or Indirect (I) (Instr. \n      4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"7%\">11. Nature of Indirect Beneficial Ownership (Instr. \n      4)\n   </th>\n</tr>\n<tr>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"4%\">Code</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"4%\">V</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"5%\">(A)</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"5%\">(D)</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"5%\">Date Exercisable</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"4%\">Expiration Date</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"10%\">Title</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"7%\">Amount or Number of Shares</th>\n</tr>\n</thead>\n<tbody><tr>\n<td align=\"left\"><span class=\"SmallFormData\">Stock Option (Right to Buy)</span></td>\n<td align=\"center\">\n<span class=\"SmallFormText\">$</span><span class=\"SmallFormData\">1.5068</span>\n</td>\n<td align=\"center\"><span class=\"SmallFormData\">10/04/2018</span></td>\n<td align=\"center\"><span class=\"SmallFormData\"></span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">M</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"SmallFormData\">3,000</span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">\n</span><span class=\"FootnoteData\"><sup>(5)</sup></span>\n</td>\n<td align=\"center\"><span class=\"SmallFormData\">06/03/2025</span></td>\n<td align=\"center\"><span class=\"SmallFormData\">Common Stock</span></td>\n<td align=\"center\"><span class=\"FormData\">3,000</span></td>\n<td align=\"center\">\n<span class=\"SmallFormText\">$</span><span class=\"SmallFormData\">0.00</span>\n</td>\n<td align=\"center\"><span class=\"SmallFormData\">108,254</span></td>\n<td align=\"center\"><span class=\"SmallFormData\">D</span></td>\n<td align=\"left\"></td>\n</tr></tbody>\n</table>\n<table border=\"0\" width=\"100%\">\n<tr><td class=\"MedSmallFormText\"><b>Explanation of Responses:</b></td></tr>\n<tr><td class=\"FootnoteData\">1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.</td></tr>\n<tr><td class=\"FootnoteData\">2. Represents the weighted average sale price of the shares sold ranging from $56.70 to $57.61 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.</td></tr>\n<tr><td class=\"FootnoteData\">3. Represents the weighted average sale price of the shares sold ranging from $57.78 to $58.68 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.</td></tr>\n<tr><td class=\"FootnoteData\">4. Represents the weighted average sale price of the shares sold ranging from $59.2750 to $59.76 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.</td></tr>\n<tr><td class=\"FootnoteData\">5. 25% of the shares subject to the option vested and became exercisable on June 4, 2016, and the remaining shares subject to this option vest and become exercisable in monthly installments through June 4, 2019, subject to the Reporting Person's continuous service to the Issuer through each vesting date.</td></tr>\n<tr><td class=\"FormText\"><b>Remarks:</b></td></tr>\n<tr><td class=\"FootnoteData\"></td></tr>\n</table>\n<table border=\"0\" width=\"100%\">\n<tr>\n<td width=\"60%\"></td>\n<td width=\"20%\"><u><span class=\"FormData\">Cynthia Ladd, Attorney-in-Fact</span></u></td>\n<td width=\"20%\"><u><span class=\"FormData\">10/05/2018</span></u></td>\n</tr>\n<tr>\n<td></td>\n<td class=\"MedSmallFormText\">** Signature of Reporting Person</td>\n<td class=\"MedSmallFormText\">Date</td>\n</tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\">Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.</td></tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\">* If the form is filed by more than one reporting person, \n                  <i>see</i>\n\n                  Instruction \n                  4\n\n                  (b)(v).</td></tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\">** Intentional misstatements or omissions of facts constitute Federal Criminal Violations \n                  <i>See</i>\n\n                  18 U.S.C. 1001 and 15 U.S.C. 78ff(a).</td></tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\">Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, \n                  <i>see</i>\n\n                  Instruction 6 for procedure.</td></tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\"><b>Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.</b></td></tr>\n</table>\n</body>\n</html>\n"}, "reportNo2": {"reportType": "Form 4", "url": ["https://www.sec.gov/Archives/edgar/data/1552451/000089924318025124/xslF345X03/doc4.xml", "2018-09-24"], "content": {"nameOfOwner": "Lee June", "position": "See Remarks", "dateOfReport": "2018-09-21", "transaction1": {"classOfStock": "Common Stock", "transactionDate": "2018-09-21", "amount": "5000", "price": "11.95", "buyOrSell": "A", "ownershipAfterTransaction": "5426"}, "transaction2": {"classOfStock": "Common Stock", "transactionDate": "2018-09-21", "amount": "4092", "price": "62.9739", "buyOrSell": "D", "ownershipAfterTransaction": "1334"}, "transaction3": {"classOfStock": "Common Stock", "transactionDate": "2018-09-21", "amount": "908", "price": "63.8359", "buyOrSell": "D", "ownershipAfterTransaction": "426"}, "transaction4": {"classOfStock": "Stock Option (Right to Buy)", "transactionDate": "2018-09-21", "amount": "5000", "price": "0.00", "buyOrSell": "D", "ownershipAfterTransaction": "145000"}}, "dateOfReport": "2018-09-21", "htmlOfReport": " <!DOCTYPE html PUBLIC \"-//W3C//DTD HTML 4.01 Transitional//EN\" \"http://www.w3.org/TR/html4/loose.dtd\">\n\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<title>SEC FORM \n            4</title>\n<style type=\"text/css\">\n              .FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;}\n              .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;}\n              .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;}\n              .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;}\n              .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;}\n              .FormNumText {font-size: small; font-weight: bold; font-family: arial, helvetica, sans-serif;}\n              .FormAttention {font-size: medium; font-weight: bold; font-family: helvetica;}\n              .FormText {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left;}\n              .FormTextR {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right;}\n              .FormTextC {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center;}\n              .FormEMText {font-size: medium; font-style: italic; font-weight: normal; font-family: arial, helvetica, sans-serif;}\n              .FormULText {font-size: medium; text-decoration: underline; font-weight: normal; font-family: arial, helvetica, sans-serif;}\n              .SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: left;}\n              .SmallFormTextR {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: right;}\n              .SmallFormTextC {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: center;}\n              .MedSmallFormText {font-size: x-small; font-family: arial, helvetica, sans-serif; text-align: left;}\n              .FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold;}\n              .FormTitle1 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; border-top: black thick solid;}\n              .FormTitle2 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold;}\n              .FormTitle3 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; padding-top: 2em; padding-bottom: 1em;}\n              .SectionTitle {font-size: small; text-align: left; font-family: arial, helvetica, sans-serif; \n              \t\tfont-weight: bold; border-top: gray thin solid; border-bottom: gray thin solid;}\n              .FormName {font-size: large; font-family: arial, helvetica, sans-serif; font-weight: bold;}\n              .CheckBox {text-align: center; width: 5px; cell-spacing: 0; padding: 0 3 0 3; border-width: thin; border-style: solid;  border-color: black:}\n              body {background: white;}\n      </style>\n</head>\n<body>SEC Form 4 \n   <table border=\"0\" cellpadding=\"4\" cellspacing=\"0\" width=\"100%\">\n<tr>\n<td align=\"center\" class=\"FormName\" colspan=\"2\" valign=\"top\" width=\"20%\">FORM 4</td>\n<td align=\"center\" rowspan=\"2\" valign=\"middle\" width=\"60%\">\n<span class=\"FormTitle\">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span><br/><span class=\"MedSmallFormText\">Washington, D.C. 20549</span><br/><br/><span class=\"FormTitle\">STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP</span><br/><br/><span class=\"MedSmallFormText\">Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934</span><br/><span class=\"MedSmallFormText\">or Section 30(h) of the Investment Company Act of 1940</span>\n</td>\n<td align=\"center\" rowspan=\"2\" valign=\"top\" width=\"20%\"><table border=\"1\" summary=\"OMB Approval Status Box\" width=\"100%\">\n<tr><td class=\"FormTextC\">OMB APPROVAL</td></tr>\n<tr><td><table border=\"0\" summary=\"OMB Interior Box\" width=\"100%\">\n<tr>\n<td class=\"SmallFormText\" colspan=\"3\">OMB Number:</td>\n<td class=\"SmallFormTextR\">3235-0287</td>\n</tr>\n<tr><td class=\"SmallFormText\" colspan=\"4\">Estimated average burden</td></tr>\n<tr>\n<td class=\"SmallFormText\" colspan=\"3\">hours per response:</td>\n<td class=\"SmallFormTextR\">0.5</td>\n</tr>\n</table></td></tr>\n</table></td>\n</tr>\n<tr valign=\"middle\">\n<td><table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\"><tr><td>\u00a0\u00a0</td></tr></table></td>\n<td class=\"SmallFormText\">Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. \n         <i>See</i>\n\n         Instruction 1(b).</td>\n</tr>\n</table>\n<table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" width=\"100%\">\n<tr>\n<td rowspan=\"3\" valign=\"top\" width=\"35%\">\n<span class=\"MedSmallFormText\">1. Name and Address of Reporting Person<sup>*</sup></span><table border=\"0\" width=\"100%\"><tr><td><a June</a></td></tr></table>\n<hr width=\"98%\"/>\n<table border=\"0\" width=\"100%\"><tr>\n<td class=\"MedSmallFormText\" width=\"33%\">(Last)</td>\n<td class=\"MedSmallFormText\" width=\"33%\">(First)</td>\n<td class=\"MedSmallFormText\" width=\"33%\">(Middle)</td>\n</tr></table>\n<table border=\"0\" width=\"100%\">\n<tr><td><span class=\"FormData\">C/O MYOKARDIA, INC.</span></td></tr>\n<tr><td><span class=\"FormData\">333 ALLERTON AVENUE</span></td></tr>\n</table>\n<hr width=\"98%\"/>\n<span class=\"MedSmallFormText\">(Street)</span><table border=\"0\" width=\"100%\"><tr>\n<td width=\"33%\"><span class=\"FormData\">SOUTH SAN FRANCISCO</span></td>\n<td width=\"33%\"><span class=\"FormData\">CA</span></td>\n<td width=\"33%\"><span class=\"FormData\">94080</span></td>\n</tr></table>\n<hr width=\"98%\"/>\n<table border=\"0\" width=\"100%\"><tr>\n<td class=\"MedSmallFormText\" width=\"33%\">(City)</td>\n<td class=\"MedSmallFormText\" width=\"33%\">(State)</td>\n<td class=\"MedSmallFormText\" width=\"33%\">(Zip)</td>\n</tr></table>\n</td>\n<td valign=\"top\" width=\"35%\">\n<span class=\"MedSmallFormText\">2. Issuer Name <b>and</b> Ticker or Trading Symbol\n      </span><br/><a Inc</a>\n     [ <span class=\"FormData\">MYOK</span> ]\n   </td>\n<td rowspan=\"2\" valign=\"top\">\n<span class=\"MedSmallFormText\">5. Relationship of Reporting Person(s) to Issuer\n      </span><br/><span class=\"MedSmallFormText\">(Check all applicable)</span><table border=\"0\" width=\"100%\">\n<tr>\n<td align=\"center\" width=\"15%\"></td>\n<td class=\"MedSmallFormText\" width=\"35%\">Director</td>\n<td align=\"center\" width=\"15%\"></td>\n<td class=\"MedSmallFormText\" width=\"35%\">10% Owner</td>\n</tr>\n<tr>\n<td align=\"center\"><span class=\"FormData\">X</span></td>\n<td class=\"MedSmallFormText\">Officer (give title below)</td>\n<td align=\"center\"></td>\n<td class=\"MedSmallFormText\">Other (specify below)</td>\n</tr>\n<tr><td align=\"center\" colspan=\"4\"><span class=\"FormData\">See Remarks</span></td></tr>\n</table>\n</td>\n</tr>\n<tr><td valign=\"top\">\n<span class=\"MedSmallFormText\">3. Date of Earliest Transaction\n         (Month/Day/Year)</span><br/><span class=\"FormData\">09/21/2018</span>\n</td></tr>\n<tr>\n<td valign=\"top\">\n<span class=\"MedSmallFormText\">4. If Amendment, Date of Original Filed\n         (Month/Day/Year)</span><br/>\n</td>\n<td valign=\"top\">\n<span class=\"MedSmallFormText\">6. Individual or Joint/Group Filing (Check Applicable Line)\n      </span><table border=\"0\" width=\"100%\">\n<tr>\n<td align=\"center\" width=\"15%\"><span class=\"FormData\">X</span></td>\n<td class=\"MedSmallFormText\" width=\"85%\">Form filed by One Reporting Person</td>\n</tr>\n<tr>\n<td align=\"center\" width=\"15%\"></td>\n<td class=\"MedSmallFormText\" width=\"85%\">Form filed by More than One Reporting Person</td>\n</tr>\n</table>\n</td>\n</tr>\n</table>\n<table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" width=\"100%\">\n<thead>\n<tr><th align=\"center\" class=\"FormTextC\" colspan=\"11\" valign=\"top\" width=\"100%\"><b>Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned</b></th></tr>\n<tr>\n<th align=\"left\" class=\"MedSmallFormText\" rowspan=\"2\" valign=\"top\" width=\"36%\">1. Title of Security (Instr. \n      3)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"6%\">2. Transaction Date\n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"5%\">2A. Deemed Execution Date, if any\n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"7%\">3. Transaction Code (Instr. \n      8)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"3\" valign=\"top\" width=\"19%\">4. Securities Acquired (A) or Disposed Of (D) (Instr. \n      3, 4 and 5)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"11%\">5. \n      Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. \n      3 and 4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"9%\">6. Ownership Form: Direct (D) or Indirect (I) (Instr. \n      4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"8%\">7. Nature of Indirect Beneficial Ownership (Instr. \n      4)\n   </th>\n</tr>\n<tr>\n<th align=\"center\" class=\"SmallFormText\" width=\"4%\">Code</th>\n<th align=\"center\" class=\"SmallFormText\" width=\"3%\">V</th>\n<th align=\"center\" class=\"SmallFormText\" width=\"8%\">Amount</th>\n<th align=\"center\" class=\"SmallFormText\" width=\"5%\">(A) or (D)</th>\n<th align=\"center\" class=\"SmallFormText\" width=\"6%\">Price</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"><span class=\"FormData\">09/21/2018</span></td>\n<td align=\"center\"><span class=\"FormData\"></span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">M</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">5,000</span></td>\n<td align=\"center\"><span class=\"FormData\">A</span></td>\n<td align=\"center\">\n<span class=\"FormText\">$</span><span class=\"FormData\">11.95</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"><span class=\"FormData\">5,426</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"left\"></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"><span class=\"FormData\">09/21/2018</span></td>\n<td align=\"center\"><span class=\"FormData\"></span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">S</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">4,092</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"center\">\n<span class=\"FormText\">$</span><span class=\"FormData\">62.9739</span><span class=\"FootnoteData\"><sup>(2)</sup></span>\n</td>\n<td align=\"center\"><span class=\"FormData\">1,334</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"left\"></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"><span class=\"FormData\">09/21/2018</span></td>\n<td align=\"center\"><span class=\"FormData\"></span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">S</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">908</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"center\">\n<span class=\"FormText\">$</span><span class=\"FormData\">63.8359</span><span class=\"FootnoteData\"><sup>(3)</sup></span>\n</td>\n<td align=\"center\"><span class=\"FormData\">426</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"left\"></td>\n</tr>\n</tbody>\n</table>\n<table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" width=\"100%\">\n<thead>\n<tr><th align=\"center\" class=\"FormTextC\" colspan=\"16\" valign=\"top\" width=\"100%\">\n<b>Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned</b><br/><b>(e.g., puts, calls, warrants, options, convertible securities)</b>\n</th></tr>\n<tr>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"13%\">1. Title of Derivative Security (Instr. \n      3)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"5%\">2. Conversion or Exercise Price of Derivative Security\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"5%\">3. Transaction Date\n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"5%\">3A. Deemed Execution Date, if any\n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"9%\">4. Transaction Code (Instr. \n      8)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"10%\">5. \n      Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. \n      3, 4 and 5)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"9%\">6. Date Exercisable and Expiration Date \n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"17%\">7. Title and Amount of Securities Underlying Derivative Security (Instr. \n      3 and 4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"6%\">8. Price of Derivative Security (Instr. \n      5)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"6%\">9. \n      Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. \n      4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"6%\">10. Ownership Form: Direct (D) or Indirect (I) (Instr. \n      4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"7%\">11. Nature of Indirect Beneficial Ownership (Instr. \n      4)\n   </th>\n</tr>\n<tr>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"4%\">Code</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"4%\">V</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"5%\">(A)</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"5%\">(D)</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"5%\">Date Exercisable</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"4%\">Expiration Date</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"10%\">Title</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"7%\">Amount or Number of Shares</th>\n</tr>\n</thead>\n<tbody><tr>\n<td align=\"left\"><span class=\"SmallFormData\">Stock Option (Right to Buy)</span></td>\n<td align=\"center\">\n<span class=\"SmallFormText\">$</span><span class=\"SmallFormData\">11.95</span>\n</td>\n<td align=\"center\"><span class=\"SmallFormData\">09/21/2018</span></td>\n<td align=\"center\"><span class=\"SmallFormData\"></span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">M</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"SmallFormData\">5,000</span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">\n</span><span class=\"FootnoteData\"><sup>(4)</sup></span>\n</td>\n<td align=\"center\"><span class=\"SmallFormData\">01/31/2027</span></td>\n<td align=\"center\"><span class=\"SmallFormData\">Common Stock</span></td>\n<td align=\"center\"><span class=\"FormData\">5,000</span></td>\n<td align=\"center\">\n<span class=\"SmallFormText\">$</span><span class=\"SmallFormData\">0.00</span>\n</td>\n<td align=\"center\"><span class=\"SmallFormData\">145,000</span></td>\n<td align=\"center\"><span class=\"SmallFormData\">D</span></td>\n<td align=\"left\"></td>\n</tr></tbody>\n</table>\n<table border=\"0\" width=\"100%\">\n<tr><td class=\"MedSmallFormText\"><b>Explanation of Responses:</b></td></tr>\n<tr><td class=\"FootnoteData\">1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.</td></tr>\n<tr><td class=\"FootnoteData\">2. Represents the weighted average sale price of the shares sold ranging from $62.40 to $63.30 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.</td></tr>\n<tr><td class=\"FootnoteData\">3. Represents the weighted average sale price of the shares sold ranging from $63.45 to $64.35 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.</td></tr>\n<tr><td class=\"FootnoteData\">4. 25% of the shares subject to the option vested and became exercisable on January 31, 2018, and the remaining shares subject to this option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.</td></tr>\n<tr><td class=\"FormText\"><b>Remarks:</b></td></tr>\n<tr><td class=\"FootnoteData\">Chief Operating Officer and Chief Development Officer</td></tr>\n</table>\n<table border=\"0\" width=\"100%\">\n<tr>\n<td width=\"60%\"></td>\n<td width=\"20%\"><u><span class=\"FormData\">/s/ Cynthia J. Ladd, Attorney-in-Fact</span></u></td>\n<td width=\"20%\"><u><span class=\"FormData\">09/24/2018</span></u></td>\n</tr>\n<tr>\n<td></td>\n<td class=\"MedSmallFormText\">** Signature of Reporting Person</td>\n<td class=\"MedSmallFormText\">Date</td>\n</tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\">Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.</td></tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\">* If the form is filed by more than one reporting person, \n                  <i>see</i>\n\n                  Instruction \n                  4\n\n                  (b)(v).</td></tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\">** Intentional misstatements or omissions of facts constitute Federal Criminal Violations \n                  <i>See</i>\n\n                  18 U.S.C. 1001 and 15 U.S.C. 78ff(a).</td></tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\">Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, \n                  <i>see</i>\n\n                  Instruction 6 for procedure.</td></tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\"><b>Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.</b></td></tr>\n</table>\n</body>\n</html>\n"}, "reportNo3": {"reportType": "8-K", "url": "https://www.sec.gov/Archives/edgar/data/1552451/000119312518274142/d624953d8k.htm", "dateOfReport": "2018-09-14", "content": "On September13, 2018, MyoKardia, Inc. (the \u0093Company\u0094) entered into a lease (the \u0093Lease\u0094) with HCP LS Brisbane, LLC,\nas landlord (\u0093HCP\u0094) for approximately 129,846 square feet of space in a building located at 1000 Sierra Point Boulevard in Brisbane, California (the \u0093Premises\u0094). The term of the Lease will commence on the date that the Premises are ready for occupancy per the terms of the Lease (the \u0093Commencement\nDate\u0094), and will expire on the day prior to the tenth (10th) anniversary of the Commencement Date. If the Commencement Date does not occur on or before June30, 2020, then the Company\nshall have the right to terminate the Lease upon written notice to HCP. The monthly base rent for the Premises under the Lease will be\nequal to $5.250 per rentable square foot of the Premises, payable by the Company to HCP for the first year of the term of the Lease, and will increase for the remaining nine years of the Lease term as follows: LeaseYearAnnualizedBaseRentMonthlyInstallmentofBaseRentApproximateMonthlyBaseRentperRSFDuring the term of the Lease, the Company will pay its share of operating expenses, taxes and any other\nexpenses payable under the Lease. The Company has (i)an option right to extend the Lease term for a period of ten (10)years, and (ii)a right of first offer during the initial Lease term with respect to any space in the last\nbuilding to be constructed in the Shore at Sierra Point project by HCP, which is currently anticipated to be Building A, with the address of 1800 Sierra Point Boulevard, if and when such building is completed by HCP. The foregoing description of the Lease does not purport to be complete and is qualified in its entirety by reference to the Lease, a complete\ncopy of which the Company intends to file with the Securities and Exchange Commission as an exhibit to its Quarterly Report on Form 10-Q for the quarter ending September30, 2018. Item2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of\na Registrant. The information set forth under ", "htmlOfReport": " <document>\n<type>8-K\n<sequence>1\n<filename>d624953d8k.htm\n<description>8-K\n<text>\n<html><head>\n<title>8-K</title>\n</head>\n<body bgcolor=\"WHITE\">\n<center><div align=\"left\" style=\"width:8.5in\">\n<p style=\"line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000\">\u00a0</p>\n<p style=\"line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000\">\u00a0</p> <p align=\"center\" style=\"margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman\"><b>UNITED STATES </b></p>\n<p align=\"center\" style=\"margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman\"><b>SECURITIES AND EXCHANGE COMMISSION </b></p>\n<p align=\"center\" style=\"margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman\"><b>Washington, D.C. 20549 </b></p> <p style=\"font-size:12pt;margin-top:0pt;margin-bottom:0pt\">\u00a0</p><center>\n<p style=\"line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%\">\u00a0</p></center> <p align=\"center\" style=\"margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman\"><b>FORM <font style=\"white-space:nowrap\">8-K</font> </b></p> <p style=\"font-size:12pt;margin-top:0pt;margin-bottom:0pt\">\u00a0</p><center>\n<p style=\"line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%\">\u00a0</p></center> <p align=\"center\" style=\"margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman\"><b>CURRENT\nREPORT </b></p> <p align=\"center\" style=\"margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman\"><b>Pursuant to Section\u00a013 or 15(d) </b></p>\n<p align=\"center\" style=\"margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman\"><b>of the Securities Exchange Act of 1934 </b></p>\n<p align=\"center\" style=\"margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman\"><b>Date of Report (Date of earliest event reported): September\u00a014, 2018 </b></p>\n<p style=\"font-size:12pt;margin-top:0pt;margin-bottom:0pt\">\u00a0</p><center> <p style=\"line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%\">\u00a0</p></center>\n<p align=\"center\" style=\"margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman\"><b>MYOKARDIA,\u00a0INC. </b></p>\n<p align=\"center\" style=\"margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman\"><b>(Exact name of registrant as specified in its charter) </b></p> <p style=\"font-size:12pt;margin-top:0pt;margin-bottom:0pt\">\u00a0</p><center>\n<p style=\"line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%\">\u00a0</p></center> <p style=\"font-size:12pt;margin-top:0pt;margin-bottom:0pt\">\u00a0</p>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt\" width=\"100%\">\n<tr>\n<td width=\"34%\"></td>\n<td valign=\"bottom\"></td>\n<td width=\"32%\"></td>\n<td valign=\"bottom\" width=\"1%\"></td>\n<td width=\"32%\"></td></tr>\n<tr style=\"page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt\">\n<td align=\"center\" valign=\"top\"><b>Delaware</b></td>\n<td valign=\"bottom\">\u00a0</td>\n<td align=\"center\" valign=\"top\"><b><font style=\"white-space:nowrap\">001-37609</font></b></td>\n<td valign=\"bottom\">\u00a0</td>\n<td align=\"center\" valign=\"top\"><b><font style=\"white-space:nowrap\">44-5500552</font></b></td></tr>\n<tr style=\"page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt\">\n<td align=\"center\" valign=\"top\"> <p align=\"center\" style=\"margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman\"><b>(State or other jurisdiction</b></p>\n<p align=\"center\" style=\"margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman\"><b>of incorporation)</b></p></td>\n<td valign=\"bottom\">\u00a0</td>\n<td align=\"center\" valign=\"top\"> <p align=\"center\" style=\"margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman\"><b>(Commission</b></p>\n<p align=\"center\" style=\"margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman\"><b>File Number)</b></p></td>\n<td valign=\"bottom\">\u00a0</td>\n<td align=\"center\" valign=\"top\"> <p align=\"center\" style=\"margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman\"><b>(I.R.S. Employer</b></p>\n<p align=\"center\" style=\"margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman\"><b>Identification No.)</b></p></td></tr>\n</table> <p align=\"center\" style=\"margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman\"><b>333 Allerton Ave. </b></p>\n<p align=\"center\" style=\"margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman\"><b>South San Francisco, CA 94080 </b></p>\n<p align=\"center\" style=\"margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman\"><b>(Address of principal executive offices, including zip code) </b></p>\n<p align=\"center\" style=\"margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman\"><b>(650) <font style=\"white-space:nowrap\">741-0900</font> </b></p>\n<p align=\"center\" style=\"margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman\"><b>(Registrant\u0092s telephone number, including area code) </b></p>\n<p align=\"center\" style=\"margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman\"><b>Not Applicable </b></p> <p align=\"center\" style=\"margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman\"><b>(Former\nName or Former Address, if Changed Since Last Report) </b></p> <p style=\"font-size:12pt;margin-top:0pt;margin-bottom:0pt\">\u00a0</p><center>\n<p style=\"line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%\">\u00a0</p></center> <p style=\"margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman\">Check the appropriate box below\nif the <font style=\"white-space:nowrap\">Form\u00a08-K</font> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </p>\n<p style=\"font-size:6pt;margin-top:0pt;margin-bottom:0pt\">\u00a0</p>\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt\" width=\"100%\">\n<tr style=\"page-break-inside:avoid\">\n<td align=\"left\" valign=\"top\" width=\"4%\">\u2610</td>\n<td align=\"left\" valign=\"top\"> <p align=\"left\" style=\" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; \">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </p></td></tr></table>\n<p style=\"font-size:6pt;margin-top:0pt;margin-bottom:0pt\">\u00a0</p>\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt\" width=\"100%\">\n<tr style=\"page-break-inside:avoid\">\n<td align=\"left\" valign=\"top\" width=\"4%\">\u2610</td>\n<td align=\"left\" valign=\"top\"> <p align=\"left\" style=\" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; \">Soliciting material pursuant to Rule <font style=\"white-space:nowrap\">14a-12</font> under the Exchange Act (17\nCFR <font style=\"white-space:nowrap\">240.14a-12)</font> </p></td></tr></table> <p style=\"font-size:6pt;margin-top:0pt;margin-bottom:0pt\">\u00a0</p>\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt\" width=\"100%\">\n<tr style=\"page-break-inside:avoid\">\n<td align=\"left\" valign=\"top\" width=\"4%\">\u2610</td>\n<td align=\"left\" valign=\"top\"> <p align=\"left\" style=\" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; \"><font style=\"white-space:nowrap\">Pre-commencement</font> communications pursuant to Rule <font style=\"white-space:nowrap\">14d-2(b)</font> under the Exchange Act (17 CFR <font style=\"white-space:nowrap\">240.14d-2(b))</font> </p></td></tr></table> <p style=\"font-size:6pt;margin-top:0pt;margin-bottom:0pt\">\u00a0</p>\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt\" width=\"100%\">\n<tr style=\"page-break-inside:avoid\">\n<td align=\"left\" valign=\"top\" width=\"4%\">\u2610</td>\n<td align=\"left\" valign=\"top\"> <p align=\"left\" style=\" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; \"><font style=\"white-space:nowrap\">Pre-commencement</font> communications pursuant to Rule <font style=\"white-space:nowrap\">13e-4(c)</font> under the Exchange Act (17 CFR <font style=\"white-space:nowrap\">240.13e-4(c))</font> </p></td></tr></table>\n<p style=\"margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman\">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (\u00a7\u00a0230.405 of this\nchapter) or Rule <font style=\"white-space:nowrap\">12b-2</font> of the Securities Exchange Act of 1934 <font style=\"white-space:nowrap\">(\u00a7\u00a0240.12b-2</font> of this chapter). </p>\n<p style=\"margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman\">Emerging growth company\u00a0\u00a0\u2612 </p> <p style=\"margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman\">If an emerging\ngrowth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section\u00a013(a) of the Exchange\nAct.\u00a0\u00a0\u2612 </p> <p style=\"font-size:10pt;margin-top:0pt;margin-bottom:0pt\">\u00a0</p> <p style=\"line-height:3.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000\">\u00a0</p>\n<p style=\"line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000\">\u00a0</p>\n</div></center>\n<p style=\"page-break-before:always\">\n<hr align=\"CENTER\" size=\"3\" style=\"COLOR:#999999\" width=\"100%\"/>\n<center><div align=\"left\" style=\"width:8.5in\">\n<p style=\"margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman\"><b>Item\u00a01.01\u00a0Entry into a Material Definitive Agreement. </b></p>\n<p style=\"margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman\">On September\u00a013, 2018, MyoKardia, Inc. (the \u0093Company\u0094) entered into a lease (the \u0093Lease\u0094) with HCP LS Brisbane, LLC,\nas landlord (\u0093HCP\u0094) for approximately 129,846 square feet of space in a building located at 1000 Sierra Point Boulevard in Brisbane, California (the \u0093Premises\u0094). </p>\n<p style=\"margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman\">The term of the Lease will commence on the date that the Premises are ready for occupancy per the terms of the Lease (the \u0093Commencement\nDate\u0094), and will expire on the day prior to the tenth (10<sup style=\"font-size:85%; vertical-align:top\">th</sup>) anniversary of the Commencement Date. If the Commencement Date does not occur on or before June\u00a030, 2020, then the Company\nshall have the right to terminate the Lease upon written notice to HCP. </p> <p style=\"margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman\">The monthly base rent for the Premises under the Lease will be\nequal to $5.250 per rentable square foot of the Premises, payable by the Company to HCP for the first year of the term of the Lease, and will increase for the remaining nine years of the Lease term as follows: </p>\n<p style=\"font-size:12pt;margin-top:0pt;margin-bottom:0pt\">\u00a0</p>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt\" width=\"100%\">\n<tr>\n<td width=\"26%\"></td>\n<td valign=\"bottom\" width=\"2%\"></td>\n<td width=\"23%\"></td>\n<td valign=\"bottom\" width=\"2%\"></td>\n<td width=\"23%\"></td>\n<td valign=\"bottom\" width=\"2%\"></td>\n<td width=\"22%\"></td></tr>\n<tr style=\"page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt\">\n<td align=\"center\" nowrap=\"\" valign=\"bottom\"> <p align=\"center\" style=\" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; \">Lease\u00a0Year</p></td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\"> <p align=\"center\" style=\"margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman\">Annualized</p>\n<p align=\"center\" style=\"margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; \">Base\u00a0Rent</p></td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\"> <p align=\"center\" style=\"margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman\">Monthly</p>\n<p align=\"center\" style=\"margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman\">Installment</p>\n<p align=\"center\" style=\"margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; \">of\u00a0Base\u00a0Rent</p></td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\"> <p align=\"center\" style=\"margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman\">Approximate</p>\n<p align=\"center\" style=\"margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman\">Monthly\u00a0Base</p>\n<p align=\"center\" style=\"margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; \">Rent\u00a0per\u00a0RSF</p></td></tr>\n<tr style=\"font-size:1pt\">\n<td height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td></tr>\n<tr bgcolor=\"#cceeff\" style=\"page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt\">\n<td align=\"center\" valign=\"top\">1\u00a0(months\u00a01\u00a0\u0096\u00a08)</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">N/A</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$340,845.75</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$5.250</td></tr>\n<tr style=\"font-size:1pt\">\n<td height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td></tr>\n<tr style=\"page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt\">\n<td align=\"center\" valign=\"top\">1\u00a0(months\u00a09\u00a0\u0096\u00a012)</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">N/A</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$681,691.50</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$5.250</td></tr>\n<tr style=\"font-size:1pt\">\n<td height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td></tr>\n<tr bgcolor=\"#cceeff\" style=\"page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt\">\n<td align=\"center\" valign=\"top\">2</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$\u00a0\u00a08,460,765.36</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$705,063.78</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$5.430</td></tr>\n<tr style=\"font-size:1pt\">\n<td height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td></tr>\n<tr style=\"page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt\">\n<td align=\"center\" valign=\"top\">3</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$\u00a0\u00a08,756,892.15</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$729,741.01</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$5.620</td></tr>\n<tr style=\"font-size:1pt\">\n<td height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td></tr>\n<tr bgcolor=\"#cceeff\" style=\"page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt\">\n<td align=\"center\" valign=\"top\">4</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$\u00a0\u00a09,063,383.37</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$755,281.95</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$5.817</td></tr>\n<tr style=\"font-size:1pt\">\n<td height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td></tr>\n<tr style=\"page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt\">\n<td align=\"center\" valign=\"top\">5</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$\u00a0\u00a09,380,601.79</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$781,716.82</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$6.020</td></tr>\n<tr style=\"font-size:1pt\">\n<td height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td></tr>\n<tr bgcolor=\"#cceeff\" style=\"page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt\">\n<td align=\"center\" valign=\"top\">6</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$\u00a0\u00a09,708,922.85</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$809,076.90</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$6.231</td></tr>\n<tr style=\"font-size:1pt\">\n<td height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td></tr>\n<tr style=\"page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt\">\n<td align=\"center\" valign=\"top\">7</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$10,048,735.15</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$837,394.60</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$6.449</td></tr>\n<tr style=\"font-size:1pt\">\n<td height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td></tr>\n<tr bgcolor=\"#cceeff\" style=\"page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt\">\n<td align=\"center\" valign=\"top\">8</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$10,400,440.88</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$866,703.41</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$6.675</td></tr>\n<tr style=\"font-size:1pt\">\n<td height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td></tr>\n<tr style=\"page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt\">\n<td align=\"center\" valign=\"top\">9</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$10,764,456.31</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$897,038.03</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$6.908</td></tr>\n<tr style=\"font-size:1pt\">\n<td height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td>\n<td colspan=\"2\" height=\"8\"></td></tr>\n<tr bgcolor=\"#cceeff\" style=\"page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt\">\n<td align=\"center\" valign=\"top\">10</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$11,141,212.29</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$928,434.36</td>\n<td valign=\"bottom\">\u00a0\u00a0</td>\n<td align=\"center\" valign=\"bottom\">$7.150</td></tr>\n</table> <p style=\"margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman\">During the term of the Lease, the Company will pay its share of operating expenses, taxes and any other\nexpenses payable under the Lease. The Company has (i)\u00a0an option right to extend the Lease term for a period of ten (10)\u00a0years, and (ii)\u00a0a right of first offer during the initial Lease term with respect to any space in the last\nbuilding to be constructed in the Shore at Sierra Point project by HCP, which is currently anticipated to be Building A, with the address of 1800 Sierra Point Boulevard, if and when such building is completed by HCP. </p>\n<p style=\"margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman\">The foregoing description of the Lease does not purport to be complete and is qualified in its entirety by reference to the Lease, a complete\ncopy of which the Company intends to file with the Securities and Exchange Commission as an exhibit to its Quarterly Report on Form <font style=\"white-space:nowrap\">10-Q</font> for the quarter ending September\u00a030, 2018. </p>\n<p style=\"margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman\"><b>Item\u00a02.03 Creation of a Direct Financial Obligation or an Obligation under an <font style=\"white-space:nowrap\">Off-Balance</font> Sheet Arrangement of\na Registrant. </b></p> <p style=\"margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman\">The information set forth under Item 1.01 of this Current Report on Form <font style=\"white-space:nowrap\">8-K</font> is incorporated\nherein by reference. </p>\n</div></center>\n<p style=\"page-break-before:always\">\n<hr align=\"CENTER\" size=\"3\" style=\"COLOR:#999999\" width=\"100%\"/>\n<center><div align=\"left\" style=\"width:8.5in\">\n<p align=\"center\" style=\"margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman\"><b>SIGNATURES </b></p>\n<p style=\"margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman\">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized. </p> <p style=\"font-size:12pt;margin-top:0pt;margin-bottom:0pt\">\u00a0</p>\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt\" width=\"100%\">\n<tr>\n<td width=\"46%\"></td>\n<td valign=\"bottom\" width=\"1%\"></td>\n<td width=\"4%\"></td>\n<td valign=\"bottom\"></td>\n<td width=\"2%\"></td>\n<td valign=\"bottom\" width=\"1%\"></td>\n<td width=\"45%\"></td></tr>\n<tr style=\"page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt\">\n<td valign=\"top\"> <p style=\" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman\">Date: September\u00a014, 2018</p></td>\n<td valign=\"bottom\">\u00a0</td>\n<td valign=\"top\"></td>\n<td valign=\"bottom\">\u00a0</td>\n<td colspan=\"3\" valign=\"top\"><b>MyoKardia, Inc.</b></td></tr>\n<tr style=\"font-size:1pt\">\n<td height=\"16\"></td>\n<td colspan=\"2\" height=\"16\"></td>\n<td colspan=\"2\" height=\"16\"></td>\n<td colspan=\"2\" height=\"16\"></td></tr>\n<tr style=\"page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt\">\n<td valign=\"top\"></td>\n<td valign=\"bottom\">\u00a0</td>\n<td valign=\"top\"></td>\n<td valign=\"bottom\">\u00a0</td>\n<td valign=\"top\"> <p style=\" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman\">By:</p></td>\n<td valign=\"bottom\">\u00a0</td>\n<td valign=\"top\"> <p style=\"margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman\">/s/ Taylor Harris</p></td></tr>\n<tr style=\"page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt\">\n<td valign=\"top\"></td>\n<td valign=\"bottom\">\u00a0</td>\n<td valign=\"top\"></td>\n<td valign=\"bottom\">\u00a0</td>\n<td valign=\"top\"></td>\n<td valign=\"bottom\">\u00a0</td>\n<td valign=\"top\"> <p style=\" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman\">Taylor Harris</p></td></tr>\n<tr style=\"page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt\">\n<td valign=\"top\"></td>\n<td valign=\"bottom\">\u00a0</td>\n<td valign=\"bottom\"></td>\n<td valign=\"bottom\">\u00a0</td>\n<td valign=\"top\"></td>\n<td valign=\"bottom\">\u00a0</td>\n<td valign=\"bottom\"> <p style=\" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman\">Chief Financial Officer\n<b>(principal</b><b></b><b>\u00a0financial</b><b></b><b>\u00a0officer)</b></p></td></tr>\n</table>\n</div></center>\n</p></p></body></html>\n</text>\n</description></filename></sequence></type></document>\n"}, "reportNo4": {"reportType": "Form 4", "url": ["https://www.sec.gov/Archives/edgar/data/1552451/000089924318023935/xslF345X03/doc4.xml", "2018-09-06"], "content": {"nameOfOwner": "Semigran Marc", "position": "Chief Medical Officer", "dateOfReport": "2018-09-04", "transaction1": {"classOfStock": "Common Stock", "transactionDate": "2018-09-04", "amount": "41400", "price": "15.95", "buyOrSell": "A", "ownershipAfterTransaction": "41400"}, "transaction2": {"classOfStock": "Common Stock", "transactionDate": "2018-09-04", "amount": "41400", "price": "59.4929", "buyOrSell": "D", "ownershipAfterTransaction": "0"}, "transaction3": {"classOfStock": "Common Stock", "transactionDate": "2018-09-05", "amount": "3600", "price": "15.95", "buyOrSell": "A", "ownershipAfterTransaction": "3600"}, "transaction4": {"classOfStock": "Common Stock", "transactionDate": "2018-09-05", "amount": "3600", "price": "60.00", "buyOrSell": "D", "ownershipAfterTransaction": "0"}, "transaction5": {"classOfStock": "Stock Option (Right to Buy)", "transactionDate": "2018-09-04", "amount": "41400", "price": "0.00", "buyOrSell": "D", "ownershipAfterTransaction": "133600"}, "transaction6": {"classOfStock": "Stock Option (Right to Buy)", "transactionDate": "2018-09-05", "amount": "3600", "price": "0.00", "buyOrSell": "D", "ownershipAfterTransaction": "130000"}}, "dateOfReport": "2018-09-04", "htmlOfReport": " <!DOCTYPE html PUBLIC \"-//W3C//DTD HTML 4.01 Transitional//EN\" \"http://www.w3.org/TR/html4/loose.dtd\">\n\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<title>SEC FORM \n            4</title>\n<style type=\"text/css\">\n              .FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;}\n              .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;}\n              .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;}\n              .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;}\n              .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;}\n              .FormNumText {font-size: small; font-weight: bold; font-family: arial, helvetica, sans-serif;}\n              .FormAttention {font-size: medium; font-weight: bold; font-family: helvetica;}\n              .FormText {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left;}\n              .FormTextR {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right;}\n              .FormTextC {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center;}\n              .FormEMText {font-size: medium; font-style: italic; font-weight: normal; font-family: arial, helvetica, sans-serif;}\n              .FormULText {font-size: medium; text-decoration: underline; font-weight: normal; font-family: arial, helvetica, sans-serif;}\n              .SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: left;}\n              .SmallFormTextR {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: right;}\n              .SmallFormTextC {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: center;}\n              .MedSmallFormText {font-size: x-small; font-family: arial, helvetica, sans-serif; text-align: left;}\n              .FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold;}\n              .FormTitle1 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; border-top: black thick solid;}\n              .FormTitle2 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold;}\n              .FormTitle3 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; padding-top: 2em; padding-bottom: 1em;}\n              .SectionTitle {font-size: small; text-align: left; font-family: arial, helvetica, sans-serif; \n              \t\tfont-weight: bold; border-top: gray thin solid; border-bottom: gray thin solid;}\n              .FormName {font-size: large; font-family: arial, helvetica, sans-serif; font-weight: bold;}\n              .CheckBox {text-align: center; width: 5px; cell-spacing: 0; padding: 0 3 0 3; border-width: thin; border-style: solid;  border-color: black:}\n              body {background: white;}\n      </style>\n</head>\n<body>SEC Form 4 \n   <table border=\"0\" cellpadding=\"4\" cellspacing=\"0\" width=\"100%\">\n<tr>\n<td align=\"center\" class=\"FormName\" colspan=\"2\" valign=\"top\" width=\"20%\">FORM 4</td>\n<td align=\"center\" rowspan=\"2\" valign=\"middle\" width=\"60%\">\n<span class=\"FormTitle\">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span><br/><span class=\"MedSmallFormText\">Washington, D.C. 20549</span><br/><br/><span class=\"FormTitle\">STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP</span><br/><br/><span class=\"MedSmallFormText\">Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934</span><br/><span class=\"MedSmallFormText\">or Section 30(h) of the Investment Company Act of 1940</span>\n</td>\n<td align=\"center\" rowspan=\"2\" valign=\"top\" width=\"20%\"><table border=\"1\" summary=\"OMB Approval Status Box\" width=\"100%\">\n<tr><td class=\"FormTextC\">OMB APPROVAL</td></tr>\n<tr><td><table border=\"0\" summary=\"OMB Interior Box\" width=\"100%\">\n<tr>\n<td class=\"SmallFormText\" colspan=\"3\">OMB Number:</td>\n<td class=\"SmallFormTextR\">3235-0287</td>\n</tr>\n<tr><td class=\"SmallFormText\" colspan=\"4\">Estimated average burden</td></tr>\n<tr>\n<td class=\"SmallFormText\" colspan=\"3\">hours per response:</td>\n<td class=\"SmallFormTextR\">0.5</td>\n</tr>\n</table></td></tr>\n</table></td>\n</tr>\n<tr valign=\"middle\">\n<td><table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\"><tr><td>\u00a0\u00a0</td></tr></table></td>\n<td class=\"SmallFormText\">Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. \n         <i>See</i>\n\n         Instruction 1(b).</td>\n</tr>\n</table>\n<table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" width=\"100%\">\n<tr>\n<td rowspan=\"3\" valign=\"top\" width=\"35%\">\n<span class=\"MedSmallFormText\">1. Name and Address of Reporting Person<sup>*</sup></span><table border=\"0\" width=\"100%\"><tr><td><a Marc</a></td></tr></table>\n<hr width=\"98%\"/>\n<table border=\"0\" width=\"100%\"><tr>\n<td class=\"MedSmallFormText\" width=\"33%\">(Last)</td>\n<td class=\"MedSmallFormText\" width=\"33%\">(First)</td>\n<td class=\"MedSmallFormText\" width=\"33%\">(Middle)</td>\n</tr></table>\n<table border=\"0\" width=\"100%\">\n<tr><td><span class=\"FormData\">C/O MYOKARDIA, INC.</span></td></tr>\n<tr><td><span class=\"FormData\">333 ALLERTON AVENUE</span></td></tr>\n</table>\n<hr width=\"98%\"/>\n<span class=\"MedSmallFormText\">(Street)</span><table border=\"0\" width=\"100%\"><tr>\n<td width=\"33%\"><span class=\"FormData\">SOUTH SAN FRANCISCO</span></td>\n<td width=\"33%\"><span class=\"FormData\">CA</span></td>\n<td width=\"33%\"><span class=\"FormData\">94080</span></td>\n</tr></table>\n<hr width=\"98%\"/>\n<table border=\"0\" width=\"100%\"><tr>\n<td class=\"MedSmallFormText\" width=\"33%\">(City)</td>\n<td class=\"MedSmallFormText\" width=\"33%\">(State)</td>\n<td class=\"MedSmallFormText\" width=\"33%\">(Zip)</td>\n</tr></table>\n</td>\n<td valign=\"top\" width=\"35%\">\n<span class=\"MedSmallFormText\">2. Issuer Name <b>and</b> Ticker or Trading Symbol\n      </span><br/><a Inc</a>\n     [ <span class=\"FormData\">MYOK</span> ]\n   </td>\n<td rowspan=\"2\" valign=\"top\">\n<span class=\"MedSmallFormText\">5. Relationship of Reporting Person(s) to Issuer\n      </span><br/><span class=\"MedSmallFormText\">(Check all applicable)</span><table border=\"0\" width=\"100%\">\n<tr>\n<td align=\"center\" width=\"15%\"></td>\n<td class=\"MedSmallFormText\" width=\"35%\">Director</td>\n<td align=\"center\" width=\"15%\"></td>\n<td class=\"MedSmallFormText\" width=\"35%\">10% Owner</td>\n</tr>\n<tr>\n<td align=\"center\"><span class=\"FormData\">X</span></td>\n<td class=\"MedSmallFormText\">Officer (give title below)</td>\n<td align=\"center\"></td>\n<td class=\"MedSmallFormText\">Other (specify below)</td>\n</tr>\n<tr><td align=\"center\" colspan=\"4\"><span class=\"FormData\">Chief Medical Officer</span></td></tr>\n</table>\n</td>\n</tr>\n<tr><td valign=\"top\">\n<span class=\"MedSmallFormText\">3. Date of Earliest Transaction\n         (Month/Day/Year)</span><br/><span class=\"FormData\">09/04/2018</span>\n</td></tr>\n<tr>\n<td valign=\"top\">\n<span class=\"MedSmallFormText\">4. If Amendment, Date of Original Filed\n         (Month/Day/Year)</span><br/>\n</td>\n<td valign=\"top\">\n<span class=\"MedSmallFormText\">6. Individual or Joint/Group Filing (Check Applicable Line)\n      </span><table border=\"0\" width=\"100%\">\n<tr>\n<td align=\"center\" width=\"15%\"><span class=\"FormData\">X</span></td>\n<td class=\"MedSmallFormText\" width=\"85%\">Form filed by One Reporting Person</td>\n</tr>\n<tr>\n<td align=\"center\" width=\"15%\"></td>\n<td class=\"MedSmallFormText\" width=\"85%\">Form filed by More than One Reporting Person</td>\n</tr>\n</table>\n</td>\n</tr>\n</table>\n<table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" width=\"100%\">\n<thead>\n<tr><th align=\"center\" class=\"FormTextC\" colspan=\"11\" valign=\"top\" width=\"100%\"><b>Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned</b></th></tr>\n<tr>\n<th align=\"left\" class=\"MedSmallFormText\" rowspan=\"2\" valign=\"top\" width=\"36%\">1. Title of Security (Instr. \n      3)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"6%\">2. Transaction Date\n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"5%\">2A. Deemed Execution Date, if any\n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"7%\">3. Transaction Code (Instr. \n      8)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"3\" valign=\"top\" width=\"19%\">4. Securities Acquired (A) or Disposed Of (D) (Instr. \n      3, 4 and 5)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"11%\">5. \n      Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. \n      3 and 4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"9%\">6. Ownership Form: Direct (D) or Indirect (I) (Instr. \n      4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"8%\">7. Nature of Indirect Beneficial Ownership (Instr. \n      4)\n   </th>\n</tr>\n<tr>\n<th align=\"center\" class=\"SmallFormText\" width=\"4%\">Code</th>\n<th align=\"center\" class=\"SmallFormText\" width=\"3%\">V</th>\n<th align=\"center\" class=\"SmallFormText\" width=\"8%\">Amount</th>\n<th align=\"center\" class=\"SmallFormText\" width=\"5%\">(A) or (D)</th>\n<th align=\"center\" class=\"SmallFormText\" width=\"6%\">Price</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"><span class=\"FormData\">09/04/2018</span></td>\n<td align=\"center\"><span class=\"FormData\"></span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">M</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">41,400</span></td>\n<td align=\"center\"><span class=\"FormData\">A</span></td>\n<td align=\"center\">\n<span class=\"FormText\">$</span><span class=\"FormData\">15.95</span>\n</td>\n<td align=\"center\"><span class=\"FormData\">41,400</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"left\"></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"><span class=\"FormData\">09/04/2018</span></td>\n<td align=\"center\"><span class=\"FormData\"></span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">S</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">41,400</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"center\">\n<span class=\"FormText\">$</span><span class=\"FormData\">59.4929</span>\n</td>\n<td align=\"center\"><span class=\"FormData\">0</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"left\"></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"><span class=\"FormData\">09/05/2018</span></td>\n<td align=\"center\"><span class=\"FormData\"></span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">M</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">3,600</span></td>\n<td align=\"center\"><span class=\"FormData\">A</span></td>\n<td align=\"center\">\n<span class=\"FormText\">$</span><span class=\"FormData\">15.95</span>\n</td>\n<td align=\"center\"><span class=\"FormData\">3,600</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"left\"></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"><span class=\"FormData\">09/05/2018</span></td>\n<td align=\"center\"><span class=\"FormData\"></span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">S</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">3,600</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"center\">\n<span class=\"FormText\">$</span><span class=\"FormData\">60</span>\n</td>\n<td align=\"center\"><span class=\"FormData\">0</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"left\"></td>\n</tr>\n</tbody>\n</table>\n<table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" width=\"100%\">\n<thead>\n<tr><th align=\"center\" class=\"FormTextC\" colspan=\"16\" valign=\"top\" width=\"100%\">\n<b>Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned</b><br/><b>(e.g., puts, calls, warrants, options, convertible securities)</b>\n</th></tr>\n<tr>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"13%\">1. Title of Derivative Security (Instr. \n      3)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"5%\">2. Conversion or Exercise Price of Derivative Security\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"5%\">3. Transaction Date\n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"5%\">3A. Deemed Execution Date, if any\n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"9%\">4. Transaction Code (Instr. \n      8)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"10%\">5. \n      Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. \n      3, 4 and 5)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"9%\">6. Date Exercisable and Expiration Date \n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"17%\">7. Title and Amount of Securities Underlying Derivative Security (Instr. \n      3 and 4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"6%\">8. Price of Derivative Security (Instr. \n      5)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"6%\">9. \n      Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. \n      4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"6%\">10. Ownership Form: Direct (D) or Indirect (I) (Instr. \n      4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"7%\">11. Nature of Indirect Beneficial Ownership (Instr. \n      4)\n   </th>\n</tr>\n<tr>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"4%\">Code</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"4%\">V</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"5%\">(A)</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"5%\">(D)</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"5%\">Date Exercisable</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"4%\">Expiration Date</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"10%\">Title</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"7%\">Amount or Number of Shares</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td align=\"left\"><span class=\"SmallFormData\">Stock Option (Right to Buy)</span></td>\n<td align=\"center\">\n<span class=\"SmallFormText\">$</span><span class=\"SmallFormData\">15.95</span>\n</td>\n<td align=\"center\"><span class=\"SmallFormData\">09/04/2018</span></td>\n<td align=\"center\"><span class=\"SmallFormData\"></span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">M</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"SmallFormData\">41,400</span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">\n</span><span class=\"FootnoteData\"><sup>(2)</sup></span>\n</td>\n<td align=\"center\"><span class=\"SmallFormData\">11/30/2026</span></td>\n<td align=\"center\"><span class=\"SmallFormData\">Common Stock</span></td>\n<td align=\"center\"><span class=\"FormData\">41,400</span></td>\n<td align=\"center\">\n<span class=\"SmallFormText\">$</span><span class=\"SmallFormData\">0.00</span>\n</td>\n<td align=\"center\"><span class=\"SmallFormData\">133,600</span></td>\n<td align=\"center\"><span class=\"SmallFormData\">D</span></td>\n<td align=\"left\"></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"SmallFormData\">Stock Option (Right to Buy)</span></td>\n<td align=\"center\">\n<span class=\"SmallFormText\">$</span><span class=\"SmallFormData\">15.95</span>\n</td>\n<td align=\"center\"><span class=\"SmallFormData\">09/05/2018</span></td>\n<td align=\"center\"><span class=\"SmallFormData\"></span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">M</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"SmallFormData\">3,600</span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">\n</span><span class=\"FootnoteData\"><sup>(2)</sup></span>\n</td>\n<td align=\"center\"><span class=\"SmallFormData\">11/30/2026</span></td>\n<td align=\"center\"><span class=\"SmallFormData\">Common Stock</span></td>\n<td align=\"center\"><span class=\"FormData\">3,600</span></td>\n<td align=\"center\">\n<span class=\"SmallFormText\">$</span><span class=\"SmallFormData\">0.00</span>\n</td>\n<td align=\"center\"><span class=\"SmallFormData\">130,000</span></td>\n<td align=\"center\"><span class=\"SmallFormData\">D</span></td>\n<td align=\"left\"></td>\n</tr>\n</tbody>\n</table>\n<table border=\"0\" width=\"100%\">\n<tr><td class=\"MedSmallFormText\"><b>Explanation of Responses:</b></td></tr>\n<tr><td class=\"FootnoteData\">1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.</td></tr>\n<tr><td class=\"FootnoteData\">2. 25% of the shares subject to the option vested and became exercisable on December 1, 2017 and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.</td></tr>\n<tr><td class=\"FormText\"><b>Remarks:</b></td></tr>\n<tr><td class=\"FootnoteData\"></td></tr>\n</table>\n<table border=\"0\" width=\"100%\">\n<tr>\n<td width=\"60%\"></td>\n<td width=\"20%\"><u><span class=\"FormData\">Cynthia Ladd, Attorney-in-Fact</span></u></td>\n<td width=\"20%\"><u><span class=\"FormData\">09/06/2018</span></u></td>\n</tr>\n<tr>\n<td></td>\n<td class=\"MedSmallFormText\">** Signature of Reporting Person</td>\n<td class=\"MedSmallFormText\">Date</td>\n</tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\">Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.</td></tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\">* If the form is filed by more than one reporting person, \n                  <i>see</i>\n\n                  Instruction \n                  4\n\n                  (b)(v).</td></tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\">** Intentional misstatements or omissions of facts constitute Federal Criminal Violations \n                  <i>See</i>\n\n                  18 U.S.C. 1001 and 15 U.S.C. 78ff(a).</td></tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\">Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, \n                  <i>see</i>\n\n                  Instruction 6 for procedure.</td></tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\"><b>Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.</b></td></tr>\n</table>\n</body>\n</html>\n"}, "reportNo5": {"reportType": "Form 4", "url": ["https://www.sec.gov/Archives/edgar/data/1413822/000089924318023934/xslF345X03/doc4.xml", "2018-09-06"], "content": {"nameOfOwner": "GIANAKAKOS ANASTASIOS", "position": "President and CEO", "dateOfReport": "2018-09-04", "transaction1": {"classOfStock": "Common Stock", "transactionDate": "2018-09-04", "amount": "3000", "price": "1.5068", "buyOrSell": "A", "ownershipAfterTransaction": "77949"}, "transaction2": {"classOfStock": "Common Stock", "transactionDate": "2018-09-04", "amount": "2500", "price": "59.2095", "buyOrSell": "D", "ownershipAfterTransaction": "75449"}, "transaction3": {"classOfStock": "Common Stock", "transactionDate": "2018-09-04", "amount": "500", "price": "59.96", "buyOrSell": "D", "ownershipAfterTransaction": "74949"}, "transaction4": {"classOfStock": "Stock Option (Right to Buy)", "transactionDate": "2018-09-04", "amount": "3000", "price": "0.00", "buyOrSell": "D", "ownershipAfterTransaction": "111254"}}, "dateOfReport": "2018-09-04", "htmlOfReport": " <!DOCTYPE html PUBLIC \"-//W3C//DTD HTML 4.01 Transitional//EN\" \"http://www.w3.org/TR/html4/loose.dtd\">\n\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<title>SEC FORM \n            4</title>\n<style type=\"text/css\">\n              .FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;}\n              .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;}\n              .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;}\n              .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;}\n              .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;}\n              .FormNumText {font-size: small; font-weight: bold; font-family: arial, helvetica, sans-serif;}\n              .FormAttention {font-size: medium; font-weight: bold; font-family: helvetica;}\n              .FormText {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left;}\n              .FormTextR {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right;}\n              .FormTextC {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center;}\n              .FormEMText {font-size: medium; font-style: italic; font-weight: normal; font-family: arial, helvetica, sans-serif;}\n              .FormULText {font-size: medium; text-decoration: underline; font-weight: normal; font-family: arial, helvetica, sans-serif;}\n              .SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: left;}\n              .SmallFormTextR {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: right;}\n              .SmallFormTextC {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: center;}\n              .MedSmallFormText {font-size: x-small; font-family: arial, helvetica, sans-serif; text-align: left;}\n              .FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold;}\n              .FormTitle1 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; border-top: black thick solid;}\n              .FormTitle2 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold;}\n              .FormTitle3 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; padding-top: 2em; padding-bottom: 1em;}\n              .SectionTitle {font-size: small; text-align: left; font-family: arial, helvetica, sans-serif; \n              \t\tfont-weight: bold; border-top: gray thin solid; border-bottom: gray thin solid;}\n              .FormName {font-size: large; font-family: arial, helvetica, sans-serif; font-weight: bold;}\n              .CheckBox {text-align: center; width: 5px; cell-spacing: 0; padding: 0 3 0 3; border-width: thin; border-style: solid;  border-color: black:}\n              body {background: white;}\n      </style>\n</head>\n<body>SEC Form 4 \n   <table border=\"0\" cellpadding=\"4\" cellspacing=\"0\" width=\"100%\">\n<tr>\n<td align=\"center\" class=\"FormName\" colspan=\"2\" valign=\"top\" width=\"20%\">FORM 4</td>\n<td align=\"center\" rowspan=\"2\" valign=\"middle\" width=\"60%\">\n<span class=\"FormTitle\">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span><br/><span class=\"MedSmallFormText\">Washington, D.C. 20549</span><br/><br/><span class=\"FormTitle\">STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP</span><br/><br/><span class=\"MedSmallFormText\">Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934</span><br/><span class=\"MedSmallFormText\">or Section 30(h) of the Investment Company Act of 1940</span>\n</td>\n<td align=\"center\" rowspan=\"2\" valign=\"top\" width=\"20%\"><table border=\"1\" summary=\"OMB Approval Status Box\" width=\"100%\">\n<tr><td class=\"FormTextC\">OMB APPROVAL</td></tr>\n<tr><td><table border=\"0\" summary=\"OMB Interior Box\" width=\"100%\">\n<tr>\n<td class=\"SmallFormText\" colspan=\"3\">OMB Number:</td>\n<td class=\"SmallFormTextR\">3235-0287</td>\n</tr>\n<tr><td class=\"SmallFormText\" colspan=\"4\">Estimated average burden</td></tr>\n<tr>\n<td class=\"SmallFormText\" colspan=\"3\">hours per response:</td>\n<td class=\"SmallFormTextR\">0.5</td>\n</tr>\n</table></td></tr>\n</table></td>\n</tr>\n<tr valign=\"middle\">\n<td><table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\"><tr><td>\u00a0\u00a0</td></tr></table></td>\n<td class=\"SmallFormText\">Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. \n         <i>See</i>\n\n         Instruction 1(b).</td>\n</tr>\n</table>\n<table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" width=\"100%\">\n<tr>\n<td rowspan=\"3\" valign=\"top\" width=\"35%\">\n<span class=\"MedSmallFormText\">1. Name and Address of Reporting Person<sup>*</sup></span><table border=\"0\" width=\"100%\"><tr><td><a ANASTASIOS</a></td></tr></table>\n<hr width=\"98%\"/>\n<table border=\"0\" width=\"100%\"><tr>\n<td class=\"MedSmallFormText\" width=\"33%\">(Last)</td>\n<td class=\"MedSmallFormText\" width=\"33%\">(First)</td>\n<td class=\"MedSmallFormText\" width=\"33%\">(Middle)</td>\n</tr></table>\n<table border=\"0\" width=\"100%\">\n<tr><td><span class=\"FormData\">C/O MYOKARDIA, INC.</span></td></tr>\n<tr><td><span class=\"FormData\">333 ALLERTON AVENUE</span></td></tr>\n</table>\n<hr width=\"98%\"/>\n<span class=\"MedSmallFormText\">(Street)</span><table border=\"0\" width=\"100%\"><tr>\n<td width=\"33%\"><span class=\"FormData\">SOUTH SAN FRANCISCO</span></td>\n<td width=\"33%\"><span class=\"FormData\">CA</span></td>\n<td width=\"33%\"><span class=\"FormData\">94080</span></td>\n</tr></table>\n<hr width=\"98%\"/>\n<table border=\"0\" width=\"100%\"><tr>\n<td class=\"MedSmallFormText\" width=\"33%\">(City)</td>\n<td class=\"MedSmallFormText\" width=\"33%\">(State)</td>\n<td class=\"MedSmallFormText\" width=\"33%\">(Zip)</td>\n</tr></table>\n</td>\n<td valign=\"top\" width=\"35%\">\n<span class=\"MedSmallFormText\">2. Issuer Name <b>and</b> Ticker or Trading Symbol\n      </span><br/><a Inc</a>\n     [ <span class=\"FormData\">MYOK</span> ]\n   </td>\n<td rowspan=\"2\" valign=\"top\">\n<span class=\"MedSmallFormText\">5. Relationship of Reporting Person(s) to Issuer\n      </span><br/><span class=\"MedSmallFormText\">(Check all applicable)</span><table border=\"0\" width=\"100%\">\n<tr>\n<td align=\"center\" width=\"15%\"><span class=\"FormData\">X</span></td>\n<td class=\"MedSmallFormText\" width=\"35%\">Director</td>\n<td align=\"center\" width=\"15%\"></td>\n<td class=\"MedSmallFormText\" width=\"35%\">10% Owner</td>\n</tr>\n<tr>\n<td align=\"center\"><span class=\"FormData\">X</span></td>\n<td class=\"MedSmallFormText\">Officer (give title below)</td>\n<td align=\"center\"></td>\n<td class=\"MedSmallFormText\">Other (specify below)</td>\n</tr>\n<tr><td align=\"center\" colspan=\"4\"><span class=\"FormData\">President and CEO</span></td></tr>\n</table>\n</td>\n</tr>\n<tr><td valign=\"top\">\n<span class=\"MedSmallFormText\">3. Date of Earliest Transaction\n         (Month/Day/Year)</span><br/><span class=\"FormData\">09/04/2018</span>\n</td></tr>\n<tr>\n<td valign=\"top\">\n<span class=\"MedSmallFormText\">4. If Amendment, Date of Original Filed\n         (Month/Day/Year)</span><br/>\n</td>\n<td valign=\"top\">\n<span class=\"MedSmallFormText\">6. Individual or Joint/Group Filing (Check Applicable Line)\n      </span><table border=\"0\" width=\"100%\">\n<tr>\n<td align=\"center\" width=\"15%\"><span class=\"FormData\">X</span></td>\n<td class=\"MedSmallFormText\" width=\"85%\">Form filed by One Reporting Person</td>\n</tr>\n<tr>\n<td align=\"center\" width=\"15%\"></td>\n<td class=\"MedSmallFormText\" width=\"85%\">Form filed by More than One Reporting Person</td>\n</tr>\n</table>\n</td>\n</tr>\n</table>\n<table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" width=\"100%\">\n<thead>\n<tr><th align=\"center\" class=\"FormTextC\" colspan=\"11\" valign=\"top\" width=\"100%\"><b>Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned</b></th></tr>\n<tr>\n<th align=\"left\" class=\"MedSmallFormText\" rowspan=\"2\" valign=\"top\" width=\"36%\">1. Title of Security (Instr. \n      3)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"6%\">2. Transaction Date\n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"5%\">2A. Deemed Execution Date, if any\n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"7%\">3. Transaction Code (Instr. \n      8)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"3\" valign=\"top\" width=\"19%\">4. Securities Acquired (A) or Disposed Of (D) (Instr. \n      3, 4 and 5)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"11%\">5. \n      Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. \n      3 and 4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"9%\">6. Ownership Form: Direct (D) or Indirect (I) (Instr. \n      4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"8%\">7. Nature of Indirect Beneficial Ownership (Instr. \n      4)\n   </th>\n</tr>\n<tr>\n<th align=\"center\" class=\"SmallFormText\" width=\"4%\">Code</th>\n<th align=\"center\" class=\"SmallFormText\" width=\"3%\">V</th>\n<th align=\"center\" class=\"SmallFormText\" width=\"8%\">Amount</th>\n<th align=\"center\" class=\"SmallFormText\" width=\"5%\">(A) or (D)</th>\n<th align=\"center\" class=\"SmallFormText\" width=\"6%\">Price</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"><span class=\"FormData\">09/04/2018</span></td>\n<td align=\"center\"><span class=\"FormData\"></span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">M</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">3,000</span></td>\n<td align=\"center\"><span class=\"FormData\">A</span></td>\n<td align=\"center\">\n<span class=\"FormText\">$</span><span class=\"FormData\">1.5068</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"><span class=\"FormData\">77,949</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"left\"></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"><span class=\"FormData\">09/04/2018</span></td>\n<td align=\"center\"><span class=\"FormData\"></span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">S</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">2,500</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"center\">\n<span class=\"FormText\">$</span><span class=\"FormData\">59.2095</span><span class=\"FootnoteData\"><sup>(2)</sup></span>\n</td>\n<td align=\"center\"><span class=\"FormData\">75,449</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"left\"></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"><span class=\"FormData\">09/04/2018</span></td>\n<td align=\"center\"><span class=\"FormData\"></span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">S</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">500</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"center\">\n<span class=\"FormText\">$</span><span class=\"FormData\">59.96</span><span class=\"FootnoteData\"><sup>(3)</sup></span>\n</td>\n<td align=\"center\"><span class=\"FormData\">74,949</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"left\"></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">85,973</span></td>\n<td align=\"center\"><span class=\"FormData\">I</span></td>\n<td align=\"left\"><span class=\"FormData\">By Reporting Person's Trust 2</span></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">500,000</span></td>\n<td align=\"center\"><span class=\"FormData\">I</span></td>\n<td align=\"left\"><span class=\"FormData\">By Reporting Person's Trust 3</span></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">12,200</span></td>\n<td align=\"center\"><span class=\"FormData\">I</span></td>\n<td align=\"left\"><span class=\"FormData\">By Trust 1</span></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">12,200</span></td>\n<td align=\"center\"><span class=\"FormData\">I</span></td>\n<td align=\"left\"><span class=\"FormData\">By Trust 2</span></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">12,200</span></td>\n<td align=\"center\"><span class=\"FormData\">I</span></td>\n<td align=\"left\"><span class=\"FormData\">By Trust 3</span></td>\n</tr>\n</tbody>\n</table>\n<table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" width=\"100%\">\n<thead>\n<tr><th align=\"center\" class=\"FormTextC\" colspan=\"16\" valign=\"top\" width=\"100%\">\n<b>Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned</b><br/><b>(e.g., puts, calls, warrants, options, convertible securities)</b>\n</th></tr>\n<tr>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"13%\">1. Title of Derivative Security (Instr. \n      3)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"5%\">2. Conversion or Exercise Price of Derivative Security\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"5%\">3. Transaction Date\n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"5%\">3A. Deemed Execution Date, if any\n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"9%\">4. Transaction Code (Instr. \n      8)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"10%\">5. \n      Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. \n      3, 4 and 5)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"9%\">6. Date Exercisable and Expiration Date \n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"17%\">7. Title and Amount of Securities Underlying Derivative Security (Instr. \n      3 and 4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"6%\">8. Price of Derivative Security (Instr. \n      5)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"6%\">9. \n      Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. \n      4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"6%\">10. Ownership Form: Direct (D) or Indirect (I) (Instr. \n      4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"7%\">11. Nature of Indirect Beneficial Ownership (Instr. \n      4)\n   </th>\n</tr>\n<tr>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"4%\">Code</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"4%\">V</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"5%\">(A)</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"5%\">(D)</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"5%\">Date Exercisable</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"4%\">Expiration Date</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"10%\">Title</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"7%\">Amount or Number of Shares</th>\n</tr>\n</thead>\n<tbody><tr>\n<td align=\"left\"><span class=\"SmallFormData\">Stock Option (Right to Buy)</span></td>\n<td align=\"center\">\n<span class=\"SmallFormText\">$</span><span class=\"SmallFormData\">1.5068</span>\n</td>\n<td align=\"center\"><span class=\"SmallFormData\">09/04/2018</span></td>\n<td align=\"center\"><span class=\"SmallFormData\"></span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">M</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"SmallFormData\">3,000</span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">\n</span><span class=\"FootnoteData\"><sup>(4)</sup></span>\n</td>\n<td align=\"center\"><span class=\"SmallFormData\">06/03/2025</span></td>\n<td align=\"center\"><span class=\"SmallFormData\">Common Stock</span></td>\n<td align=\"center\"><span class=\"FormData\">3,000</span></td>\n<td align=\"center\">\n<span class=\"SmallFormText\">$</span><span class=\"SmallFormData\">0.00</span>\n</td>\n<td align=\"center\"><span class=\"SmallFormData\">111,254</span></td>\n<td align=\"center\"><span class=\"SmallFormData\">D</span></td>\n<td align=\"left\"></td>\n</tr></tbody>\n</table>\n<table border=\"0\" width=\"100%\">\n<tr><td class=\"MedSmallFormText\"><b>Explanation of Responses:</b></td></tr>\n<tr><td class=\"FootnoteData\">1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.</td></tr>\n<tr><td class=\"FootnoteData\">2. Represents the weighted average sale price of the shares sold ranging from $58.65 to $59.60 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.</td></tr>\n<tr><td class=\"FootnoteData\">3. Represents the weighted average sale price of the shares sold ranging from $59.80 to $60.10 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.</td></tr>\n<tr><td class=\"FootnoteData\">4. 25% of the shares subject to the option vested and became exercisable on June 4, 2016, and the remaining shares subject to this option vest and become exercisable in monthly installments through June 4, 2019, subject to the Reporting Person's continuous service to the Issuer through each vesting date.</td></tr>\n<tr><td class=\"FormText\"><b>Remarks:</b></td></tr>\n<tr><td class=\"FootnoteData\"></td></tr>\n</table>\n<table border=\"0\" width=\"100%\">\n<tr>\n<td width=\"60%\"></td>\n<td width=\"20%\"><u><span class=\"FormData\">Cynthia Ladd, Attorney-in-Fact</span></u></td>\n<td width=\"20%\"><u><span class=\"FormData\">09/06/2018</span></u></td>\n</tr>\n<tr>\n<td></td>\n<td class=\"MedSmallFormText\">** Signature of Reporting Person</td>\n<td class=\"MedSmallFormText\">Date</td>\n</tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\">Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.</td></tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\">* If the form is filed by more than one reporting person, \n                  <i>see</i>\n\n                  Instruction \n                  4\n\n                  (b)(v).</td></tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\">** Intentional misstatements or omissions of facts constitute Federal Criminal Violations \n                  <i>See</i>\n\n                  18 U.S.C. 1001 and 15 U.S.C. 78ff(a).</td></tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\">Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, \n                  <i>see</i>\n\n                  Instruction 6 for procedure.</td></tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\"><b>Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.</b></td></tr>\n</table>\n</body>\n</html>\n"}, "reportNo6": {"reportType": "Form 4", "url": ["https://www.sec.gov/Archives/edgar/data/1413822/000089924318021742/xslF345X03/doc4.xml", "2018-08-08"], "content": {"nameOfOwner": "GIANAKAKOS ANASTASIOS", "position": "President and CEO", "dateOfReport": "2018-08-06", "transaction1": {"classOfStock": "Common Stock", "transactionDate": "2018-08-06", "amount": "3000", "price": "1.5068", "buyOrSell": "A", "ownershipAfterTransaction": "77949"}, "transaction2": {"classOfStock": "Common Stock", "transactionDate": "2018-08-06", "amount": "800", "price": "56.975", "buyOrSell": "D", "ownershipAfterTransaction": "77149"}, "transaction3": {"classOfStock": "Common Stock", "transactionDate": "2018-08-06", "amount": "2200", "price": "57.65", "buyOrSell": "D", "ownershipAfterTransaction": "74949"}, "transaction4": {"classOfStock": "Stock Option (Right to Buy)", "transactionDate": "2018-08-06", "amount": "3000", "price": "0.00", "buyOrSell": "D", "ownershipAfterTransaction": "114254"}}, "dateOfReport": "2018-08-06", "htmlOfReport": " <!DOCTYPE html PUBLIC \"-//W3C//DTD HTML 4.01 Transitional//EN\" \"http://www.w3.org/TR/html4/loose.dtd\">\n\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<title>SEC FORM \n            4</title>\n<style type=\"text/css\">\n              .FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;}\n              .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;}\n              .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;}\n              .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;}\n              .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;}\n              .FormNumText {font-size: small; font-weight: bold; font-family: arial, helvetica, sans-serif;}\n              .FormAttention {font-size: medium; font-weight: bold; font-family: helvetica;}\n              .FormText {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left;}\n              .FormTextR {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right;}\n              .FormTextC {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center;}\n              .FormEMText {font-size: medium; font-style: italic; font-weight: normal; font-family: arial, helvetica, sans-serif;}\n              .FormULText {font-size: medium; text-decoration: underline; font-weight: normal; font-family: arial, helvetica, sans-serif;}\n              .SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: left;}\n              .SmallFormTextR {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: right;}\n              .SmallFormTextC {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: center;}\n              .MedSmallFormText {font-size: x-small; font-family: arial, helvetica, sans-serif; text-align: left;}\n              .FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold;}\n              .FormTitle1 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; border-top: black thick solid;}\n              .FormTitle2 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold;}\n              .FormTitle3 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; padding-top: 2em; padding-bottom: 1em;}\n              .SectionTitle {font-size: small; text-align: left; font-family: arial, helvetica, sans-serif; \n              \t\tfont-weight: bold; border-top: gray thin solid; border-bottom: gray thin solid;}\n              .FormName {font-size: large; font-family: arial, helvetica, sans-serif; font-weight: bold;}\n              .CheckBox {text-align: center; width: 5px; cell-spacing: 0; padding: 0 3 0 3; border-width: thin; border-style: solid;  border-color: black:}\n              body {background: white;}\n      </style>\n</head>\n<body>SEC Form 4 \n   <table border=\"0\" cellpadding=\"4\" cellspacing=\"0\" width=\"100%\">\n<tr>\n<td align=\"center\" class=\"FormName\" colspan=\"2\" valign=\"top\" width=\"20%\">FORM 4</td>\n<td align=\"center\" rowspan=\"2\" valign=\"middle\" width=\"60%\">\n<span class=\"FormTitle\">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span><br/><span class=\"MedSmallFormText\">Washington, D.C. 20549</span><br/><br/><span class=\"FormTitle\">STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP</span><br/><br/><span class=\"MedSmallFormText\">Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934</span><br/><span class=\"MedSmallFormText\">or Section 30(h) of the Investment Company Act of 1940</span>\n</td>\n<td align=\"center\" rowspan=\"2\" valign=\"top\" width=\"20%\"><table border=\"1\" summary=\"OMB Approval Status Box\" width=\"100%\">\n<tr><td class=\"FormTextC\">OMB APPROVAL</td></tr>\n<tr><td><table border=\"0\" summary=\"OMB Interior Box\" width=\"100%\">\n<tr>\n<td class=\"SmallFormText\" colspan=\"3\">OMB Number:</td>\n<td class=\"SmallFormTextR\">3235-0287</td>\n</tr>\n<tr><td class=\"SmallFormText\" colspan=\"4\">Estimated average burden</td></tr>\n<tr>\n<td class=\"SmallFormText\" colspan=\"3\">hours per response:</td>\n<td class=\"SmallFormTextR\">0.5</td>\n</tr>\n</table></td></tr>\n</table></td>\n</tr>\n<tr valign=\"middle\">\n<td><table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\"><tr><td>\u00a0\u00a0</td></tr></table></td>\n<td class=\"SmallFormText\">Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. \n         <i>See</i>\n\n         Instruction 1(b).</td>\n</tr>\n</table>\n<table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" width=\"100%\">\n<tr>\n<td rowspan=\"3\" valign=\"top\" width=\"35%\">\n<span class=\"MedSmallFormText\">1. Name and Address of Reporting Person<sup>*</sup></span><table border=\"0\" width=\"100%\"><tr><td><a ANASTASIOS</a></td></tr></table>\n<hr width=\"98%\"/>\n<table border=\"0\" width=\"100%\"><tr>\n<td class=\"MedSmallFormText\" width=\"33%\">(Last)</td>\n<td class=\"MedSmallFormText\" width=\"33%\">(First)</td>\n<td class=\"MedSmallFormText\" width=\"33%\">(Middle)</td>\n</tr></table>\n<table border=\"0\" width=\"100%\">\n<tr><td><span class=\"FormData\">C/O MYOKARDIA, INC.</span></td></tr>\n<tr><td><span class=\"FormData\">333 ALLERTON AVENUE</span></td></tr>\n</table>\n<hr width=\"98%\"/>\n<span class=\"MedSmallFormText\">(Street)</span><table border=\"0\" width=\"100%\"><tr>\n<td width=\"33%\"><span class=\"FormData\">SOUTH SAN FRANCISCO</span></td>\n<td width=\"33%\"><span class=\"FormData\">CA</span></td>\n<td width=\"33%\"><span class=\"FormData\">94080</span></td>\n</tr></table>\n<hr width=\"98%\"/>\n<table border=\"0\" width=\"100%\"><tr>\n<td class=\"MedSmallFormText\" width=\"33%\">(City)</td>\n<td class=\"MedSmallFormText\" width=\"33%\">(State)</td>\n<td class=\"MedSmallFormText\" width=\"33%\">(Zip)</td>\n</tr></table>\n</td>\n<td valign=\"top\" width=\"35%\">\n<span class=\"MedSmallFormText\">2. Issuer Name <b>and</b> Ticker or Trading Symbol\n      </span><br/><a Inc</a>\n     [ <span class=\"FormData\">MYOK</span> ]\n   </td>\n<td rowspan=\"2\" valign=\"top\">\n<span class=\"MedSmallFormText\">5. Relationship of Reporting Person(s) to Issuer\n      </span><br/><span class=\"MedSmallFormText\">(Check all applicable)</span><table border=\"0\" width=\"100%\">\n<tr>\n<td align=\"center\" width=\"15%\"><span class=\"FormData\">X</span></td>\n<td class=\"MedSmallFormText\" width=\"35%\">Director</td>\n<td align=\"center\" width=\"15%\"></td>\n<td class=\"MedSmallFormText\" width=\"35%\">10% Owner</td>\n</tr>\n<tr>\n<td align=\"center\"><span class=\"FormData\">X</span></td>\n<td class=\"MedSmallFormText\">Officer (give title below)</td>\n<td align=\"center\"></td>\n<td class=\"MedSmallFormText\">Other (specify below)</td>\n</tr>\n<tr><td align=\"center\" colspan=\"4\"><span class=\"FormData\">President and CEO</span></td></tr>\n</table>\n</td>\n</tr>\n<tr><td valign=\"top\">\n<span class=\"MedSmallFormText\">3. Date of Earliest Transaction\n         (Month/Day/Year)</span><br/><span class=\"FormData\">08/06/2018</span>\n</td></tr>\n<tr>\n<td valign=\"top\">\n<span class=\"MedSmallFormText\">4. If Amendment, Date of Original Filed\n         (Month/Day/Year)</span><br/>\n</td>\n<td valign=\"top\">\n<span class=\"MedSmallFormText\">6. Individual or Joint/Group Filing (Check Applicable Line)\n      </span><table border=\"0\" width=\"100%\">\n<tr>\n<td align=\"center\" width=\"15%\"><span class=\"FormData\">X</span></td>\n<td class=\"MedSmallFormText\" width=\"85%\">Form filed by One Reporting Person</td>\n</tr>\n<tr>\n<td align=\"center\" width=\"15%\"></td>\n<td class=\"MedSmallFormText\" width=\"85%\">Form filed by More than One Reporting Person</td>\n</tr>\n</table>\n</td>\n</tr>\n</table>\n<table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" width=\"100%\">\n<thead>\n<tr><th align=\"center\" class=\"FormTextC\" colspan=\"11\" valign=\"top\" width=\"100%\"><b>Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned</b></th></tr>\n<tr>\n<th align=\"left\" class=\"MedSmallFormText\" rowspan=\"2\" valign=\"top\" width=\"36%\">1. Title of Security (Instr. \n      3)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"6%\">2. Transaction Date\n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"5%\">2A. Deemed Execution Date, if any\n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"7%\">3. Transaction Code (Instr. \n      8)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"3\" valign=\"top\" width=\"19%\">4. Securities Acquired (A) or Disposed Of (D) (Instr. \n      3, 4 and 5)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"11%\">5. \n      Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. \n      3 and 4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"9%\">6. Ownership Form: Direct (D) or Indirect (I) (Instr. \n      4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"8%\">7. Nature of Indirect Beneficial Ownership (Instr. \n      4)\n   </th>\n</tr>\n<tr>\n<th align=\"center\" class=\"SmallFormText\" width=\"4%\">Code</th>\n<th align=\"center\" class=\"SmallFormText\" width=\"3%\">V</th>\n<th align=\"center\" class=\"SmallFormText\" width=\"8%\">Amount</th>\n<th align=\"center\" class=\"SmallFormText\" width=\"5%\">(A) or (D)</th>\n<th align=\"center\" class=\"SmallFormText\" width=\"6%\">Price</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"><span class=\"FormData\">08/06/2018</span></td>\n<td align=\"center\"><span class=\"FormData\"></span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">M</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">3,000</span></td>\n<td align=\"center\"><span class=\"FormData\">A</span></td>\n<td align=\"center\">\n<span class=\"FormText\">$</span><span class=\"FormData\">1.5068</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"><span class=\"FormData\">77,949</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"left\"></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"><span class=\"FormData\">08/06/2018</span></td>\n<td align=\"center\"><span class=\"FormData\"></span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">S</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">800</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"center\">\n<span class=\"FormText\">$</span><span class=\"FormData\">56.975</span><span class=\"FootnoteData\"><sup>(2)</sup></span>\n</td>\n<td align=\"center\"><span class=\"FormData\">77,149</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"left\"></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"><span class=\"FormData\">08/06/2018</span></td>\n<td align=\"center\"><span class=\"FormData\"></span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">S</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">2,200</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"center\">\n<span class=\"FormText\">$</span><span class=\"FormData\">57.65</span><span class=\"FootnoteData\"><sup>(3)</sup></span>\n</td>\n<td align=\"center\"><span class=\"FormData\">74,949</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"left\"></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">85,973</span></td>\n<td align=\"center\"><span class=\"FormData\">I</span></td>\n<td align=\"left\"><span class=\"FormData\">By Reporting Person's Trust 2</span></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">500,000</span></td>\n<td align=\"center\"><span class=\"FormData\">I</span></td>\n<td align=\"left\"><span class=\"FormData\">By Reporting Person's Trust 3</span></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">12,200</span></td>\n<td align=\"center\"><span class=\"FormData\">I</span></td>\n<td align=\"left\"><span class=\"FormData\">By Trust 1</span></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">12,200</span></td>\n<td align=\"center\"><span class=\"FormData\">I</span></td>\n<td align=\"left\"><span class=\"FormData\">By Trust 2</span></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">12,200</span></td>\n<td align=\"center\"><span class=\"FormData\">I</span></td>\n<td align=\"left\"><span class=\"FormData\">By Trust 3</span></td>\n</tr>\n</tbody>\n</table>\n<table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" width=\"100%\">\n<thead>\n<tr><th align=\"center\" class=\"FormTextC\" colspan=\"16\" valign=\"top\" width=\"100%\">\n<b>Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned</b><br/><b>(e.g., puts, calls, warrants, options, convertible securities)</b>\n</th></tr>\n<tr>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"13%\">1. Title of Derivative Security (Instr. \n      3)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"5%\">2. Conversion or Exercise Price of Derivative Security\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"5%\">3. Transaction Date\n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"5%\">3A. Deemed Execution Date, if any\n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"9%\">4. Transaction Code (Instr. \n      8)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"10%\">5. \n      Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. \n      3, 4 and 5)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"9%\">6. Date Exercisable and Expiration Date \n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"17%\">7. Title and Amount of Securities Underlying Derivative Security (Instr. \n      3 and 4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"6%\">8. Price of Derivative Security (Instr. \n      5)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"6%\">9. \n      Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. \n      4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"6%\">10. Ownership Form: Direct (D) or Indirect (I) (Instr. \n      4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"7%\">11. Nature of Indirect Beneficial Ownership (Instr. \n      4)\n   </th>\n</tr>\n<tr>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"4%\">Code</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"4%\">V</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"5%\">(A)</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"5%\">(D)</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"5%\">Date Exercisable</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"4%\">Expiration Date</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"10%\">Title</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"7%\">Amount or Number of Shares</th>\n</tr>\n</thead>\n<tbody><tr>\n<td align=\"left\"><span class=\"SmallFormData\">Stock Option (Right to Buy)</span></td>\n<td align=\"center\">\n<span class=\"SmallFormText\">$</span><span class=\"SmallFormData\">1.5068</span>\n</td>\n<td align=\"center\"><span class=\"SmallFormData\">08/06/2018</span></td>\n<td align=\"center\"><span class=\"SmallFormData\"></span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">M</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"SmallFormData\">3,000</span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">\n</span><span class=\"FootnoteData\"><sup>(4)</sup></span>\n</td>\n<td align=\"center\"><span class=\"SmallFormData\">06/03/2025</span></td>\n<td align=\"center\"><span class=\"SmallFormData\">Common Stock</span></td>\n<td align=\"center\"><span class=\"FormData\">3,000</span></td>\n<td align=\"center\">\n<span class=\"SmallFormText\">$</span><span class=\"SmallFormData\">0.00</span>\n</td>\n<td align=\"center\"><span class=\"SmallFormData\">114,254</span></td>\n<td align=\"center\"><span class=\"SmallFormData\">D</span></td>\n<td align=\"left\"></td>\n</tr></tbody>\n</table>\n<table border=\"0\" width=\"100%\">\n<tr><td class=\"MedSmallFormText\"><b>Explanation of Responses:</b></td></tr>\n<tr><td class=\"FootnoteData\">1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.</td></tr>\n<tr><td class=\"FootnoteData\">2. Represents the weighted average sale price of the shares sold ranging from $56.30 to $57.25 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.</td></tr>\n<tr><td class=\"FootnoteData\">3. Represents the weighted average sale price of the shares sold ranging from $57.40 to $58.05 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.</td></tr>\n<tr><td class=\"FootnoteData\">4. 25% of the shares subject to the option vested and became exercisable on June 4, 2016, and the remaining shares subject to this option vest and become exercisable in monthly installments through June 4, 2019, subject to the Reporting Person's continuous service to the Issuer through each vesting date.</td></tr>\n<tr><td class=\"FormText\"><b>Remarks:</b></td></tr>\n<tr><td class=\"FootnoteData\"></td></tr>\n</table>\n<table border=\"0\" width=\"100%\">\n<tr>\n<td width=\"60%\"></td>\n<td width=\"20%\"><u><span class=\"FormData\">/s/ Cynthia Ladd, Attorney-in-Fact</span></u></td>\n<td width=\"20%\"><u><span class=\"FormData\">08/08/2018</span></u></td>\n</tr>\n<tr>\n<td></td>\n<td class=\"MedSmallFormText\">** Signature of Reporting Person</td>\n<td class=\"MedSmallFormText\">Date</td>\n</tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\">Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.</td></tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\">* If the form is filed by more than one reporting person, \n                  <i>see</i>\n\n                  Instruction \n                  4\n\n                  (b)(v).</td></tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\">** Intentional misstatements or omissions of facts constitute Federal Criminal Violations \n                  <i>See</i>\n\n                  18 U.S.C. 1001 and 15 U.S.C. 78ff(a).</td></tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\">Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, \n                  <i>see</i>\n\n                  Instruction 6 for procedure.</td></tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\"><b>Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.</b></td></tr>\n</table>\n</body>\n</html>\n"}, "reportNo7": {"reportType": "10-Q", "url": "https://www.sec.gov/Archives/edgar/data/1552451/000156459018020521/myok-10q_20180630.htm", "dateOfReport": "2018-08-08", "content": {"isInThousands": "true", "isInMillions": "false", "balanceSheetTableCode": "<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">June 30,</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2018</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">December 31,</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">As\u00a0Revised\u00a0(Note\u00a02)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Assets</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Current assets</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Cash and cash equivalents</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">346,827</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">224,571</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Short-term investments</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">51,766</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">31,933</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Receivable from collaboration partner</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">1,013</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Prepaid expenses and other current assets</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">2,604</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">1,876</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Total current assets</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">401,197</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">259,393</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Property and equipment, net</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">4,883</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">3,147</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Long-term investments</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">27,648</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">19,900</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Other long-term assets</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">426</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">368</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Total assets</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">434,154</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">282,808</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Liabilities and stockholders\u2019 equity</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Current liabilities</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Accounts payable</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">2,766</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">2,301</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Accrued liabilities</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">13,553</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">11,639</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Prepayment from collaboration partner</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">9,115</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">4,432</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Deferred revenue</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">21,588</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">33,558</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Total current liabilities</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">47,022</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">51,930</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Other long-term liabilities</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">99</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">202</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Total liabilities</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">47,121</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">52,132</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Commitments and contingencies (Note 6)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Stockholders\u2019 equity</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Preferred stock, $0.0001 par value; 5,000,000 shares authorized; none</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0\u00a0 issued and outstanding</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Common stock, $0.0001 par value, 150,000,000 and 150,000,000</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0\u00a0 shares authorized at June 30, 2018 and December 31, 2017,</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0\u00a0 respectively; 40,049,160 and 35,812,791 shares issued and outstanding</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0\u00a0 at June 30, 2018 and December 31, 2017, respectively</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">4</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">4</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Additional paid-in capital</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">558,376</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">365,719</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Accumulated other comprehensive loss</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(259</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(192</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Accumulated deficit</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(171,088</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(134,855</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Total stockholders\u2019 equity</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">387,033</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">230,676</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Total liabilities and stockholders\u2019 equity</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">434,154</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">282,808</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n</table>", "operationsTableCode": "<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"6\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Three Months Ended</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">June 30,</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"6\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Six Months Ended</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">June 30,</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2018</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2018</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">As\u00a0Revised\u00a0(Note\u00a02)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">As\u00a0Revised\u00a0(Note\u00a02)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Collaboration and license revenue</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">6,639</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">3,001</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">11,970</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">5,411</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Operating expenses:</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Research and development</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">17,218</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">13,689</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">33,836</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">25,606</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">General and administrative</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">8,912</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">5,082</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">16,225</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">10,558</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Total operating expenses</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">26,130</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">18,771</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">50,061</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">36,164</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Loss from operations</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(19,491</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(15,770</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(38,091</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(30,753</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Interest and other income, net</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">1,078</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">309</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">1,858</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">530</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Net loss</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(18,413</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(15,461</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(36,233</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(30,223</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Other comprehensive income (loss)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">70</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(3</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(67</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(58</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Comprehensive loss</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(18,343</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(15,464</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(36,300</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(30,281</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Net loss attributable to common stockholders</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(18,413</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(15,461</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(36,233</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(30,223</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Net loss per share attributable to common stockholders, basic</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0\u00a0 and diluted</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(0.49</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(0.50</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(0.99</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(0.97</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Weighted average number of shares used to compute net loss</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0\u00a0 per share attributable to common stockholders, basic and diluted</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">37,440,024</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">31,200,773</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">36,620,747</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">31,151,216</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n</table>", "warrantsTableCode": "False", "cashFlowTable": "<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"6\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Six Months Ended</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">June 30,</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2018</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">As\u00a0Revised\u00a0(Note\u00a02)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Cash flow from operating activities:</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Net loss</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(36,233</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(30,223</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Adjustments to reconcile net loss to net cash (used in) provided by operating activities:</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Stock-based compensation expense</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">8,413</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">2,746</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Depreciation</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">723</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">634</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Amortization of premiums on investments</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(53</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">41</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Change in operating assets and liabilities:</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Receivable from collaboration partner</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">1,013</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">45,000</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Prepaid expenses and other current assets</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(728</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">152</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Other long-term assets</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(58</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(80</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Accounts payable</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">698</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(488</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Accrued liabilities</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">1,388</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">1,470</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Prepayment from collaboration partner</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">4,683</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Other long-term liabilities</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(88</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(86</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Deferred revenue</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(11,970</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(5,411</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Net cash (used in) provided by operating activities</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(32,212</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">13,755</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Cash flow from investing activities:</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Purchases of investments</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(39,595</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(36,022</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Sales of investments</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">4,000</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Maturities of investments</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">12,000</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Purchases of property and equipment</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(2,356</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(617</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Net cash (used in) investing activities</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(29,951</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(32,639</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Cash flow from financing activities:</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Proceeds from issuance of common stock during follow-on offerings,</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0\u00a0 net of issuance costs</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">182,450</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Payments of financing-related costs</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(381</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(38</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Proceeds from exercise of stock options and employee stock purchase plan</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">2,350</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">430</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Net cash provided by financing activities</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">184,419</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">392</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Net increase (decrease) in cash, cash equivalents and restricted cash</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">122,256</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(18,492</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Cash, cash equivalents and restricted cash, beginning of period</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">224,857</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">136,056</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Cash, cash equivalents and restricted cash, end of period</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">347,113</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">117,564</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Non-cash investing and financing activities:</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Vesting of early exercised options and restricted stock</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">32</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">99</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Unpaid financing-related costs</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">206</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Unpaid portion of property and equipment purchases included in</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0\u00a0 period-end accounts payable and accrued liabilities</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">386</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">218</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n</table>"}, "htmlOfReport": " <document>\n<type>10-Q\n<sequence>1\n<filename>myok-10q_20180630.htm\n<description>10-Q\n<text>\n<!DOCTYPE HTML PUBLIC \"-//W3C//DTD HTML 4.01 Transitional//EN\" \"http://www.w3.org/TR/html4/loose.dtd\">\n\n<html>\n<head>\n<title>\nmyok-10q_20180630.htm\n</title>\n</head>\n<!-- NG Converter v5.0.18157.137 -->\n<body>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p>\n<p style=\"border-bottom:Double 2.25pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:1pt;\">\u00a0</p>\n<p style=\"text-align:center;margin-top:4pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">UNITED STATES</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">SECURITIES AND EXCHANGE COMMISSION</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">WASHINGTON, DC 20549</p>\n<p style=\"margin-bottom:0pt;text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;\">\u00a0</p>\n<p style=\"text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">FORM 10-Q</p>\n<p style=\"margin-bottom:0pt;text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;\">\u00a0</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(Mark One)</p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';\"><font style=\"font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';\"></font><font style=\"font-size:10pt;font-family:'Times New Roman'\">\u2612</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;\">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p></td></tr></table></div>\n<p style=\"text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">For the quarterly period ended June 30, 2018</p>\n<p style=\"text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">or</p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';\"><font style=\"font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';\"></font><font style=\"font-size:10pt;font-family:'Times New Roman'\">\u2610</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;\">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p></td></tr></table></div>\n<p style=\"text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">For the transition period from \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 to \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0</p>\n<p style=\"text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Commission File Number: 001-37609</p>\n<p style=\"text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">MYOKARDIA, INC.</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(Exact name of registrant as specified in its charter)</p>\n<p style=\"margin-bottom:0pt;text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:49%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Delaware</p></td>\n<td style=\"width:2%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:49%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">44-5500552</p></td>\n</tr>\n<tr>\n<td style=\"width:49%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(State or other jurisdiction of</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">incorporation or organization)</p></td>\n<td style=\"width:2%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:49%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(I.R.S. Employer</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Identification No.)</p></td>\n</tr>\n</table></div>\n<p style=\"text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">333 Allerton Ave.</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">South San Francisco, CA</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(Address of principal executive offices)</p>\n<p style=\"text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">94080</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(Zip Code)</p>\n<p style=\"text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(650) 741-0900</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(Registrant\u2019s telephone number, including area code)</p>\n<p style=\"margin-bottom:0pt;text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;\">\u00a0</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Indicate by check mark whether the registrant (1)\u00a0has filed all reports required to be filed by Section\u00a013 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)\u00a0has been subject to such filing requirements for the past 90 days.\u00a0Yes\u00a0<font style=\"font-family:'Times New Roman';\"><font style=\"font-size:9pt;font-family:'Times New Roman'\">\u2612</font></font>\u00a0No\u00a0<font style=\"font-family:'Times New Roman';\"><font style=\"font-size:9pt;font-family:'Times New Roman'\">\u2610</font></font></p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (\u00a7232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).\u00a0Yes\u00a0<font style=\"font-family:'Times New Roman';\"><font style=\"font-size:9pt;font-family:'Times New Roman'\">\u2612</font></font>\u00a0No\u00a0<font style=\"font-family:'Times New Roman';\"><font style=\"font-size:9pt;font-family:'Times New Roman'\">\u2610</font></font></p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of \u201clarge accelerated filer,\u201d \u201caccelerated filer,\u201d \u201csmaller reporting company,\u201d and \u201cemerging growth company\u201d in Rule 12b-2 of the Exchange Act.</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:20.56%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Large\u00a0accelerated\u00a0filer</p></td>\n<td style=\"width:1.14%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td style=\"width:51.96%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';\"><font style=\"font-size:9pt;font-family:'Times New Roman'\">\u2610</font></p></td>\n<td style=\"width:1.02%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0\u00a0</p></td>\n<td style=\"width:22.32%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Accelerated\u00a0filer</p></td>\n<td style=\"width:1.02%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td style=\"width:1.98%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';\"><font style=\"font-size:9pt;font-family:'Times New Roman'\">\u2612</font></p></td>\n</tr>\n<tr>\n<td style=\"width:20.56%;\" valign=\"bottom\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Non-accelerated filer</p></td>\n<td style=\"width:1.14%;\" valign=\"bottom\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td style=\"width:51.96%;\" valign=\"bottom\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';\"><font style=\"font-size:9pt;font-family:'Times New Roman'\">\u2610</font><font style=\"font-family:Times New Roman;\">\u00a0\u00a0(Do not check if a smaller reporting company)</font></p></td>\n<td style=\"width:1.02%;\" valign=\"bottom\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0\u00a0</p></td>\n<td style=\"width:22.32%;\" valign=\"bottom\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Smaller\u00a0reporting\u00a0company</p></td>\n<td style=\"width:1.02%;\" valign=\"bottom\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td style=\"width:1.98%;\" valign=\"bottom\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';\"><font style=\"font-size:9pt;font-family:'Times New Roman'\">\u2610</font></p></td>\n</tr>\n<tr>\n<td style=\"width:20.56%;\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Emerging growth company\u00a0\u00a0\u00a0\u00a0 </p></td>\n<td style=\"width:1.14%;\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;\">\u00a0</p></td>\n<td style=\"width:51.96%;\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';\"><font style=\"font-size:9pt;font-family:'Times New Roman'\">\u2612</font></p></td>\n<td style=\"width:1.02%;\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;\">\u00a0</p></td>\n<td style=\"width:22.32%;\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;\">\u00a0</p></td>\n<td style=\"width:1.02%;\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;\">\u00a0</p></td>\n<td style=\"width:1.98%;\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;\">\u00a0</p></td>\n</tr>\n</table></div>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.\u00a0\u00a0\u00a0\u00a0 <font style=\"color:#000000;font-family:'Times New Roman';\"><font style=\"font-size:9pt;font-family:'Times New Roman'\">\u2612</font></font></p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).\u00a0Yes\u00a0<font style=\"font-family:'Times New Roman';\"><font style=\"font-size:9pt;font-family:'Times New Roman'\">\u2610</font></font>\u00a0No\u00a0<font style=\"font-family:'Times New Roman';\"><font style=\"font-size:9pt;font-family:'Times New Roman'\">\u2612</font></font></p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The number of outstanding shares of the registrant\u2019s common stock on August 5, 2018 was 40,115,401 shares.</p>\n<p style=\"border-bottom:Double 2.25pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU2\"></a><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">MYOKARDIA, INC.</font></p>\n<p style=\"text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">TABLE OF CONTENTS</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:96%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td colspan=\"2\" style=\"width:4%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Page</p></td>\n</tr>\n<tr>\n<td style=\"width:96%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a style=\"text-decoration:underline;\">PART I\u2014FINANCIAL INFORMATION</font></a><font style=\"font-weight:normal;\"></font></p></td>\n<td style=\"width:1%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td style=\"width:3%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">3</p></td>\n</tr>\n<tr>\n<td style=\"width:96%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:28.6pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a style=\"text-decoration:underline;\">Item\u00a01. Condensed Consolidated Financial Statements</font></a></p></td>\n<td style=\"width:1%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td style=\"width:3%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">3</p></td>\n</tr>\n<tr>\n<td style=\"width:96%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:48.4pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a style=\"text-decoration:underline;\">Condensed Consolidated Balance Sheets as of June 30, 2018 and December 31, 2017 (unaudited)</font></a></p></td>\n<td style=\"width:1%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td style=\"width:3%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">3</p></td>\n</tr>\n<tr>\n<td style=\"width:96%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:60.5pt;;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a style=\"text-decoration:underline;\">Condensed Consolidated Statements of Operations and Comprehensive Loss for the three and six months ended June 30, 2018 and 2017 (unaudited)</font></a></p></td>\n<td style=\"width:1%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td style=\"width:3%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">4</p></td>\n</tr>\n<tr>\n<td style=\"width:96%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:60.5pt;;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a style=\"text-decoration:underline;\">Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2018 and 2017 (unaudited)</font></a></p></td>\n<td style=\"width:1%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td style=\"width:3%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">5</p></td>\n</tr>\n<tr>\n<td style=\"width:96%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:48.4pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a style=\"text-decoration:underline;\">Notes to Condensed Consolidated Financial Statements (unaudited)</font></a></p></td>\n<td style=\"width:1%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td style=\"width:3%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">6</p></td>\n</tr>\n<tr>\n<td style=\"width:96%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:28.6pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a style=\"text-decoration:underline;\">Item\u00a02. Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations</font></a></p></td>\n<td style=\"width:1%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td style=\"width:3%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">20</p></td>\n</tr>\n<tr>\n<td style=\"width:96%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:28.6pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a style=\"text-decoration:underline;\">Item\u00a03. Quantitative and Qualitative Disclosures About Market Risk</font></a></p></td>\n<td style=\"width:1%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:3%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">27</p></td>\n</tr>\n<tr>\n<td style=\"width:96%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:28.6pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a style=\"text-decoration:underline;\">Item\u00a04. Controls and Procedures</font></a></p></td>\n<td style=\"width:1%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:3%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">27</p></td>\n</tr>\n<tr>\n<td style=\"width:96%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a style=\"text-decoration:underline;\">PART II\u2014OTHER INFORMATION</font></a><font style=\"font-weight:normal;\"></font></p></td>\n<td style=\"width:1%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td style=\"width:3%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">28</p></td>\n</tr>\n<tr>\n<td style=\"width:96%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:28.6pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a style=\"text-decoration:underline;\">Item\u00a01. Legal Proceedings</font></a></p></td>\n<td style=\"width:1%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td style=\"width:3%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">28</p></td>\n</tr>\n<tr>\n<td style=\"width:96%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:28.6pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a style=\"text-decoration:underline;\">Item\u00a01A. Risk Factors</font></a></p></td>\n<td style=\"width:1%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td style=\"width:3%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">28</p></td>\n</tr>\n<tr>\n<td style=\"width:96%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:28.6pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a style=\"text-decoration:underline;\">Item\u00a02. Unregistered Sales of Equity Securities and Use of Proceeds</font></a></p></td>\n<td style=\"width:1%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td style=\"width:3%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">58</p></td>\n</tr>\n<tr>\n<td style=\"width:96%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:28.6pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a style=\"text-decoration:underline;\">Item\u00a03. Defaults Upon Senior Securities</font></a></p></td>\n<td style=\"width:1%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td style=\"width:3%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">58</p></td>\n</tr>\n<tr>\n<td style=\"width:96%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:28.6pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a style=\"text-decoration:underline;\">Item\u00a04. Mine Safety Disclosures</font></a></p></td>\n<td style=\"width:1%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td style=\"width:3%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">58</p></td>\n</tr>\n<tr>\n<td style=\"width:96%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:28.6pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a style=\"text-decoration:underline;\">Item\u00a05. Other Information</font></a></p></td>\n<td style=\"width:1%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td style=\"width:3%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">58</p></td>\n</tr>\n<tr>\n<td style=\"width:96%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:28.6pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a style=\"text-decoration:underline;\">Item\u00a06. Exhibits</font></a></p></td>\n<td style=\"width:1%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td style=\"width:3%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">59</p></td>\n</tr>\n<tr>\n<td style=\"width:96%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a style=\"text-decoration:underline;\">EXHIBIT INDEX</font></a><font style=\"font-weight:normal;\"></font></p></td>\n<td style=\"width:1%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:3%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">59</p></td>\n</tr>\n<tr>\n<td style=\"width:96%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a style=\"text-decoration:underline;\">SIGNATURES</font></a><font style=\"font-weight:normal;\"></font></p></td>\n<td style=\"width:1%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:3%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">60</p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">2</p></body></html></text></description></filename></sequence></type></document>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU3\"></a><a name=\"PART_IFINANCIAL_INFORMATION\"></a><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"PART_IFINANCIAL_INFORMATION\"></a>PART I\u2014FINANCI</font><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">AL INFORMATION </font></p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;\">\u00a0</p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:10.27%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Item\u00a01.</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;\"><a name=\"ITEM_1_FINANCIAL_STATEMENTS\"></a><a name=\"ITEM_1_FINANCIAL_STATEMENTS\"></a>Condensed Consolidated Financial Statements</p></td></tr></table></div>\n<p style=\"text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">MYOKARDIA, INC.</p>\n<p style=\"text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"CONDENSED_CONSOLIDATED_BALANCE_SHEETS\"></a><a name=\"CONDENSED_CONSOLIDATED_BALANCE_SHEETS\"></a>Condensed Consolidated Balance Sheets</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(In thousands, except share and per share amounts)</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(Unaudited)</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">June 30,</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2018</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">December 31,</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">As\u00a0Revised\u00a0(Note\u00a02)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Assets</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Current assets</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Cash and cash equivalents</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">346,827</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">224,571</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Short-term investments</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">51,766</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">31,933</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Receivable from collaboration partner</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">1,013</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Prepaid expenses and other current assets</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">2,604</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">1,876</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Total current assets</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">401,197</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">259,393</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Property and equipment, net</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">4,883</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">3,147</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Long-term investments</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">27,648</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">19,900</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Other long-term assets</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">426</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">368</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Total assets</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">434,154</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">282,808</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Liabilities and stockholders\u2019 equity</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Current liabilities</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Accounts payable</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">2,766</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">2,301</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Accrued liabilities</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">13,553</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">11,639</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Prepayment from collaboration partner</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">9,115</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">4,432</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Deferred revenue</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">21,588</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">33,558</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Total current liabilities</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">47,022</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">51,930</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Other long-term liabilities</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">99</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">202</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Total liabilities</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">47,121</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">52,132</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Commitments and contingencies (Note 6)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Stockholders\u2019 equity</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Preferred stock, $0.0001 par value; 5,000,000 shares authorized; none</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0\u00a0 issued and outstanding</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Common stock, $0.0001 par value, 150,000,000 and 150,000,000</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0\u00a0 shares authorized at June 30, 2018 and December 31, 2017,</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0\u00a0 respectively; 40,049,160 and 35,812,791 shares issued and outstanding</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0\u00a0 at June 30, 2018 and December 31, 2017, respectively</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">4</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">4</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Additional paid-in capital</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">558,376</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">365,719</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Accumulated other comprehensive loss</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(259</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(192</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Accumulated deficit</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(171,088</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(134,855</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Total stockholders\u2019 equity</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">387,033</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">230,676</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Total liabilities and stockholders\u2019 equity</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">434,154</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">282,808</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"text-align:center;margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">3</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU4\"></a><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">MYOKARDIA, INC.</font></p>\n<p style=\"text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"CONDENSED_CONSOLIDATED_STATEMENTS_OPERAT\"></a><a name=\"CONDENSED_CONSOLIDATED_STATEMENTS_OPERAT\"></a>Condensed Consolidated Statements of Operations and Comprehensive Loss</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(In thousands, except share and per share amounts)</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(Unaudited)</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"6\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Three Months Ended</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">June 30,</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"6\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Six Months Ended</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">June 30,</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2018</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2018</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">As\u00a0Revised\u00a0(Note\u00a02)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">As\u00a0Revised\u00a0(Note\u00a02)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Collaboration and license revenue</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">6,639</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">3,001</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">11,970</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">5,411</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Operating expenses:</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Research and development</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">17,218</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">13,689</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">33,836</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">25,606</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">General and administrative</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">8,912</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">5,082</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">16,225</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">10,558</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Total operating expenses</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">26,130</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">18,771</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">50,061</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">36,164</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Loss from operations</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(19,491</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(15,770</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(38,091</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(30,753</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Interest and other income, net</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">1,078</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">309</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">1,858</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">530</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Net loss</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(18,413</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(15,461</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(36,233</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(30,223</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Other comprehensive income (loss)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">70</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(3</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(67</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(58</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Comprehensive loss</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(18,343</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(15,464</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(36,300</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(30,281</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Net loss attributable to common stockholders</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(18,413</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(15,461</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(36,233</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(30,223</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Net loss per share attributable to common stockholders, basic</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0\u00a0 and diluted</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(0.49</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(0.50</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(0.99</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(0.97</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Weighted average number of shares used to compute net loss</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0\u00a0 per share attributable to common stockholders, basic and diluted</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">37,440,024</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">31,200,773</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">36,620,747</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">31,151,216</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p>\n<p style=\"text-align:center;margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">4</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU5\"></a><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">MYOKARDIA, INC.</font></p>\n<p style=\"text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"CONDENSED_CONSOLIDATED_STATEMENTS_CASH_F\"></a><a name=\"CONDENSED_CONSOLIDATED_STATEMENTS_CASH_F\"></a>Condensed Consolidated Statements of Cash Flows</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(In thousands)</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(Unaudited)</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"6\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Six Months Ended</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">June 30,</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2018</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">As\u00a0Revised\u00a0(Note\u00a02)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Cash flow from operating activities:</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Net loss</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(36,233</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(30,223</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Adjustments to reconcile net loss to net cash (used in) provided by operating activities:</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Stock-based compensation expense</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">8,413</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">2,746</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Depreciation</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">723</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">634</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Amortization of premiums on investments</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(53</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">41</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Change in operating assets and liabilities:</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Receivable from collaboration partner</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">1,013</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">45,000</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Prepaid expenses and other current assets</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(728</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">152</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Other long-term assets</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(58</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(80</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Accounts payable</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">698</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(488</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Accrued liabilities</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">1,388</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">1,470</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Prepayment from collaboration partner</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">4,683</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Other long-term liabilities</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(88</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(86</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Deferred revenue</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(11,970</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(5,411</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Net cash (used in) provided by operating activities</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(32,212</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">13,755</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Cash flow from investing activities:</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Purchases of investments</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(39,595</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(36,022</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Sales of investments</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">4,000</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Maturities of investments</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">12,000</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Purchases of property and equipment</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(2,356</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(617</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Net cash (used in) investing activities</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(29,951</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(32,639</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Cash flow from financing activities:</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Proceeds from issuance of common stock during follow-on offerings,</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0\u00a0 net of issuance costs</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">182,450</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Payments of financing-related costs</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(381</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(38</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Proceeds from exercise of stock options and employee stock purchase plan</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">2,350</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">430</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Net cash provided by financing activities</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">184,419</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">392</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Net increase (decrease) in cash, cash equivalents and restricted cash</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">122,256</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(18,492</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Cash, cash equivalents and restricted cash, beginning of period</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">224,857</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">136,056</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Cash, cash equivalents and restricted cash, end of period</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">347,113</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">117,564</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Non-cash investing and financing activities:</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Vesting of early exercised options and restricted stock</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">32</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">99</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Unpaid financing-related costs</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">206</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Unpaid portion of property and equipment purchases included in</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0\u00a0 period-end accounts payable and accrued liabilities</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">386</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">218</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p>\n<p style=\"text-align:center;margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;\">\u00a0</p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">5</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU6\"></a><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">MYOKARDIA, INC.</font></p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"NOTES_TO_CONDENSED_CONSOLIDATED_FINANCIA\"></a><a name=\"NOTES_TO_CONDENSED_CONSOLIDATED_FINANCIA\"></a>Notes to Condensed Consolidated Financial Statements</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(Unaudited)</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">1. Organization</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">MyoKardia, Inc. (the \u201cCompany\u201d) is a clinical-stage biopharmaceutical company pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. The Company\u2019s initial focus is on the treatment of heritable cardiomyopathies, a group of rare, genetically driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. The Company has used its precision medicine platform to generate a robust pipeline of therapeutic programs for the chronic treatment of the two most common forms of heritable cardiomyopathy\u2014hypertrophic cardiomyopathy (\u201cHCM\u201d), and dilated cardiomyopathy (\u201cDCM\u201d).\u00a0\u00a0The Company was incorporated on June\u00a08, 2012 in Delaware and its corporate headquarters and operations are located in South San Francisco, California.</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">Liquidity</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The Company has incurred significant operating losses since inception and has an accumulated deficit of $171.1 million as of June 30, 2018. The Company has relied on its ability to fund its operations through private and public equity financings, and to a lesser extent through a license and collaboration arrangement with its collaboration partner, Sanofi S.A. (\u201cSanofi\u201d) through its subsidiary, Aventis, Inc.\u00a0The Company has not yet received regulatory approval to commercialize or sell any product and does not have customers. Management expects operating losses and negative operating cash flows to continue for the foreseeable future.\u00a0As the Company continues to incur losses, the transition to profitability is dependent upon the successful development, approval, and commercialization of its products and product candidates and the achievement of a level of revenues adequate to support its cost structure.\u00a0The <font style=\"Background-color:#FFFFFF;\">Company\u2019s ultimate success depends on the outcome of its research and development activities. The Company expects to incur additional losses and negative cash flows for the foreseeable future and it anticipates the need to raise additional capital to fully implement its business plan. The Company intends to raise such capital through the issuance of additional equity, debt and/or strategic alliances with partner companies. </font></p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:2pt;text-indent:4.54%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"Background-color:#FFFFFF;\">On March 8, 2018 the Company filed a Registration Statement on Form S-3ASR (the \u201c2018 Shelf Registration Statement\u201d) covering the potential offering, issuance, and sale of an indeterminate amount of </font>common stock, preferred stock, debt securities, warrants and/or units. In May 2018, the Company completed a follow-on offering under the 2018 Shelf Registration Statement pursuant to which the Company issued 3,750,000 <font style=\"Background-color:#FFFFFF;\">shares of common stock at a price of $49.00 per share. In addition, in June 2018, the Company sold an additional 211,174 shares of common stock directly to the underwriters when they partially exercised their over-allotment option at the price of $49.00 per share.\u00a0</font>During the three months ended June 30, 2018, the Company received proceeds totaling approximately $181.9 million from the offering, net of underwriting discounts and commissions and offering expenses, which includes approximately $9.7 million received due to the underwriters\u2019 partial exercise of their over-allotment option.\u00a0\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:2pt;text-indent:4.54%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"Background-color:#FFFFFF;\">As of June 30, 2018, the Company had $426.2 million of cash, cash equivalents and short and long-term investments and management believes the existing cash, cash equivalents and short and long-term investments will be sufficient to meet the Company\u2019s anticipated operating and capital expenditure requirements for the twelve months following the date of this Form 10-Q. </font>Management\u2019s belief with respect to its ability to fund operations is based on estimates that are subject to risks and uncertainties.\u00a0If actual results are different from management\u2019s estimates, the Company may need to seek additional funding. </p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">2. Basis of Presentation and Summary of Significant Accounting Policies</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">Basis of Presentation</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The accompanying condensed consolidated financial statements are unaudited, include the Company\u2019s accounts and those of its wholly-owned subsidiary and have been prepared in conformity with accounting principles generally accepted in the United States of America (\u201cGAAP\u201d). <font style=\"color:#000000;\">All intercompany balances and transactions have been eliminated in consolidation.\u00a0See \u201c</font><font style=\"font-style:italic;color:#000000;\">Adopted Accounting Pronouncements \u2013 Revenue Recognition</font><font style=\"color:#000000;\">\u201d below for a discussion of certain revisions to prior period financial statements made in connection with the Company\u2019s adoption of new revenue recognition guidance. See\u00a0\u00a0\u201c</font><font style=\"font-style:italic;\">Adopted Accounting Pronouncements \u2013 Other\u201d</font> below for a discussion of a revisions to previous periods in the statement of cash flows, whereby restricted cash is included with cash and cash equivalents when reconciling the beginning of period and end of period total amounts.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The Company currently operates in one business segment, which is the identification, development and commercialization of <font style=\"color:#000000;\">therapies for the treatment of serious and neglected rare </font>cardiovascular diseases and has a single reporting and operating unit. These interim statements, in the opinion of management, reflect all normal recurring adjustments necessary for the fair presentation of the Company\u2019s financial position and results of operations for the interim periods ended June 30, 2018 and 2017.\u00a0\u00a0</p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">6</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">MYOKARDIA, INC.</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Notes to Condensed Consolidated Financial Statements\u2014(Continued)</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(Unaudited)</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU7\"></a><font style=\"color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full fiscal year or any interim period </font><font style=\"color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">and should be read in conjunction with the audited financial statements for the year ended December\u00a031, 2017 and the notes thereto, which are included in the Company\u2019s Annual Report on Form\u00a010-K as of and for the year ended December\u00a031, 2017.\u00a0The significa</font><font style=\"color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">nt accounting policies used in preparation of these condensed consolidated financial statements for the three and six months ended June 30, 2018 are consistent with those discussed in Note 2 to the consolidated financial statements in the Company\u2019s 2017 An</font><font style=\"color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">nual Report on Form 10-K and are updated below as necessary.</font><font style=\"color:#000000;\"> </font></p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">Reclassifications</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The cash and cash equivalents on the condensed consolidated statements of cash flows for the six-month period ended June 30, 2017 has been reclassified to include restricted cash to conform to the current period\u2019s presentation. Such reclassification did not impact the Company\u2019s net loss or financial position.</p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\"><a name=\"_Hlk512437959\"></a>Use of Estimates</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, other comprehensive gain (loss) and the related disclosures.\u00a0\u00a0On an ongoing basis, management evaluates its estimates, including estimates related to license and collaboration revenues, accrued clinical trial and manufacturing development expenses and stock-based compensation expense. Significant estimates in these condensed consolidated financial statements include estimates made in connection with accrued research and development expenses, stock-based compensation expense and revenue.\u00a0\u00a0The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances.\u00a0\u00a0Actual results may differ from those estimates or assumptions.</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_cp_text_1_26\"></a>Significant accounting policies are described in Note 2 to the consolidated financial statements as of and for the year ended December 31, 2017 included in <a name=\"_cp_text_1_26\"></a>the Annual Report.\u00a0\u00a0There have been no changes to the Company\u2019s significant accounting policies during the six months ended June 30, 2018, except\u00a0as described below.</p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;\">Adopted Accounting Pronouncements - Revenue Recognition</p>\n<p style=\"Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;\">\u00a0</p>\n<p style=\"Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Effective January 1, 2018, the Company adopted Accounting Standards Codification Topic 606,\u00a0<font style=\"font-style:italic;\">Revenue from Contracts with Customers</font>\u00a0(\u201cASC 606\u201d) using the full retrospective transition method.\u00a0\u00a0This standard applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, certain collaboration arrangements and financial instruments.\u00a0\u00a0Under ASC 606, the Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services.\u00a0\u00a0To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance obligation.\u00a0\u00a0The Company only applies the five-step model to contracts when it is probable that Company will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer.\u00a0\u00a0At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct.\u00a0\u00a0The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</p>\n<p style=\"Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">Licenses of intellectual property<font style=\"font-style:normal;\">:\u00a0\u00a0 Upon the inception of a Collaboration Agreement, if the license to the Company\u2019s intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenue from non-refundable, up-front fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. For licenses that are bundled with other promises, the Company utilizes judgement to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring proportional performance for purposes of recognizing revenue from non-refundable, up-front fees. The Company evaluates the measure of proportional performance each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition.\u00a0\u00a0</font></p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">7</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">MYOKARDIA, INC.</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Notes to Condensed Consolidated Financial Statements\u2014(Continued)</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(Unaudited)</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU8\"></a><font style=\"font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">Milestone payments</font><font style=\"font-style:normal;\">:\u00a0\u00a0At the inception of each ar</font><font style=\"font-style:normal;\">rangement that includes development, regulatory or commercial milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price. ASC 606 suggests two a</font><font style=\"font-style:normal;\">lternatives to use when estimating the amount of variable consideration: the expected value method and the most likely amount method. Under the expected value method, an entity considers the sum of probability-weighted amounts in a range of possible consid</font><font style=\"font-style:normal;\">eration amounts. Under the most likely amount method, an entity considers the single most likely amount in a range of possible consideration amounts. Whichever method is used, it should be consistently applied throughout the life of the contract; however, </font><font style=\"font-style:normal;\">it is not necessary for the Company to use the same approach for all contracts. The Company expects to use the most likely amount method for development and regulatory milestone payments. If it is probable that a significant revenue reversal would not occu</font><font style=\"font-style:normal;\">r, the associated milestone value is included in the transaction price. Milestone payments that are not within the control of the Company or the licensee, such as regulatory approvals, are not considered probable of being achieved until those approvals are</font><font style=\"font-style:normal;\"> received. The transaction price is then allocated to each performance obligation on a relative stand-alone selling price basis. The Company recognizes revenue when the performance obligations under the contract are satisfied. At the end of each subsequent</font><font style=\"font-style:normal;\"> reporting period, the Company re-evaluates the probability or achievement of each such milestone and any related constraint, and if necessary, adjusts its estimates of the overall transaction price. Any such adjustments are recorded on a cumulative catch-</font><font style=\"font-style:normal;\">up basis, which would affect revenues and earnings in the period of adjustment. </font></p>\n<p style=\"Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">Royalties<font style=\"font-style:normal;\">:\u00a0\u00a0For arrangements that include sales-based royalties, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company recognizes revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied). To date, the Company has not recognized any royalty revenue resulting from its collaboration arrangement.</font></p>\n<p style=\"Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Up-front payments and fees are recorded as deferred revenue upon receipt or when due and may require deferral of revenue recognition to a future period until the Company performs its obligations under these arrangements. Amounts payable to the Company are recorded as accounts receivable when the Company\u2019s right to consideration is unconditional. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customer and the transfer of the promised goods or services to the customer will be one year or less.</p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">Impact of Adoption \u2013 ASC 606</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;\">\u00a0</p>\n<p style=\"Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The Company entered into a license and collaboration agreement that became effective in August 2014, which is within the scope of ASC 606, under which it has licensed certain rights to its HCM-1 (which includes mavacamten), HCM-2 and DCM-1 (which includes MYK-491) programs to Sanofi and may enter into other such arrangements in the future. The terms of the arrangement include payment to the Company of one or more of the following: non-refundable, up-front license fees, development and regulatory and commercial milestone payments, and royalties on net sales of licensed products.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The Company has applied the five-step model of the new standard to the Company\u2019s contract with Sanofi, as it is the only contract that will be impacted by the adoption of the new revenue standards. The Company has implemented the new revenue standards using the full retrospective transition method and has revised its comparative financial statements as if ASC 606 had been effective for those periods.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The following tables summarize the financial statement line items that were affected due to <font style=\"color:#000000;\">the Company\u2019s implementation of ASC 606 </font>(in thousands, except for share and per share amounts)<font style=\"letter-spacing:-0.1pt;\">: </font></p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Condensed Consolidated Balance Sheet</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.54%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"10\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.06%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">As of</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">December 31, 2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.54%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">As Originally Reported</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Effect of Change</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">As Revised</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.54%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Deferred revenue - current</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">22,500</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">11,058</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">33,558</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.54%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Accumulated deficit</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(123,797</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(11,058</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(134,855</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">8</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">MYOKARDIA, INC.</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Notes to Condensed Consolidated Financial Statements\u2014(Continued)</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(Unaudited)</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU9\"></a><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Condensed Consolidated Statement of Operations and Comprehensive Loss</font></p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"10\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Six Months Ended</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">June 30, 2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">As Originally Reported</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Effect of Change</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">As Revised</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Collaboration and license revenue</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">11,250</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(5,839</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">5,411</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Operating expenses:</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Research and development</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">25,606</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">25,606</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">General and administrative</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">10,558</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">10,558</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Total operating expenses</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">36,164</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">36,164</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Loss from operations</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(24,914</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(5,839</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(30,753</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Interest and other income, net</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">530</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">530</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Net loss</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(24,384</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(5,839</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(30,223</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Other comprehensive loss</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(58</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(58</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Comprehensive loss</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(24,442</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(5,839</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(30,281</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Net loss attributable to common stockholders</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(24,384</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(5,839</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(30,223</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Net loss per share attributable to common stockholders, basic and diluted</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(0.78</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(0.19</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(0.97</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Weighted average number of shares used to compute net loss per share</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0\u00a0 attributable to common stockholders, basic and diluted</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">31,151,216</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">31,151,216</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Condensed Consolidated Statement of Cash Flows</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.54%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"10\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.06%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Six Months Ended</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">June 30, 2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.54%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">As Originally Reported</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Effect of Change</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">As Revised</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.54%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Net loss</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(24,384</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(5,839</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(30,223</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.54%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Adjustments to reconcile net loss to net cash used in operating activities:</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.54%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Deferred revenue</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(11,250</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">5,839</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(5,411</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.54%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Cash, cash equivalents and restricted cash, beginning of period</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">135,797</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">259</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">136,056</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.54%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Cash, cash equivalents and restricted cash, end of period</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">117,305</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">259</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">117,564</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:6pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:6pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The change to net loss and deferred revenue in the condensed consolidated statement of cash flows, as revised above, reflects (i) the Company\u2019s determination that the Sanofi continuation payment of $45.0 million received in January 2017 relates to three performance obligations that were previously accounted for as one combined unit of accounting and (ii) the result of the Company utilizing a cost-based input method to measure proportional performance for each interim period during the year ending December 31, 2017, instead of straight-line. </p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">Impact of Adoption \u2013 ASU 2016-18</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">As discussed in \u201cAdopted Accounting Pronouncements \u2013 Other\u201d below, the change to cash, cash equivalents and restricted cash in the table above reflects the Company\u2019s implementation of ASU 2016-18 whereby amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning of period and end of period total amounts shown on the statement of cash flows.\u00a0\u00a0The Company implemented this change using a retrospective transition method.</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">9</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">MYOKARDIA, INC.</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Notes to Condensed Consolidated Financial Statements\u2014(Continued)</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(Unaudited)</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU10\"></a><font style=\"color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The following table summarizes the cash balances that were affec</font><font style=\"color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">ted due to the </font><font style=\"color:#000000;\">Company\u2019s implementation of ASU 2016-18 </font><font style=\"color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(in </font><font style=\"color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">thousands):</font></p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Condensed Consolidated Statement of Cash Flows</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:36.88%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">June 30, 2018</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">December 31, 2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">June 30, 2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">December 31, 2016</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:36.88%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">As Revised</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">As Revised</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">As Revised</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.88%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Cash and cash equivalents</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.14%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">346,827</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.14%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">224,571</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.14%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">117,305</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.14%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">135,797</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:36.88%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Restricted cash \u2013 noncurrent</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">286</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">286</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">259</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">259</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:36.88%; border-bottom:double 2.5pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Total cash, cash equivalents and restricted cash</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">347,113</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">224,857</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">117,564</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">136,056</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;\">Adopted Accounting Pronouncements \u2013 Other</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">In May 2017, the <font style=\"color:#000000;\">Financial Accounting Standards Board (\u201c</font>FASB\u201d) issued <font style=\"font-style:italic;color:#000000;\">ASU No. 2017-09\u2014Compensation\u2014Stock Compensation (Topic 718): Scope of Modification Accounting.</font><font style=\"color:#000000;\"> The amendments in this ASU provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718 to address diversity in practice. An entity should account for the effects of a modification unless all the three specified conditions are met. The current disclosure requirements in Topic 718 apply regardless of whether an entity is required to apply modification accounting under the amendments in this ASU. The amendments in this ASU are effective for all entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2017, with early adoption permitted. The amendments in this ASU should be applied prospectively to an award modified on or after the adoption date. The adoption of this standard did not have a material impact on the Company\u2019s consolidated financial statements</font>. </p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">In November 2016, the FASB issued <font style=\"font-style:italic;color:#000000;\">ASU</font><font style=\"font-style:italic;\"> No. 2016-18 (Topic 230), Restricted Cash, Statement of Cash Flows</font>. This ASU 2016-18 requires that a state<font style=\"color:#000000;\">ment of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. ASU 2016-18 is effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years, with early adoption permitted. The amendments in this ASU should be applied using a retrospective transition method to each period presented. Other than the change in presentation in the accompanying consolidated statements of cash flows, the adoption of this guidance had no effect on the Company\u2019s financial position, results of operations or liquidity.</font></p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;margin-left:2.27%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;\">Recent Accounting Pronouncements</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company\u2019s consolidated financial statements upon adoption. Under the Jumpstart Our Business Startups Act of 2012, as amended (the \u201cJOBS Act\u201d), the Company meets the definition of an emerging growth company and has irrevocably elected to opt out of the extended transition period for complying with new or revised accounting standards pursuant to Section\u00a0107(b) of the JOBS Act.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_Hlk521441985\"></a><a name=\"_Hlk521435769\"></a>In February 2016, the FASB issued ASU No. 2016-02 (Topic 842), Leases and in July 2018, issued ASU 2018-10, Codification Improvements to Topic 842, Leases, which provides clarification to ASU 2016-02. These ASUs, taken together, modify\u00a0lease\u00a0accounting for lessees to increase transparency and comparability by recording\u00a0lease\u00a0assets and liabilities for operating\u00a0leases\u00a0and disclosing key information about\u00a0leasing\u00a0arrangements. Current guidance requires the adoption of the new lease standard using the modified retrospective transition method.\u00a0However, the FASB has proposed a change in ASU 2018-10 that allows entities to elect an optional transition method, where entities could continue to apply the existing lease guidance during the comparative periods and apply the new lease requirements through a cumulative effect adjustment in the period of adoption rather than in the earliest period presented.\u00a0The Company plans to adopt the new standard on January 1, 2019 and will evaluate the transition method when the FASB issues new guidance that permits the optional transition m<a name=\"_Hlk521435769\"></a>ethod. Although the Company anticipates recording\u00a0leased\u00a0assets and liabilities for its three facilities in South San Francisco, the ultimate impact of adopting ASU 2016-02 will depend on the Company\u2019s\u00a0lease portfolio as of the adoption date<font style=\"color:#000000;\">.</font></p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">10</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">MYOKARDIA, INC.</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Notes to Condensed Consolidated Financial Statements\u2014(Continued)</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(Unaudited)</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU11\"></a><font style=\"font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">In February 2</font><font style=\"font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">018, the FASB issued </font><font style=\"font-style:italic;\">ASU No. </font><font style=\"font-style:italic;\">2018-05</font><font style=\"font-style:italic;\"> (Topic 740) Income Taxes, Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulle</font><font style=\"font-style:italic;\">tin No. 118</font><font style=\"font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">.\u00a0\u00a0The update provides guidance that gives entities the option to reclassify to retained earnings tax effects related to items in accumulated other comprehensive income (OCI) that the FASB refers to as having been stranded in accumulated OCI as </font><font style=\"font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">a result of tax reform. Entities can early adopt the guidance in any interim or annual period for which financial statements have not yet been issued and apply it either (1) in the period of adoption or (2) retrospectively to each period in which the incom</font><font style=\"font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">e tax effects of the Tax Cuts and Jobs Act related to items in accumulated OCI are recognized.\u00a0 </font><font style=\"font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The Company will adopt ASU 2018-05 in the first quarter of 2019 utilizing the modified retrospective transition method</font><font style=\"font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">. The adoption of this standard has not ha</font><font style=\"font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">d and through the one-year period of adoption, is not expected to have a material impact to the Company\u2019s financial statements.</font></p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">In June 2018, the FASB issued <font style=\"font-style:italic;\">ASU No. 2018-07 (Topic 718), Compensation \u2013 Stock Compensation</font>.\u00a0\u00a0The update represents an expansion of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. An entity should apply the requirements of Topic 718 to nonemployee awards except for specific guidance on inputs to an option pricing model and the attribution of cost (that is, the period of time over which share-based payment awards vest and the pattern of cost recognition over that period). The amendments specify that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor\u2019s own operations by issuing share-based payment awards. The amendments also clarify that Topic 718 does not apply to share-based payments used to effectively provide (1) financing to the issuer or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under Topic 606, Revenue from Contracts with Customers.\u00a0\u00a0The Company will adopt ASU 2018-17 in the first quarter of 2019 and it is not expected to have a material impact to the Company\u2019s financial statements.</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:9pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">3. Sanofi License and Collaboration Agreement</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;margin-left:2.27%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;\">Sanofi (Aventis Inc.)</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">In August 2014, the Company entered into an exclusive License and Collaboration Agreement (\u201cCollaboration Agreement\u201d) with Aventis Inc., a wholly-owned subsidiary of Sanofi, for the research, development and potential commercialization of pharmaceutical products for the treatment, prevention and diagnosis of hypertrophic and dilated cardiomyopathy, as well as potential additional indications.\u00a0\u00a0The Company has determined that Sanofi is a related party of the Company due to its close collaborative relationship and that it is the Company\u2019s only partner.\u00a0\u00a0In addition, Sanofi is a beneficial shareholder of the Company\u2019s common stock.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Under the Collaboration Agreement, the Company granted Sanofi royalty-bearing licenses to develop and commercialize products resulting from its lead candidate programs HCM-1, HCM-2 and DCM-1. The licenses provide Sanofi with worldwide rights in the case of DCM-1 and rights outside the United States with respect to the HCM-1 and HCM-2 programs. The terms of the Collaboration Agreement also state that the Company is responsible for conducting research and development activities through early human efficacy studies for all three programs, except for specified research activities to be conducted by Sanofi. </p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Upon entering into this agreement, the Company received an up-front non-refundable cash payment of $35.0 million and Sanofi made an up-front equity purchase of $10.0 million (additional equity investments from Sanofi totaling $14.0 million were received subsequent to the effective date of the Collaboration Agreement). The Company was also eligible to receive additional payments and services, as follows: (1) a one-time, non-refundable payment of $25.0 million contingent upon submission of an Investigational New Drug (\u201cIND\u201d) application before certain regulatory authority(ies) for its DCM-1 program; (2) up to $45.0 million in funding from Sanofi of approved in-kind research and clinical activities; (3) a non-refundable continuation payment of $45.0 million contingent upon Sanofi\u2019s notification of its decision to continue the agreement beyond December 31, 2016; and, (4) up to $15.0 million in research and development funding per program if studies leading to proof-of-concept (\u201cPOC\u201d) are extended beyond December 31, 2018. </p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_Hlk513283075\"></a>During the fourth quarter of 2016, the Company submitted an IND application to the U.S. Food and Drug Administration and as a result, the Company received the $25.0 million milestone payment from Sanofi.\u00a0\u00a0</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">In December 2016, Sanofi provided notice to the Company of its election to continue the collaboration through December 31, 2018 pursuant to the terms of the Collaboration Agreement. In connection with Sanofi\u2019s decision to continue the collaboration, the Company received the $45.0 million milestone payment.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The Company is also entitled to receive tiered royalties ranging from the mid-single digits to the mid-teens on net sales of certain HCM-1, HCM-2 and DCM-1 finished products outside the United States and on net sales of certain DCM-1 finished products in the United States. Sanofi is eligible to receive tiered royalties ranging from the mid-single digits to the low-teens on net sales of certain HCM-1 and HCM-2 finished products in the United States.</p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">11</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">MYOKARDIA, INC.</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Notes to Condensed Consolidated Financial Statements\u2014(Continued)</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(Unaudited)</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU12\"></a><font style=\"font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">Revenue Recognition</font></p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The Company evaluated the Collaboration Agreement under ASC 606 and determined that it had the following performance obligations:<font style=\"color:#000000;\"> (1) the licenses of intellectual property for each of the HCM-1, HCM-2 and DCM-1 programs, and (2) the performance of research and development services, including regulatory support, for each of the three programs.\u00a0\u00a0The Company considered whether the licenses have standalone functionality and are capable of being distinct; however, given the fact that the research and development services are of such a specialized nature that can only be performed by the Company and Sanofi cannot benefit from the intellectual property licenses without the Company\u2019s performance, the Company determined that the intellectual property licenses are not distinct from the research and development services and thus the license and research and development services for each program are combined into three separate performance obligations.</font></p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">Contract Term</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">For revenue recognition purposes, the Company determined that the Collaboration Agreement is a period to period contract for which the Company had enforceable rights and obligations from inception through December 31, 2016.\u00a0\u00a0Sanofi had the right to terminate the Collaboration Agreement prior to December 31, 2016 or to extend the contract term through December 31, 2018.\u00a0\u00a0If Sanofi had elected to terminate the agreement, the termination would have had taken effect on December 31, 2016 and all licensed rights would have reverted to the Company. The Company did not have any obligation to reimburse Sanofi any portion of the payments received if Sanofi had terminated the agreement.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">In December 2016, Sanofi elected to continue the Collaboration Agreement through an extended term ending December 31, 2018 and made the $45.0 million continuation payment to the Company. The Company determined that the extended term was to be treated as a separate contract because such an extension was not probable at the inception of the contract, the extension represents additional goods and services, and such activities are priced commensurate to the effort required and do not involve any significant discount. It was also concluded that the extended term provides the Company with enforceable rights and obligations for the two-year period ending December 31, 2018.\u00a0\u00a0</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Because Sanofi retains the option in the Collaboration Agreement to extend the arrangement, neither party is committed to perform and the contract does not have enforceable rights and obligations beyond December 31, 2018.</p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">Transaction Price<font style=\"font-style:normal;\"> </font></p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The Company\u2019s assessment of the transaction price included an analysis of amounts it expected to be entitled for providing goods or services to the customer which at contract inception consisted of the upfront cash payment, valued at $34.3 million, net of the fair value of $0.7 million allocated to the option provided to Sanofi to acquire equity, and variable consideration of $25.0 million, subject to an IND application.\u00a0\u00a0Sanofi paid the Company the $25.0 million milestone upon the Company\u2019s application for the IND. In 2016, after the IND application was made and when the Company determined it was deemed probable that significant reversal in the amount of cumulative revenue recognized will not occur, the Company included this amount in the transaction price.\u00a0\u00a0As of December 31, 2016, all performance obligations associated with the initial term were satisfied.\u00a0\u00a0 <font style=\"color:#000000;\">\u00a0</font>\u00a0\u00a0 </p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The extended term (from January 1, 2017 to December 31, 2018) has a fixed fee of $45.0 million, paid by Sanofi contemporaneously with the notice of continuation of the contract.\u00a0\u00a0The Company therefore determined that the transaction price for this extended term is $45.0 million. </p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">As previously noted above, the Collaboration Agreement also includes up to $45.0 million in funding from Sanofi of approved in-kind research and clinical activities. Sanofi is the decision maker on how to provide these services and such services are used in the development of joint program technology which is co-owned by both parties. As such the Company concluded that these in-kind contributions do not constitute consideration paid by Sanofi to the Company.\u00a0\u00a0</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Any consideration related to sales-based royalties will be recognized when the related sales occur and therefore have also been excluded from the transaction price.\u00a0\u00a0 </p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">12</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">MYOKARDIA, INC.</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Notes to Condensed Consolidated Financial Statements\u2014(Continued)</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(Unaudited)</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU13\"></a><font style=\"font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">Methodology for Recognition</font></p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Since the Company has determined that the three performance obligations are satisfied over time, the Company has selected a single revenue recognition method that it believes most faithfully depicts the Company\u2019s performance in transferring control of the services. ASC 606 allows entities to choose between two methods to measure progress toward complete satisfaction of a performance obligation:\u00a0\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">1. Output methods - recognize revenue on the basis of direct measurements of the value to the customer of the goods or services transferred to date relative to the remaining goods or services promised under the contract (e.g. surveys of performance completed to date, appraisals of results achieved, milestones reached, time elapsed, and units produced, or units delivered); or </p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">2. Input methods - recognize revenue on the basis of the entity\u2019s efforts or inputs to the satisfaction of a performance obligation (e.g., resources consumed, labor hours expended, costs incurred, or time elapsed) relative to the total expected inputs to the satisfaction of that performance obligation. </p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The Company concluded that it will utilize a cost-based input method to measure proportional performance and to calculate the corresponding amount of revenue to recognize. The Company believes this is the best measure of progress because other measures do not reflect how the Company executes its performance obligations under the contract with Sanofi. In applying the cost-based input methods of revenue recognition, the Company uses actual costs incurred relative to budgeted costs to fulfill the combined performance obligations. Revenue will be recognized based on actual costs incurred as a percentage of total actual and budgeted costs as the Company completes its performance obligations, which will be fulfilled by December 31, 2018. A cost-based input method of revenue recognition requires management to make estimates of costs to complete the Company\u2019s performance obligations. In making such estimates, significant judgment is required to evaluate assumptions related to cost estimates. The cumulative effect of revisions to estimated costs to complete the Company\u2019s performance obligations will be recorded in the period in which changes are identified and amounts can be reasonably estimated. A significant change in these assumptions and estimates could have a material impact on the timing and amount of revenue recognized in future periods. </p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">For the six months ended June 30, 2017 and 2018, the Company recognized $5.4 million and $12.0 million of license and collaboration revenue, respectively.\u00a0\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The following table presents changes in the Company\u2019s contract assets and liabilities, which excludes research and development reimbursements under the mavacamten registration program plan, for the six months ended June 30, 2017 and 2018 (in thousands):</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:52.6%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"14\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.12%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Six Months Ended June 30, 2018</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:52.6%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Balance at</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Beginning\u00a0of\u00a0Period</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Additions</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Deductions</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Balance at End</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">of Period</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.6%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Contract liabilities:</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.78%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.02%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.5%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.96%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.6%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Deferred revenue</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.78%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">33,558</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.02%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.5%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(11,970</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.96%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">21,588</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:52.6%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"14\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.12%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Six Months Ended June 30, 2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:52.6%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Balance at</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Beginning\u00a0of\u00a0Period</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Additions</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Deductions</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Balance at End</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">of Period</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.6%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Contract assets:</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.78%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.02%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.5%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.96%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.6%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Receivable from collaboration partner</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.78%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">45,000</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.02%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.5%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(45,000</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.96%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.6%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Contract liabilities:</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.78%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.02%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.5%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.96%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.6%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Deferred revenue</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.78%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">45,000</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.02%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.5%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(5,411</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.96%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">39,589</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:3.33%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Deferred revenue of $21.6 million as of June 30, 2018 consists of the $45.0 million continuation payment received in January 2017, less $11.4 million recognized in the year ended December 31, 2017 and $12.0 million recognized during the six months ending June 30, 2018. The $21.6 million in deferred revenue will be recognized through December 31, 2018 as the performance obligations are satisfied. </p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:3.33%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">13</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">MYOKARDIA, INC.</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Notes to Condensed Consolidated Financial Statements\u2014(Continued)</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(Unaudited)</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU14\"></a><font style=\"font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">Registration Program Plan Cost Sharing</font></p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">In <font style=\"color:#000000;\">addition</font> to amounts due to the Company under the Collaboration Agreement, Sanofi is conditionally responsible for sharing one half or more of the registration program plan (\u201cRPP\u201d) costs after the clinical proof of concept is established for each of the HCM-1 and HCM-2 programs. Effective October 2017, Sanofi is sharing RPP costs for the mavacamten program during the remainder of the contract term. Registration program costs are subject to review and approval by the Company and Sanofi and include amounts incurred relating to clinical trials, development and manufacturing of, and obtaining regulatory approvals for mavacamten and include direct employee costs and direct out-of-pocket costs incurred, by or on behalf of a party, that are specifically identifiable or reasonably and directly allocable to those activities.\u00a0\u00a0</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Estimated reimbursements are invoiced to Sanofi before each interim period based on budgeted amounts.\u00a0\u00a0These estimates consist of one half of the Company\u2019s mavacamten development budget in excess of Sanofi\u2019s mavacamten development budget each interim period. After each period end, a review of the actual expenses occurs and adjustments to future invoices are applied as a result of an analysis of the budgeted versus incurred expenses. Actual amounts received from Sanofi for the applicable period are recorded by the Company to reduce its research and development expenses each interim period.\u00a0\u00a0</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The Company recorded a $1.0 million and zero receivable for reimbursable RPP expenses, as of December 31, 2017 and June 30, 2018, respectively, which is recorded as receivable from collaboration partner and included in current assets in the condensed consolidated balance sheets. As of December 31, 2017 and June 30, 2018, the Company has received $4.4 million and $11.8 million, respectively, as prepayments from collaboration partner, to apply to future research and development expenses. Prepayments from collaboration partner are included in current liabilities in the condensed consolidated balance sheets. The Company recorded zero and $7.1 million as reductions to research and development expenses for the six months ending June 30, 2017 and 2018, respectively. </p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The following table presents the RPP related receivables and prepayments during the six months ending June 30, 2018 (in thousands):</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Balance at</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">December 31, 2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Payments</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Received from</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Sanofi under RPP</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Actual<font style=\"font-family:Calibri;\">\u00a0</font>Expenses</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Incurred</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Balance at</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">June 30, 2018</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Receivable from collaboration partner</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">1,013</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(1,013</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Prepayment from collaboration partner</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">4,432</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">11,809</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(7,126</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">9,115</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">4. Fair Value Measurements</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Financial assets and liabilities are recorded at fair value. The accounting guidance for fair value provides a framework for measuring fair value, clarifies the definition of fair value and expands disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The accounting guidance establishes a three-tiered hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as follows:</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Level 1\u2014Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Level 2\u2014Inputs other than quoted market prices included in Level 1 are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument\u2019s anticipated life.</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Level 3\u2014Inputs reflect management\u2019s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.</p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">14</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">MYOKARDIA, INC.</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Notes to Condensed Consolidated Financial Statements\u2014(Continued)</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(Unaudited)</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU15\"></a><font style=\"font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The following table sets forth the Company\u2019s financial instruments that were measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands):</font></p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"14\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Fair Value Measurements at June 30, 2018</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Total</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Level 1</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Level 2</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Level 3</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Assets</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Money market funds</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">348,525</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">348,525</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">U.S. government agency obligations</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">23,819</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">23,819</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Corporate securities</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">55,595</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">55,595</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Total</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">427,939</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">348,525</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">79,414</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"14\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Fair Value Measurements at December 31, 2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Total</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Level 1</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Level 2</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Level 3</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Assets</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Money market funds</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">223,568</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">223,568</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">U.S. government agency obligations</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">27,878</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">27,878</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Corporate securities</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">23,955</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">23,955</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Total</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">275,401</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">223,568</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">51,833</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The following table is a summary of amortized cost, unrealized gain and loss, and fair value of the Company\u2019s marketable securities by contractual maturities (in thousands):</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.7%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"14\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.04%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Fair Value Measurements at June 30, 2018</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.7%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Amortized\u00a0Cost</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Unrealized\u00a0Gain</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Unrealized\u00a0Loss</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Fair\u00a0Value</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.7%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Cash equivalents (due within 90 days)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">348,525</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.54%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">348,525</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.7%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Short-term investments (due within one year)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">51,576</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.54%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(190</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">51,766</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.7%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Long-term investments (due between one and two years)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">27,584</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(64</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">27,648</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.7%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Total</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">427,685</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.54%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(254</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">427,939</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.7%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.54%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.7%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"14\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.04%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Fair<font style=\"font-family:Calibri;\">\u00a0</font>Value\u00a0Measurements\u00a0at\u00a0December\u00a031,\u00a02017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.7%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Amortized\u00a0Cost</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Unrealized\u00a0Gain</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Unrealized\u00a0Loss</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Fair\u00a0Value</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.7%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Cash equivalents (due within 90 days)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">223,568</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.54%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">223,568</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.7%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Short-term investments (due within one year)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">32,010</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.54%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(77</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">31,933</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.7%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Long-term investments (due between one and two years)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">20,010</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(110</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">19,900</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.7%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Total</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">275,588</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.54%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(187</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">275,401</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">5. Balance Sheet Components</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;margin-left:2.27%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;\">Property and Equipment</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Property and equipment consist of the following (in thousands):</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.02%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">June 30,</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2018</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">December 31,</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Scientific equipment</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">8,160</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">5,935</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Furniture and equipment</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">1,172</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">1,064</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Capitalized software</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">278</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">278</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.02%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Leasehold improvements</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">418</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">331</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Total</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">10,028</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">7,608</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.02%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Less: Accumulated depreciation</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(5,145</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(4,461</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.02%; border-bottom:double 2.5pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Property and equipment, net</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">4,883</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">3,147</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Depreciation expense was $0.4 million and $0.3 million for the three months ended June 30, 2018 and 2017, respectively and $0.7 million and $0.6 million for the six months ended June 30, 2018 and 2017, respectively.</p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">15</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">MYOKARDIA, INC.</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Notes to Condensed Consolidated Financial Statements\u2014(Continued)</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(Unaudited)</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;margin-left:2.27%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU16\"></a><font style=\"font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;\">Accrued Liabilities</font></p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Accrued liabilities consist of the following (in thousands):</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">June 30,</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2018</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">December 31,</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Clinical research and development</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">8,458</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">5,981</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Payroll related liabilities</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">4,095</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">4,412</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Other</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">1,000</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">1,246</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Total accrued liabilities</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">13,553</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">11,639</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">6. Commitments and Contingencies</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;margin-left:2.27%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;\">Purchase Commitments</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The Company conducts product research and development programs through a combination of internal and collaborative programs that include, among others, arrangements with universities, contract research organizations and clinical research sites. The Company has contractual arrangements with these organizations; however, these contracts are generally cancelable on 30 days\u2019 notice and the obligations under these contracts are largely based on services performed.</p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;margin-left:2.27%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;\">Facility Leases</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">On June\u00a029, 2012, the Company entered into a 66-month lease for approximately 12,000 square feet of office and laboratory space in South San Francisco with annual payments of approximately $0.5 million. In connection with this lease agreement, the Company also entered into a shared facilities and services agreement with Global Blood Therapeutics, Inc. (\u201cGBT\u201d), a co-tenant in the office building. In October 2014, the Company entered into a lease assignment agreement with the owner of the building and GBT to allow GBT to sublease the Company\u2019s portion of the building beginning in March 2015. For the three months ended June 30, 2018 and 2017, the Company recorded approximately zero and $0.1 million, respectively, of sublease income and zero and $0.1 million, respectively, of sublease expense, which is recorded in interest and other income, net in the consolidated statements of operations and comprehensive loss. For the six months ended June 30, 2018 and 2017, the Company recorded approximately $0.1 million and $0.2 million, respectively, of sublease income and $0.1 million and $0.2 million, respectively, of sublease expense, which is recorded in interest and other income, net in the consolidated statements of operations and comprehensive loss.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">On September\u00a015, 2014, the Company entered into a five-year lease for approximately 34,400 square feet of office and laboratory space in South San Francisco. The Company may extend the lease for an additional three-year term. The initial annual lease payments are $1.3 million, increasing to $1.6 million in the final year of the agreement. The lease period commenced in January 2015. The Company received a lease abatement for the first three months of the lease term, which is recorded as deferred rent and recognized over the lease term. On October 1, 2017, the Company entered into an additional 25-month sublease agreement for approximately 8,000 square feet of office space in South San Francisco with annual payments of approximately $0.3 million. The lease period commenced on October 1, 2017 and expires on October 31, 2019. On January 1, 2018, the Company expanded its office and laboratory space at the same location in South San Francisco by 6,000 square feet for an approximate annual cost of $0.4 million.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The Company has provided deposits for letters of credit totaling $0.3 million to secure its obligations under its leases, which have been classified as other long-term assets in the Company\u2019s consolidated balance sheet as of June 30, 2018.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Rent expense, net was $0.6 million and $0.4 million for the three months ended June 30, 2018 and 2017, respectively and was $1.0 million and $0.7 million for the six months ended June 30, 2018 and 2017, respectively.</p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;margin-left:2.27%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;\">Contingencies</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">From time to time, the Company may have contingent liabilities that arise in the ordinary course of business activities. The Company accrues for such a liability when it is probable that future expenditures will be made and such expenditures can be reasonably estimated.  There were no contingent liabilities requiring accrual or disclosure as of June 30, 2018 or December 31, 2017.</p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">16</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">MYOKARDIA, INC.</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Notes to Condensed Consolidated Financial Statements\u2014(Continued)</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(Unaudited)</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;margin-left:2.27%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU17\"></a><font style=\"font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;\">Guarantees and Indemnifications</font></p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The Company enters into standard indemnification arrangements in the ordinary course of business.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Pursuant to certain of these arrangements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified parties for losses suffered or incurred by the indemnified party, in connection with any trade secret, copyright, patent or other intellectual property infringement claim by any third-party with respect to the Company\u2019s technology. The term of these indemnification arrangements is generally perpetual. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable because it involves claims that may be made against the Company in the future, but have not yet been made.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The Company indemnifies its officers and directors for certain events or occurrences, subject to certain limits, while the officer or director is or was serving at the Company\u2019s request in such capacity, as permitted under Delaware law and in accordance with its certificate of incorporation and bylaws, and agreements providing for indemnification entered into with its officers and directors. The term of the indemnification period lasts as long as an officer or director may be subject to any proceeding arising out of acts or omissions of such officer or director in such capacity.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The maximum amount of potential future indemnification of directors and officers is unlimited; however, the Company currently holds director and officer liability insurance. This insurance allows the transfer of risk associated with its exposure and may enable it to recover a portion of any future amounts paid.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The Company believes that the fair value of these indemnification obligations is minimal. Accordingly, the Company has not recognized any liabilities relating to these obligations for any period presented.</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">7. Stockholders\u2019 Equity</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"Background-color:#FFFFFF;\">On March 8, 2018 the Company filed the 2018 Shelf Registration Statement covering the potential offering, issuance, and sale of an indeterminate amount of </font>common stock, preferred stock, debt securities, warrants and/or units. In May 2018, the Company completed a follow-on offering under the 2018 Shelf Registration Statement pursuant to which the Company issued 3,750,000 <font style=\"Background-color:#FFFFFF;\">shares of common stock at a price of $49.00 per share. In addition, in June 2018, the Company sold an additional 211,174 shares of common stock directly to the underwriters when they partially exercised their over-allotment option at the price of $49.00 per share.</font> During the three months ending June 30, 2018, the Company received proceeds totaling approximately $181.9 million from the offering, net of underwriting discounts and commissions and offering expenses, which includes approximately $9.7 million received due to the underwriters\u2019 partial exercise of their over-allotment option.</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-top:8pt;margin-bottom:0pt;margin-left:2.27%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;\">Common Stock Reserved for Issuance</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The Company has reserved shares of common stock for issuance as follows:</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">June 30,</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2018</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">December 31,</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Options and awards issued and outstanding</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">3,904,668</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">2,964,549</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Shares available for issuance under 2015 Stock Option and Incentive Plan</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">1,093,555</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">863,538</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Shares available for issuance under 2015 Employee Stock Purchase Plan</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">794,724</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">449,444</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Total</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">5,792,947</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">4,277,531</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">17</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">MYOKARDIA, INC.</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Notes to Condensed Consolidated Financial Statements\u2014(Continued)</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(Unaudited)</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU18\"></a><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">8. Stock-Based Compensation</font></p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The Company classifies stock-based compensation expense in the accompanying condensed consolidated statements of operations and comprehensive loss based on the department to which a recipient belongs. The following table sets forth stock-based compensation expense related to equity awards granted to employees and consultants for all periods presented (in thousands):</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.24%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"6\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.5%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Three<font style=\"font-family:Calibri;\">\u00a0</font>Months\u00a0Ended June 30,</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.52%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"6\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.5%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Six Months Ended June 30,</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.24%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2018</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.52%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2018</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.24%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Research and development</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">2,050</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">610</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">3,641</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">1,200</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.24%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">General and administrative</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">2,732</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">731</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.52%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">4,772</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">1,546</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.24%; border-bottom:double 2.5pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Total</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">4,782</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">1,341</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.52%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">8,413</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">2,746</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The following summarizes option and other equity award activity under the 2012 Equity Incentive Plan and 2015 Stock Option and Incentive Plan:</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Shares Subject to</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Weighted Average</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Outstanding</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Options</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Exercise\u00a0Price</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">per\u00a0Share</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Balance at December 31, 2017</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">2,964,549</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">11.54</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Options granted</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">1,167,256</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">51.41</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Options exercised</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(263,145</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">7.31</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Options canceled/forfeited</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(99,248</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">20.26</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Balance at June 30, 2018</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">3,769,412</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">23.95</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Shares Subject to</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Weighted Average</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Outstanding</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Awards</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Grant Date</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Fair Value</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Balance at December 31, 2017</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2014</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Restricted stock units granted</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">138,086</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">51.88</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Restricted stock units forfeited</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(2,830</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">53.77</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Balance at June 30, 2018</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">135,256</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">51.84</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Restricted stock units (\u201c<font style=\"color:#000000;\">RSUs\u201d) settle into shares of common stock upon vesting and the exercise price is the market price on the date of vesting</font>.</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Pursuant to the terms of the Company\u2019s 2015 Employee Stock Purchase Plan (the \u201c2015 ESPP\u201d), on April\u00a030, 2018, the Company issued 12,847 shares to participants in the 2015 ESPP in exchange for their contributions during the period from November 1, 2017 to April 30,\u00a02018.</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">In relation to stock options and awards to purchase common stock that vest upon the achievement of performance criteria, $40,000 and zero <font style=\"color:#000000;\">in stock-based compensation expense was recorded for the three months ended June 30, 2018 and 2017, respectively, and </font>$193,000 and $174,000 <font style=\"color:#000000;\">in stock-based compensation expense was recorded for the six months ended June 30, 2018 and 2017, respectively. </font>The Company begins to recognize expenses related to these stock options and awards during the period upon concluding that certain performance criteria are considered probable.</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;\">\u00a0</p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">18</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">MYOKARDIA, INC.</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Notes to Condensed Consolidated Financial Statements\u2014(Continued)</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(Unaudited)</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU19\"></a><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">9. Net Loss per Share Attributable to Common Stockholders</font></p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share amounts):</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"6\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Three Months Ended June 30,</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"6\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Six Months Ended June 30,</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2018</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2018</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Numerator</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Net loss</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(18,413</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(15,461</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(36,233</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(30,223</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Net loss attributable to common stockholders, basic and diluted</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(18,413</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(15,461</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(36,233</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(30,223</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Denominator</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Weighted average shares outstanding</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">37,490,960</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">31,446,235</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">36,694,820</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">31,437,448</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Less: weighted average shares subject to repurchase</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(50,936</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(245,462</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(74,073</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(286,232</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Weighted average shares used to compute basic and diluted net</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0\u00a0 loss per share</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">37,440,024</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">31,200,773</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">36,620,747</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">31,151,216</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Net loss per share attributable to common stockholders, basic</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0\u00a0 and diluted</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(0.49</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(0.50</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(0.99</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(0.97</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been antidilutive:</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"6\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">As of June 30,</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2018</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">RSUs and stock options to purchase common stock</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">3,904,668</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">3,332,142</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Common stock subject to repurchase</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">32,361</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">219,267</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">As of June 30, 2018, the Company has contributions from plan participants of $213,000 under the 2015 ESPP, which if converted, would be equivalent to 4,952 shares based on 85% of the stock price at the beginning of the offering period. As of June 30, 2017, the Company had contributions from plan participants of $130,000 under the 2015 Employee Stock Purchase Plan, which if converted, would have been equivalent to 11,216 shares based on 85% of the stock price at the beginning of the offering period.</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">10. Income taxes</p>\n<p style=\"Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#222222;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">On December 22, 2017, the Tax Cuts and Jobs Act of 2017 (\u201cTax Act\u201d) was signed into law making significant changes to the Internal Revenue Code. Changes include, but are not limited to, a corporate tax rate decrease from 35% to 21% effective for tax years beginning after December 31, 2017, the transition of U.S. international taxation from a worldwide tax system to a territorial system, and a one-time transition tax on the mandatory deemed repatriation of cumulative foreign earnings as of December 31, 2017.\u00a0</p>\n<p style=\"Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#222222;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_Hlk520391367\"></a>Also on December 22, 2017, Staff Accounting Bulletin No. 118 (\u201cSAB 118\u201d) was issued to address the application of U.S. GAAP in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computa<a name=\"_Hlk520391367\"></a>tions) in reasonable detail to complete the accounting for certain income tax effects of the Act. For the six months ended June 30, 2018, the Company noted no additional guidance or information that affects the provisional amounts initially recorded at zero for the transition tax and the remeasurement of the deferred tax assets for the year ended December 31, 2017. As a result, the Company recorded no adjustment to the transition tax and the remeasurement of the deferred tax assets. The Company will continue to monitor and analyze any additional guidance and information that may be issued by the federal and state tax authorities. Any subsequent adjustment to these amounts will be recorded to current tax expense in the 2018 interim period during which the analysis is complete.\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:10.27%;text-indent:-10.27%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:10.27%;text-indent:-10.27%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:10.27%;text-indent:-10.27%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">19</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:10.27%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Item\u00a02.</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU20\"></a><a name=\"ITEM_2_MANAGEMENTS_DISCUSSION_ANALYSIS_F\"></a><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"></font><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"ITEM_2_MANAGEMENTS_DISCUSSION_ANALYSIS_F\"></a>Management\u2019s Discussion and Analysis o</font><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">f Financial Condition and Results of Operation</font></p></td></tr></table></div>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\"><a name=\"_cp_text_1_89\"></a><a name=\"_cp_text_1_91\"></a>You should read the following management\u2019s discussion and analysis of our financial condition and results of operations in conjunction with our unaudited condensed consolidated financial statements and notes thereto included in Part I, Item\u00a01 of this Quarterly Report on Form 10-Q and with our audited consolidated financial statements and notes thereto for the year ended December\u00a031, 2017, <a name=\"_cp_text_1_89\"></a>included in our Annual Report on <a name=\"_cp_text_1_91\"></a>Form 10-K for the year ended December 31, 2017, filed with the U.S. Securities and Exchange Commission (SEC) on March 8, 2018 (the \u201cAnnual Report\u201d).</p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Special note regarding forward-looking statements</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_cp_text_1_92\"></a><a name=\"_cp_text_1_94\"></a><a name=\"_cp_text_1_95\"></a><a name=\"_cp_text_1_96\"></a>This report contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those discussed in these forward-looking statements. The statements contained in this report that are not purely historica<a name=\"_cp_text_1_92\"></a>l are forward-looking statements within the meaning of Section\u00a027A of the Securities Act of 1933, as amended (the \u201cSecurities Act\u201d) <a name=\"_cp_text_1_94\"></a>and Section\u00a021E of the Securities Exchange Act of 1934, as amended (<a name=\"_cp_text_1_95\"></a>the \u201c<a name=\"_cp_text_1_96\"></a>Exchange Act\u201d). Forward-looking statements are often identified by the use of words such as, but not limited to, \u201canticipate,\u201d \u201cbelieve,\u201d \u201ccan,\u201d \u201ccontinue,\u201d \u201ccould,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cmay,\u201d \u201cplan,\u201d \u201cproject,\u201d \u201cseek,\u201d \u201cshould,\u201d \u201cstrategy,\u201d \u201ctarget,\u201d \u201cwill,\u201d \u201cwould\u201d and similar expressions or variations intended to identify forward-looking statements. These statements are based on the beliefs and assumptions of our management based on information currently available to management. Such forward-looking statements are subject to risks, uncertainties and other important factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those identified below and those discussed in the section titled \u201cRisk Factors\u201d included under Part II, Item\u00a01A below. Furthermore, such forward-looking statements speak only as of the date of this report. Except as required by law, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements.</p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Overview</p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_cp_text_1_100\"></a>We are a clinical-stage biopharmaceutical company pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. Our initial focus is on the treatment of heritable cardiomyopathies, a group of rare, genetically driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. We have generated a robust pipeline of therapeutic programs for the <a name=\"_cp_text_1_100\"></a>chronic treatment of the two most common forms of heritable cardiomyopathy\u2014hypertrophic cardiomyopathy, or HCM, and dilated cardiomyopathy, or DCM. </p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;letter-spacing:-0.15pt;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We are currently enrolling patients into a pivotal Phase 3 clinical trial of <font style=\"color:#000000;\">mavacamten</font>, our product candidate for the treatment of symptomatic, obstructive HCM (\u201coHCM\u201d), based on results from our Phase 2 clinical trial in this population in which mavacamten demonstrated improvements in symptoms of oHCM. Patients from the Phase 2 clinical study of mavacamten in oHCM are currently being enrolled in an open-label extension study intended to provide data on long-term exposure to mavacamten.\u00a0\u00a0Mavacamten is also being evaluated in a randomized Phase 2 clinical trial for the treatment of symptomatic non-obstructive HCM (\u201cnHCM\u201d).\u00a0\u00a0Our second clinical-stage candidate, MYK-491, is currently being studied in a Phase 1b single-ascending dose clinical trial in DCM patients with stable heart failure, based on results from a completed Phase 1 clinical trial in healthy volunteers. <font style=\"color:#000000;\">Additionally, we have identified multiple preclinical programs, focused on regulating or normalizing cardiac muscle contractility and relaxation</font>.</p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Financial Overview</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We have not generated net income from operations, and, as of June 30, 2018, we had an accumulated deficit of $171.1 million, primarily as a result of research and development and general and administrative expenses. To date, all our revenue has been derived from non-refundable payments under the license and collaboration agreement we entered into with Aventis Inc., a wholly-owned subsidiary of Sanofi S.A. (\u201cSanofi\u201d), in August 2014, which we refer to as the Collaboration Agreement, and we have not yet generated any revenue from product sales. We have never been profitable and have incurred net losses in each year since commencement of our operations. We expect to incur significant and increasing losses from operations for the foreseeable future, and we can provide no assurance that we will ever generate significant revenue or profits.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU21\"></a>Through June 30, 2018, we have financed our operations through an initial public offering (\u201cIPO\u201d), three follow-on public offerings, private placements of redeemable convertible preferred stock and funds received in connection with the Collaboration Agreement with Sanofi.\u00a0\u00a0We received net proceeds of $93.9 million from the sale of shares of our Series A, A-1 and B redeemable convertible preferred stock. On November 3, 2015, we completed our IPO of 6,253,125 shares of common stock at an offering price of $10.00\u00a0per share, resulting in net proceeds of approximately $55.6 million, after deducting underwriting discounts, commissions and offering costs. On October 3, 2016, we completed a follow-on public offering of 4,370,000 shares of common stock at an offering price of $15.00 per share, resulting in net proceeds of approximately $61.1 million, after deducting underwriting discounts, commissions and offering costs. On August 14, 2017, we completed our second follow-on public offering of 4,025,000 shares of common stock at an offering price of $35.50 per share, resulting in net proceeds of approximately $133.9 million, after deducting </p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">20</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">underwriting discounts, commissions and offering costs. On May 25, 2018, we completed our third follow-on public offering of 3,750,000 shares of common stock at an offering price of $49.00 per share,</font><font style=\"font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"> resulting in net proceeds of approximately $172.2 million, after deducting underwriting discount, commissions and offering costs. On June 22, 2018, the underwriters partially exercised their over-allotment option, purchasing 211,147 shares of our common s</font><font style=\"font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">tock at an offering price of $49.00 per share, resulting in net proceeds of approximately $9.7 million, after deducting underwriting discounts, commissions and offering costs. Net proceeds of $181.9 million from these two offerings are net of $0.6 million </font><font style=\"font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">in offering costs. Included in the May 25, 2018 sale of common stock was a sale of 150,000 shares to Sanofi.</font></p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">In connection with the Collaboration Agreement, we have received $130.5 million from Sanofi, consisting of a $35.0 million upfront payment, a $25.0 million milestone payment for the submission of an Investigational New Drug (\u201cIND\u201d) application for MYK-491 with the U.S. government\u2019s Food and Drug Administration (\u201cFDA\u201d) in November 2016, a $45.0 million continuation payment from Sanofi in January 2017 and $17.8 million in reimbursements and prepayments for research and development costs under a Registration Program Plan (\u201cRPP\u201d) for mavacamten. As of June 30, 2018, we had cash and cash equivalents of $346.8 million, short-term investments of $51.8 million and long-term investments of $27.6 million.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_cp_text_1_107\"></a><a name=\"_cp_text_1_109\"></a>We have no manufacturing facilities and all of our manufacturing activities are contracted out to a third party. We currently utilize third-party <a name=\"_cp_text_1_107\"></a>clinical research organizations (\u201c<a name=\"_cp_text_1_109\"></a>CROs\u201d) to carry out our clinical development and trials. We do not yet have a sales organization.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_cp_text_1_111\"></a>We expect to incur substantial expenditures in the foreseeable future for the advancement of our precision medicine platform, the development and potential commercialization of <font style=\"color:#000000;\">mavacamten</font> and MYK-491, and the discovery, development and potential commercialization of any additional product candidates we may pursue. <a name=\"_cp_text_1_111\"></a>Specifically, we expect to continue to incur substantial expenses in connection with our ongoing clinical trials of <font style=\"color:#000000;\">mavacamten, including a Phase 3 pivotal trial in symptomatic oHCM, a Phase 2 clinical trial in symptomatic nHCM,</font> and any additional clinical trials that we may conduct for <font style=\"color:#000000;\">mavacamten</font>, as well as our ongoing and planned clinical development activities for MYK-491. We will need substantial additional funding to support operating activities as we advance <font style=\"color:#000000;\">mavacamten</font>, MYK-491, and other potential product candidates through clinical development, seek regulatory approval and proceed to commercialization. Adequate funding may not be available to us on acceptable terms, or at all.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The research and development expenses incurred in the development and potential commercialization of <font style=\"color:#000000;\">mavacamten</font>, MYK-491 and other product candidates are net of $4.3 million and $7.1 million in mavacamten RPP credits during the three and six months ending June 30, 2018, respectively (in thousands):</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.26%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"6\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.48%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Three Months Ended June 30,</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"6\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.48%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Six Months Ended June 30,</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.26%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2018</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2018</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.26%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Mavacamten</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.54%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">6,878</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.54%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">7,448</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.54%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">14,818</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.54%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">12,424</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.26%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">MYK-491</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.54%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">2,859</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.54%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">2,521</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.54%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">5,679</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.54%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">5,396</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.26%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Other</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">7,481</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">3,720</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">13,339</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">7,786</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.26%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Total research and development expenses:</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.54%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">17,218</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.54%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">13,689</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.54%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">33,836</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.54%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">25,606</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Sanofi License and Collaboration Agreement</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">In August 2014, we entered into the Collaboration Agreement with Sanofi that covers three main research programs: our first program in HCM (referred to as HCM-1), a second program in HCM (referred to as HCM-2) and our first program in DCM (referred to as DCM-1).</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Under the Collaboration Agreement, we are responsible for conducting research and development activities through early human efficacy studies, except for specified research activities to be conducted by Sanofi. Thereafter, we will lead worldwide development and U.S. commercial activities for the <font style=\"color:#000000;\">HCM-1</font> and HCM-2 programs, Sanofi will lead global development and commercial activities for DCM-1 and Sanofi will lead commercial activities for the <font style=\"color:#000000;\">HCM-1</font> and HCM-2 programs where it has commercialization rights outside of the U.S.\u00a0\u00a0Sanofi also has the option to co-promote the <font style=\"color:#000000;\">HCM-1</font> and HCM-2 programs in the United States only in the event of a potential expanded cardiovascular disease indication outside of the genetically targeted indications. We have co-commercialization rights to DCM-1 in the United States, at our option.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We are entitled to receive tiered royalties ranging from the mid-single digits to the mid-teens on net sales of certain HCM-1, HCM-2 and DCM-1 finished products outside the United States and on net sales of certain DCM-1 finished products in the United States. Sanofi is eligible to receive tiered royalties ranging from the mid-single digits to the low-teens on net sales of certain HCM-1 and HCM-2 finished products in the United States.</p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">21</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU22\"></a><font style=\"font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Under the Collaboration Agreement, Sanofi agreed to provide upfront and milestone payments, equity investments and research and development support. As of June 30, 2018, we have received from Sanofi an initial non-refundable upfront cash payment of $35.0 m</font><font style=\"font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">illion and equity investments of $10.0 million in exchange for Series\u00a0A-1 redeemable convertible preferred stock, a $25.0 million milestone-based payment and a $45.0 million continuation payment. In addition, we have received equity funding outside of the </font><font style=\"font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">original agreement of $5.0 million in exchange for Series\u00a0B redeemable convertible preferred stock and $9.0 million in exchange for shares of our common stock in our IPO. </font><font style=\"font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Included in the May 25, 2018 follow-on offering sale of common stock was a sale of 15</font><font style=\"font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">0,000 shares to Sanofi. </font><font style=\"font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We are also eligible to receive up to $45.0 million of approved in-kind research and clinical activities, for which eligibility expires on December 31, 2018</font><font style=\"font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">.</font></p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Critical Accounting Policies and Significant Judgments and Estimates</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">This discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_cp_text_1_115\"></a>Our significant accounting policies are fully described in Note 2 of<a name=\"_cp_text_1_115\"></a> our Annual Report.\u00a0\u00a0We believe that the accounting policies discussed in our Annual Report are critical to understanding our historical and future performance, as these policies relate to the more significant areas involving management\u2019s judgments and estimates. There have been no changes to our significant accounting policies during the six months ended June 30, 2018, except\u00a0with\u00a0respect\u00a0to\u00a0changes\u00a0in\u00a0our\u00a0revenue recognition policy upon the adoption of <font style=\"font-style:italic;Background-color:#FFFFFF;color:#000000;\">ASU No. 2014-09</font><font style=\"Background-color:#FFFFFF;color:#000000;\">,\u00a0</font><font style=\"font-style:italic;Background-color:#FFFFFF;color:#000000;\">Revenue from Contracts with Customers (Topic\u00a0606)</font>.</p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Components of Operating Results</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;\">Collaboration and License Revenue</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We generate revenue from the Collaboration Agreement with Sanofi for the development and commercialization of products under the collaboration.</p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;\">Operating Expense</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:2.31%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">Research and Development Expenses</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Research and development expenses consist of salaries and benefits, including stock-based compensation, lab supplies and facility costs, and fees paid to CROs to conduct certain research and development activities on our behalf. Amounts incurred in connection with collaboration and license agreements are also included in research and development expense. Payments made prior to the receipt of goods or services are capitalized until the goods or services are received.</p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:2.27%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">General and Administrative Expenses</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;letter-spacing:-0.1pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">General and administrative expenses consist principally of salaries and benefits, including stock based compensation, professional fees for legal, consulting, audit and tax services, market research, rent and other general operating expenses not otherwise classified as research and development expenses.</p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;\">Interest and Other Income, Net</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Interest and other income, net consists primarily of interest income earned on our cash and cash equivalents, short-term investments and long-term investments.</p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">22</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU23\"></a><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Results of Operations</font></p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;\"><a name=\"_Hlk512003308\"></a>Comparison of the Three-Month Periods Ended June 30, 2018 and 2017 </p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The following table compares the operating results (in thousands):</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.3%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"6\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.28%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Three Months Ended</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">June 30,</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.6%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.3%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2018</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.6%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Increase/(Decrease)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.3%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">As\u00a0Revised\u00a0(Note\u00a02)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.3%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Collaboration and license revenue</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">6,639</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">3,001</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">3,638</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.3%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Operating expenses:</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.3%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Research and development</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">17,218</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">13,689</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">3,529</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.3%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">General and administrative</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">8,912</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">5,082</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">3,830</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.3%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Total operating expenses</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">26,130</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">18,771</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">7,359</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.3%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Loss from operations</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(19,491</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(15,770</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">3,721</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.3%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Interest and other income, net</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">1,078</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">309</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">769</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.3%; border-bottom:double 2.5pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Net loss and comprehensive loss</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(18,413</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(15,461</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">2,952</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-top:8pt;margin-bottom:0pt;text-indent:2.27%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">Collaboration and License Revenue</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Collaboration and license revenue increased $3.6 million, from $3.0 million to $6.6 million for the three months ended June 30, 2017 and 2018, respectively.\u00a0\u00a0The amounts for the periods ended June 30, 2017 and 2018 relate to revenue we recognized from the <font style=\"color:#000000;\">continuation payment of $45.0 million under the Collaboration Agreement.\u00a0\u00a0Revenues have been retroactively restated to reflect implementation of the ASU 606 revenue standard and as revised reflect a higher level of research and development efforts incurred and expected to be incurred in 2018 as compared to the same period in 2017.</font></p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-top:8pt;margin-bottom:0pt;text-indent:2.27%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">Research and Development Expenses</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Research and development expenses increased $3.5 million, or 26%, from $13.7 million for the three months ended June 30, 2017 to $17.2 million for the three months ended June 30, 2018. The increase in research and development expenses was primarily due to a $3.2 million increase in clinical expenses related to our mavacamten and MYK-491 clinical trials, a $1.3\u00a0million increase in personnel expenses as a result of an increase in employee headcount, a $1.3 million increase in stock compensation expense, a $0.8 million increase in contract research, chemistry and biology expenses on discovery and pre-clinical programs including HCM-2 and a back-up program for DCM-1, a $0.4 million in increase in medical affairs and scientific advisory board expenses, a $0.3 million increase in facilities expenses, and a $0.3 million increase in other research and development related expenses.\u00a0\u00a0Increases in research and development expenses were offset by $0 and $4.3 million in RPP credits from Sanofi during the three months ended June 30, 2017 and 2018, respectively.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We expect research and development expenses to increase in future periods as we continue the development of our lead product candidate, mavacamten, in clinical trials as well as preclinical and subsequent clinical activities for our MYK-491, HCM-2, additional mechanisms within DCM, and other additional programs. As product candidates in later stages of clinical development generally have higher development costs than those in earlier stages of clinical development, primarily due to the increased size and duration of later-stage clinical trials, we expect that our research and development expenses will increase substantially in the future.</p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:2.27%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">General and Administrative Expenses</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">General and administrative expenses increased $3.8 million, or 75%, from $5.1 million for the three months ended June 30, 2017 to $8.9 million for the three months ended June 30, 2018. The increase in general and administrative expenses was primarily due to a $1.9 million increase in stock compensation expense, a $1.0 million increase in personnel expenses as a result of an increase in employee headcount, a $0.3 million increase in professional and consulting fees, a $0.3 million increase in facilities and office expenses and $0.3 million increase in recruiting expenses.\u00a0\u00a0We expect general and administrative expenses to continue to increase in future periods in order to provide administrative support for our clinical development efforts, potential future commercialization of mavacamten and the ongoing and planned clinical development of MYK-491.</p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">23</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:2.27%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU24\"></a><font style=\"font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">Interest and Other Income, Net</font></p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Interest and other income, net increased $0.8 million, or 249%, from $0.3 million for the three months ended June 30, 2017 to $1.1 million for the three months ending June 30, 2018. The increase in interest income was primarily due to a higher balance of cash equivalents and investments.</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p>\n<p style=\"margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;\">Comparison of the Six-Month Periods Ended June 30, 2018 and 2017 </p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The following table compares the operating results (in thousands):</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.68%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"6\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.44%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Six Months Ended</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">June 30,</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.04%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.68%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2018</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.04%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Increase/(Decrease)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.68%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">As\u00a0Revised\u00a0(Note\u00a02)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.04%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.68%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Collaboration and license revenue</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">11,970</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">5,411</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.04%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">6,559</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.68%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Operating expenses:</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.04%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.68%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Research and development</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">33,836</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">25,606</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.04%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">8,230</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.68%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">General and administrative</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">16,225</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">10,558</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.04%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">5,667</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.68%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Total operating expenses</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">50,061</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">36,164</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">13,897</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.68%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Loss from operations</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(38,091</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(30,753</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.04%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">7,338</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.68%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Interest and other income, net</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">1,858</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">530</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.04%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">1,328</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.68%; border-bottom:double 2.5pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Net loss and comprehensive loss</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(36,233</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(30,223</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.04%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">6,010</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-top:8pt;margin-bottom:0pt;text-indent:2.27%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">Collaboration and License Revenue</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Collaboration and license revenue increased $6.6 million, from $5.4 million for the three months ended June 30, 2017 to $12.0 million for the six months ended June 30, 2018.\u00a0\u00a0<font style=\"color:#000000;\">The amounts for the periods ended June 30, 2017 and 2018 relate to revenue we recognized from the continuation payment of $45.0 million under the Collaboration Agreement.\u00a0\u00a0Revenues have been retroactively restated to reflect implementation of the ASU 606 revenue standard and as revised reflect a higher level of research and development efforts incurred and expected to be incurred in 2018 as compared to the same period in 2017.</font></p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:2.27%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">Research and Development Expenses</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Research and development expenses increased $8.2 million, or 32%, from $25.6 million for the six months ended June 30, 2017 to $33.8 million for the six months ended June 30, 2018. The increase in research and development expenses was primarily due to a $6.8 million increase in clinical expenses related to our mavacamten and MYK-491 clinical trials, a $2.6\u00a0million increase in personnel expenses as a result of an increase in employee headcount, a $2.3 million increase in stock compensation expense, a $2.1 million increase in contract research, chemistry and biology expenses on discovery and pre-clinical programs including HCM-2 and a back-up program for DCM-1, a $0.5 million in increase in medical affairs and scientific advisory board expenses, a $0.6 million increase in facilities expenses, and a $0.5 million increase in other research and development related expenses. Increases in research and development expenses were offset by $0 and $7.1 million in RPP credits from Sanofi during the six months ended June 30, 2017 and 2018, respectively.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We expect research and development expenses to increase in future periods as we continue the development of our lead product candidate, mavacamten, in clinical trials as well as preclinical and subsequent clinical activities for our MYK-491, HCM-2, additional mechanisms within DCM, and other back-up programs. As product candidates in later stages of clinical development generally have higher development costs than those in earlier stages of clinical development, primarily due to the increased size and duration of later-stage clinical trials, we expect that our research and development expenses will increase substantially in the future.</p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:2.27%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">General and Administrative Expenses</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">General and administrative expenses increased $5.7 million, or 54%, from $10.6 million for the six months ended June 30, 2017 to $16.2 million for the six months ended June 30, 2018. The increase in general and administrative expenses was primarily due to a $3.2 million increase in stock compensation expense, a $1.3 million increase in personnel expenses as a result of an increase in employee headcount, a $0.2 million increase in professional and consulting fees, a $0.7 million increase in facilities and office expenses and a $0.2 million increase in recruiting expenses.\u00a0\u00a0We expect general and administrative expenses to continue to increase in future periods in order to provide administrative support for our clinical development efforts, potential future commercialization of mavacamten and the ongoing and planned clinical development of MYK-491.</p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">24</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:2.27%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU25\"></a><font style=\"font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">Interest and Other Income, Net</font></p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Interest and other income increased $1.3 million or 251%, from $0.5 million to $1.9 million for the six months ended June 30, 2017 and 2018, respectively.\u00a0\u00a0The increase in interest income was primarily due to a higher balance of cash equivalents and investments.</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Liquidity and Capital Resources</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Since our inception, we have financed our operations primarily through private placements of our equity securities, payments received in connection with the Collaboration Agreement, and our public offerings of common stock. A<font style=\"letter-spacing:-0.1pt;\">s of June 30, 2018, we had cash and cash equivalents of $346.8 million, </font><font style=\"color:#000000;\">short-term investments of $51.8 million and long-term investments of $27.6 million, w</font><font style=\"letter-spacing:-0.1pt;\">hich we believe will be sufficient to fund our planned operations through at least the next twelve months from the date of this filing.\u00a0\u00a0</font>To date, we have not generated any revenue from product sales. We do not know when, or if, we will generate any revenue from product sales and do not expect to generate significant revenue from product sales unless and until we obtain regulatory approval of and commercialize <font style=\"color:#000000;\">mavacamten</font>, MYK-491 or other product candidates.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;letter-spacing:-0.1pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We expect that our existing cash and cash equivalents will provide sufficient funds to sustain operations through at least the next 12 months from the date of this filing based on our existing business plan. However, we expect to incur substantial expenditures in the foreseeable future for the advancement of our precision medicine platform, the development and potential commercialization of <font style=\"color:#000000;\">mavacamten</font> and MYK-491, and the discovery, development and potential commercialization of any additional product candidates we may pursue. Specifically, we have incurred substantial expenses in connection with our clinical trials of <font style=\"color:#000000;\">mavacamten</font> and expect to continue to incur substantial expenses in connection with our ongoing Phase\u00a02 and Phase 3 clinical trial of <font style=\"color:#000000;\">mavacamten in HCM </font>and any additional clinical trials that we may conduct, as well as our ongoing and planned clinical development activities for MYK-491. Furthermore, if our clinical trials for <font style=\"color:#000000;\">mavacamten</font> are successful, or our other product candidates, including MYK-491, enter into late-stage clinical trials or more advanced discovery and development stages, we may need to raise additional capital in order to further advance our product candidates towards regulatory approval.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We will continue to require additional financing to develop our product candidates and fund operations for the foreseeable future through equity or debt financings, collaborative or other arrangements with corporate sources, or through other sources of financing. Adequate additional funding may not be available to us on acceptable terms or at all. Our failure to raise capital as and when needed could have a negative impact on our financial condition and our ability to pursue our business strategies. We anticipate that we will need to raise substantial additional capital, the requirements of which will depend on many factors, including:</p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the rate of progress and the costs of, and our ability to generate positive date from, our ongoing and planned clinical trials of mavacamten and MYK-491;</font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><a name=\"_cp_blt_1_129\"></a><a name=\"_cp_text_1_130\"></a><font style=\"font-family:Times New Roman;\">our ability to receive additional payments from Sanofi pursuant to the Collaboration Agreement and timing thereof;</font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the number of product candidates that we intend to develop using our precision medicine platform;</font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the costs of research and preclinical studies to support the advancement of other product candidates into clinical development;</font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the timing of, and costs involved in, executing our clinical development plans, seeking and obtaining approvals from the FDA and comparable foreign regulatory authorities, including the potential by the FDA or comparable regulatory authorities to require that we perform more studies than those that we currently expect;</font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the costs of preparing to manufacture </font><font style=\"color:#000000;font-family:Times New Roman;\">mavacamten</font><font style=\"font-family:Times New Roman;\"> on a larger scale, and to manufacture MYK-491 for clinical development;</font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the costs of commercialization activities if </font><font style=\"color:#000000;font-family:Times New Roman;\">mavacamten</font><font style=\"font-family:Times New Roman;\"> or any future product candidate is approved, including the formation of a sales force;</font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the degree and rate of market acceptance of any products launched by us or our partners;</font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights;</font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">our need and ability to hire additional personnel;</font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">our ability to enter into additional collaboration, licensing, commercialization or other arrangements and the terms and timing of such arrangements; and</font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the emergence of competing technologies or other adverse market developments.</font></p></td></tr></table></div>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">25</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU26\"></a><font style=\"font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We may seek funds through borrowings or additional rounds of financing, including private or public equity or debt offerings and collaborative arrangements with corporate partners. If we raise</font><font style=\"font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"> additional funds by issuing equity securities, our stockholders may experience dilution. Any future debt financing into which we enter may impose upon us additional covenants that restrict our operations, including limitations on our ability to incur lien</font><font style=\"font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">s or additional debt, pay dividends, repurchase our common stock, make certain investments and engage in certain merger, consolidation or asset sale transactions. Any debt financing or additional equity that we raise may contain terms that are not favorabl</font><font style=\"font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">e to us or our stockholders. If we are unable to raise additional funds when needed, we may be required to delay, reduce, or terminate some or all of our development programs and clinical trials.</font></p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;\">Cash Flows</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The following table sets forth the primary sources and uses of cash for each of the periods presented below (in thousands):</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"6\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Six Months Ended June 30,</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2018</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"2\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">2017</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" colspan=\"6\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">(in thousands)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Cash Flows from Continuing Operations:</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Net cash (used in) provided by operating activities</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(32,212</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">13,755</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Net cash (used in) investing activities</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(29,951</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(32,639</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Net cash provided by financing activities</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">184,419</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">392</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Net increase (decrease) in cash, cash equivalents and restricted cash</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">122,256</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">$</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(18,492</p></td>\n<td bgcolor=\"#CFF0FC\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">)</p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-top:8pt;margin-bottom:0pt;text-indent:2.27%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">Cash Provided by / Used in Operating Activities</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Net cash used in operating activities for the six months ended June 30, 2018 was $32.2 million, and was primarily due to the net loss for the period of $36.2 million, a decrease in deferred revenue of $12.0 million, and stock-based compensation expense of $8.4 million, and was also affected by changes in operating assets and liabilities, including an increase in prepayment from collaboration partner of $4.7 million, an increase in accrued liabilities of $1.4 million and a reduction in receivable from collaboration partner of $1.0 million.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Net cash provided by operating activities for the six months ended June 30, 2017 was $13.7 million, and was primarily due to the $45.0 million continuation payment received from Sanofi, partially offset by the net loss for the period of $30.2 million and a decrease in deferred revenue of $5.4 million, stock-based compensation expense of $2.7 million, and changes in operating assets and liabilities including an increase in accrued liabilities of $1.5 million.</p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:2.27%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">Cash Used in Investing Activities</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Cash used in investing activities for the six months ended June 30, 2018 consisted primarily of purchases of investments of $39.6\u00a0million and investments in equipment of $2.4 million, offset by maturities of investments of $12.0 million. </p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Cash used in investing activities for the six months ended June 30, 2017 consisted primarily of purchases of investments of $36.0\u00a0million, offset by sale of investments of $4.0 million. During the six months ended June 30, 2017, we also invested $0.6 million in property and equipment.  </p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:2.27%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">Cash Provided by / Used in Financing Activities</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Cash provided by financing activities for the six months ended June 30, 2018 consisted of net proceeds of approximately $182.5 million from the issuance of 3,961,147 shares of our common stock in a follow-on offering, partially offset by payments of financing-related costs of $0.4 million, as well as proceeds from the issuance of common stock in connection with purchases pursuant to the 2015 ESPP and funds received as a result of common stock option exercises of $2.4 million.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Cash provided by financing activities for the six months ended June 30, 2017 consisted of proceeds from the issuance of common stock in connection with purchases pursuant to the 2015 ESPP and funds received as a result of common stock option exercises of $0.4 million, partially offset by payments of financing-related costs.</p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Contractual Obligations and Other Commitments</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_cp_text_1_142\"></a>There have been no material changes outside the ordinary course of our business to our con<a name=\"_cp_text_1_142\"></a>tractual obligations during the six months ended June 30, 2018, as compared to those disclosed in our Annual Report.</p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">26</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU27\"></a><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Off-Balance Sheet Arrangements</font></p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Since our inception, we have not engaged in any off-balance sheet arrangements, as defined in the rules and regulations of the SEC.</p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Jumpstart Our Business Startups Act of 2012 </p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The JOBS Act permits an \u201cemerging growth company\u201d such as us to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies. We are choosing to \u201copt out\u201d of this provision and, as a result, we will comply with new or revised accounting standards as required when they are adopted. This decision to opt out of the extended transition period under the JOBS Act is irrevocable. See Note 2, Summary of Significant Accounting Policies, to our consolidated financial statements appearing in our Annual Report regarding recent accounting pronouncements and Note 2 of the Notes to Condensed Consolidated Financial Statements in this document for revisions to those policies.</p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:10.27%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Item\u00a03.</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;\"><a name=\"QUANTITATIVE_QUALITATIVE_DISCLOSURES_ABO\"></a><a name=\"QUANTITATIVE_QUALITATIVE_DISCLOSURES_ABO\"></a>Quantitative and Qualitative Disclosures about Market Risk</p></td></tr></table></div>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The market risk inherent in our financial instruments represents the potential loss arising from adverse changes in interest rates or exchange rates. As of June 30, 2018, we had cash and cash equivalents of $346.8 million, consisting of interest-bearing money market accounts, short-term investments of $51.8 million, consisting of corporate securities, and long-term investments of $27.6 million, consisting of United States government agency obligations, which would be affected by changes in the general level of United States interest rates. However, due to the low- risk profile of our investments, an immediate 100 basis point change in interest rates would not have a material effect on the fair value of our cash and cash equivalents. </p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">In addition, <font style=\"color:#000000;\">we are also exposed to foreign currency exchange rate risk inherent in our contracts with research institutions and contract research organizations as certain services are performed by them outside the United States. W</font>e have payments due to one Australian vendor in foreign currency. A significant movement in the Australian dollar may have a material impact on our financial position in the future.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We do not believe that inflation, interest rate changes or exchange rate fluctuations had a significant impact on our results of operations for any periods presented.</p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:10.27%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Item\u00a04.</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;\"><a name=\"ITEM_4_CONTROLS_PROCEDURES\"></a><a name=\"ITEM_4_CONTROLS_PROCEDURES\"></a>Controls and Procedures</p></td></tr></table></div>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Evaluation of Disclosure Controls and Procedures</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The term \u201cdisclosure controls and procedures,\u201d as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, refers to controls and procedures that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC\u2019s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company\u2019s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and our management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their control objectives.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2018, the end of the period covered by this Quarterly Report on Form 10-Q. Based upon such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of such date.</p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Changes in Internal Control over Financial Reporting</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">There was no change in our internal control over financial reporting that occurred during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;\">\u00a0</p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">27</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU28\"></a><a name=\"PART_II_OR_INFORMATION\"></a><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"PART_II_OR_INFORMATION\"></a>PART II \u2013 OTHE</font><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">R INFORMATION</font></p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:10.27%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:12pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Item\u00a01.</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-top:12pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;\"><a name=\"ITEM_1_LEGAL_PROCEEDINGS\"></a><a name=\"ITEM_1_LEGAL_PROCEEDINGS\"></a>Legal Proceedings</p></td></tr></table></div>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We are not currently a party to any material litigation or other material legal proceedings.</p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:10.27%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Item\u00a01A.</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;\"><a name=\"ITEM_1A_RISK_FACTORS\"></a><a name=\"ITEM_1A_RISK_FACTORS\"></a>RISK FACTORS</p></td></tr></table></div>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;\">You should consider carefully the following risk factors, together with all the other information in this report, including our consolidated financial statements and notes thereto, and in our other public filings with the SEC.\u00a0\u00a0<font style=\"Background-color:#FFFFFF;color:#000000;\">The occurrence of any of the following risks could harm our business, financial condition, results of operations and/or growth prospects or cause our actual results to differ materially from those contained in forward-looking statements we have made in this report and those we may make from time to time. You should consider all of the risk factors described when evaluating our business.</font> </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Risks Related to Our Limited Operating History, Financial Condition and Capital Requirements </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">Our limited operating history may make it difficult for you to evaluate the success of our business to date and to assess our future viability. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We are an early-stage company. We were incorporated and commenced operations in June 2012. Our operations to date have been limited to organizing and staffing our company, business planning, raising capital, developing our technology, creating and expanding on our precision medicine platform, identifying potential product candidates, undertaking preclinical studies for our programs, completing our ongoing clinical trials for our most advanced product candidate, mavacamten, planning further clinical development of mavacamten and completing our ongoing clinical development of our second product candidate, MYK-491. We have not yet demonstrated our ability to successfully complete the clinical development of a product candidate, including the completion of any clinical trials designed to support the registration of a product candidate, obtain marketing approvals, manufacture a commercial scale medicine, or arrange for a third party to do so on our behalf, or conduct sales and marketing activities necessary for successful commercialization. Typically, it takes many years to develop a new medicine from the time it is discovered to when it is available for treating patients. Consequently, any predictions you make about our future success or viability may not be as accurate as they could be if we had a longer operating history. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">In addition, as a new business, we may encounter unforeseen expenses, difficulties, complications, delays and other known and unknown factors. We will need to transition from a company with a research focus to a company capable of supporting larger scale clinical development and commercial activities. If we are not successful in such a transition, our business, results and financial condition will be harmed. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">We have a history of significant losses and may not achieve or sustain profitability and, as a result, you may lose all or part of your investment. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Our initial product candidates, mavacamten and MYK-491, are in various stages of clinical testing and we must conduct significant additional clinical trials before we can seek the regulatory approvals necessary to begin commercial sales of these or any other product candidates we may develop. We have incurred operating losses in each year since our inception due to costs incurred in connection with our research and development activities and general and administrative costs associated with our operations. Our net loss for the six months ended June 30, 2018 and 2017 was $36.2\u00a0million and $30.2 million, respectively. As of June 30, 2018, we had an accumulated deficit of $171.1 million. We expect to incur increasing losses for several years as we continue our research activities and conduct development of, and seek regulatory approvals for, our initial product candidates, and commercialize any approved drugs. If our product candidates fail in clinical trials or do not gain regulatory approval, or if our product candidates do not achieve market acceptance, we will not be profitable. If we fail to become and remain profitable, or if we are unable to fund our continuing losses, you could lose all or part of your investment. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">We have never generated any revenue from product sales and may never be profitable. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Our ability to generate revenue and achieve profitability depends on our ability, alone or with strategic collaborators, to successfully complete the development of, and obtain the regulatory approvals necessary to commercialize, our product candidates. We do not anticipate generating revenues from product sales for the foreseeable future, if ever. Our ability to generate future revenue from product sales depends heavily on our success in: </p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">completing research and preclinical and clinical development of our product candidates; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">seeking and obtaining regulatory approvals to market product candidates for which we complete clinical trials; </font></p></td></tr></table></div>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">28</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU29\"></a><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"></font><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"></font><font style=\"font-family:Times New Roman;\">developing a sustainable, sc</font><font style=\"font-family:Times New Roman;\">alable, reproducible and transferable manufacturing process for our product candidates; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">establishing and maintaining supply and manufacturing relationships with third parties that can provide adequate (in amount and quality) products and services to support clinical development and the market demand, if any, for our product candidates, if approved; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">launching and commercializing product candidates for which we obtain regulatory approval, either through a collaboration or, if launched independently, by establishing a sales force, marketing and distribution infrastructure; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">obtaining market acceptance of our product candidates and the use of precision medicine as a viable treatment option for cardiovascular diseases; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">addressing any competing technological and market developments; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">implementing additional internal systems and infrastructure, as needed; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">identifying and validating new product candidates from our platform; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">maintaining our existing collaboration agreement with Sanofi and negotiating favorable terms in any new collaboration, licensing or other arrangements into which we may enter; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">maintaining, protecting and expanding our portfolio of intellectual property rights, including patents, trade secrets and know-how; and </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">attracting, hiring and retaining qualified personnel who are suitable to our culture and mission. </font></p></td></tr></table></div>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_cp_text_1_159\"></a><a name=\"_cp_text_1_160\"></a><a name=\"_cp_text_1_161\"></a><a name=\"_cp_text_1_163\"></a><a name=\"_cp_text_1_164\"></a><a name=\"_cp_text_1_166\"></a>Even if one or more of the product candidates that we are developing is approved for commercial sale, we anticipate incurring significant costs associated wi<a name=\"_cp_text_1_159\"></a>th commercializing any approved product candidate. Our expenses could increase beyond our expectations if we are required by the U.S. Food and Drug Administration (<a name=\"_cp_text_1_160\"></a>the \u201c<a name=\"_cp_text_1_161\"></a>FDA\u201d)<a name=\"_cp_text_1_163\"></a>, the European Medicines Agency (<a name=\"_cp_text_1_164\"></a>the \u201c<a name=\"_cp_text_1_166\"></a>EMA\u201d) or other regulatory agencies, domestic or foreign, to perform clinical trials and other studies in addition to those that we currently anticipate. Even if we are able to generate revenues from the sale of any approved products, we may not become profitable and may need to obtain additional funding to continue operations. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">We will need to raise additional funding, which may not be available on acceptable terms, or at all. Failure to obtain this necessary capital when needed may force us to delay, limit or terminate our product development efforts or other operations. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We are currently advancing <font style=\"color:#000000;\">mavacamten</font> and MYK-491, our initial product candidates, through clinical development, and conducting preclinical discovery and development activities in our other programs. Drug development is expensive, and we expect our research and development expenses to increase substantially in connection with our ongoing activities, particularly as we advance our product candidates in clinical trials.</p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">As of June 30, 2018, our cash and cash equivalents, including investments, were $426.2 million. We intend to use our cash and cash equivalents to fund the advancement of our <font style=\"color:#000000;\">mavacamten</font> clinical development program, including our ongoing Phase 3 clinical trial in symptomatic oHCM patients and our planned additional clinical trials of mavacamten, the progression of MYK-491 through clinical proof-of-concept, our ongoing preclinical, discovery and research programs and the expansion of our platform, as well as for working capital and general corporate purposes. However, our operating plan may change as a result of many factors currently unknown to us, and we may need to seek additional funds sooner than planned, through public or private equity or debt financings, government or other third-party funding, marketing and distribution arrangements and other collaborations, strategic and licensing arrangements or a combination of these approaches. In any event, we will require additional capital to obtain regulatory approval for, and to commercialize, <font style=\"color:#000000;\">mavacamten</font>, MYK-491 or any other product candidates we may identify and develop. Even if we believe we have sufficient funds for our current or future operating plans, we may seek additional capital if market conditions are favorable or if we have specific strategic considerations. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Our funding requirements and the timing of our need for additional capital are subject to change based on a number of factors, including: </p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the rate of progress and the cost of our ongoing and planned clinical trials of </font><font style=\"color:#000000;font-family:Times New Roman;\">mavacamten</font><font style=\"font-family:Times New Roman;\"> and MYK-491; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">our ability to successfully maintain our collaboration with Sanofi, and the amount and timing of any subsequent payments we may receive pursuant to the collaboration;</font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the number of product candidates that we intend to develop using our precision medicine platform; </font></p></td></tr></table></div>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">29</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU30\"></a><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"></font><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"></font><font style=\"font-family:Times New Roman;\">the costs of research and preclinical studies to support the advancement of other product candidates into clinical development; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the timing of, and costs involved in, seeking and obtaining approvals from the FDA and comparable foreign regulatory authorities, including the potential by the FDA or comparable regulatory authorities to require that we perform more studies than those that we currently expect; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the costs of preparing to manufacture </font><font style=\"color:#000000;font-family:Times New Roman;\">mavacamten</font><font style=\"font-family:Times New Roman;\"> on a larger scale, and to manufacture MYK-491 for further clinical development; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the costs of commercialization activities if </font><font style=\"color:#000000;font-family:Times New Roman;\">mavacamten</font><font style=\"font-family:Times New Roman;\"> or any future product candidate is approved, including the formation of a sales force; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the degree and rate of market acceptance of any products launched by us or our partners; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">our need and ability to hire additional personnel; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">our ability to enter into additional collaboration, licensing, commercialization or other arrangements and the terms and timing of such arrangements; and </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the emergence of competing technologies or other adverse market developments. </font></p></td></tr></table></div>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Any additional fundraising efforts may divert our management from their day-to-day activities, which may adversely affect our ability to develop and commercialize our product candidates. In addition, we cannot guarantee that future financing will be available in sufficient amounts or on terms acceptable to us, if at all. Moreover, the terms of any financing may adversely affect the holdings or the rights of our stockholders and the issuance of additional securities, whether equity or debt, by us, or the possibility of such issuance, may cause the market price of our shares to decline. The sale of additional equity or convertible securities would dilute all of our stockholders. The incurrence of indebtedness would result in increased fixed payment obligations and we may be required to agree to certain restrictive covenants, such as limitations on our ability to incur additional debt, limitations on our ability to acquire, sell or license intellectual property rights and other operating restrictions that could adversely impact our ability to conduct our business. We could also be required to seek funds through arrangements with collaborative partners or otherwise at a different stage than otherwise would be desirable and we may be required to relinquish rights to some of our technologies or product candidates or otherwise agree to terms unfavorable to us, any of which may have a material adverse effect on our business, operating results and prospects. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">If we are unable to obtain funding on a timely basis, we may be required to significantly curtail, delay or discontinue one or more of our research or development programs or the commercialization of any product candidates or be unable to expand our operations or otherwise capitalize on our business opportunities, as desired, which could materially and adversely affect our business, financial condition and results of operations. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\"><font style=\"Background-color:#FFFFFF;\">Our reported financial results may be adversely affected by changes in accounting principles generally accepted in the U.S. </font></p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"Background-color:#FFFFFF;\">We prepare our financial statements in conformity with accounting principles generally accepted in the U.S. These accounting principles are subject to interpretation by the Financial Accounting Standards Board (\u201cFASB\u201d) and the Securities and Exchange Commission. A change in these policies or interpretations could have a significant effect on our reported financial results, may retroactively affect previously reported results, could cause unexpected financial reporting fluctuations, and may require us to make costly changes to our operational processes and accounting systems. In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers which supersedes nearly all existing U.S. GAAP revenue recognition guidance. The new standard and its amendments will be effective for our fiscal year 2018 with early adoption permitted for our fiscal year 2017. Although we are currently in the process of evaluating the impact of ASU 2014-09 on our consolidated financial statements, it could change the way we account for certain of our revenue transactions. Thus, adoption of the standard could have a significant impact on our financial statements and may retroactively affect the accounting treatment of transactions completed before adoption. See \u201cNote 2 \u2013 </font><font style=\"color:#000000;\">Summary of Significant Accounting Policies</font><font style=\"Background-color:#FFFFFF;\">\u201d for additional discussion of the accounting changes.</font></p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">30</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU31\"></a><font style=\"font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Risks Related to Our Precision Medicine Platform and the Discovery and Development of Our Product Candidates </font></p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">The precision medicine approach we are taking to discover and develop drugs for heritable cardiovascular diseases is novel and may never lead to marketable products. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We have concentrated our therapeutic product research and development efforts on the application of precision medicine to the treatment of heritable cardiovascular diseases, and our future success depends on the successful development of products based on our precision medicine platform and the continued development of this platform. We believe we are the first company to apply precision medicine to the treatment of cardiovascular disease, and neither we nor any other company has received regulatory approval to market therapeutics specifically targeting any form of heritable cardiomyopathy. The scientific discoveries that form the basis for our efforts to discover and develop product candidates are novel, and the scientific evidence to support the feasibility of developing product candidates based on these discoveries is both preliminary and limited. If we do not successfully develop and commercialize product candidates based upon our technological approach, we will not become profitable and the value of our common stock may decline. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Further, our focus solely on precision medicine for the development of drugs for heritable cardiomyopathies as opposed to multiple, more proven technologies for drug development increases the risks associated with the ownership of our common stock. If we are not successful in developing any product candidates using our precision medicine platform, we may be required to change the scope and direction of our product development activities. In that case, we may not be able to identify and implement successfully an alternative product development strategy, which would materially and adversely affect our business, financial condition and results of operations. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">We depend heavily on the success of mavacamten and MYK-491, our initial product candidates. Other than mavacamten and MYK-491, all of our other programs are in discovery or preclinical development. Preclinical testing and clinical trials of our product candidates may not be successful. If we are unable to commercialize our product candidates or experience significant delays in doing so, our business will be materially harmed. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_cp_text_1_170\"></a><a name=\"_cp_text_1_171\"></a><a name=\"_cp_text_1_172\"></a>We have invested a significant portion of our efforts and financial resources in the identification of our initial product candidates, <font style=\"color:#000000;\">mavacamten</font><a name=\"_cp_text_1_170\"></a> for the treatment of hypertrophic cardiomyopathy (\u201c<a name=\"_cp_text_1_171\"></a>HCM\u201d) and MYK-491 for the treatment of dilated cardiomyopathy (\u201cDCM\u201d). We are currently evaluating <font style=\"color:#000000;\">mavacamten</font> and MYK-491 in clinica<a name=\"_cp_text_1_172\"></a>l trials, and, if these product candidates fail to demonstrate safety or efficacy in their respective target indications to the satisfaction of the FDA or other comparable regulatory authorities, we will need to identify and rely on other product candidates or target indications, or both, for clinical development. All of our other programs are still in discovery or preclinical development. Our ability to generate revenue from product sales, which we do not expect will occur for many years, if ever, will depend heavily on the successful development and eventual commercialization of <font style=\"color:#000000;\">mavacamten</font>, MYK-491 or other product candidates that we may identify from our precision medicine platform. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The success of <font style=\"color:#000000;\">mavacamten</font>, MYK-491 and any other product candidates that we discover and develop will depend on many factors, including the following: </p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">timely and successful initiation of, enrollment in, and completion of, clinical trials, </font><font style=\"Background-color:#FFFFFF;color:#000000;font-family:Times New Roman;\">including our Phase 2 and Phase 3 clinical trials of </font><font style=\"color:#000000;font-family:Times New Roman;\">mavacamten</font><font style=\"Background-color:#FFFFFF;color:#000000;font-family:Times New Roman;\"> in HCM, our Phase 1b and Phase 2 clinical trials of MYK-491 in DCM and any additional clinical trials of these product candidates</font><font style=\"font-family:Times New Roman;\">; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">our ability to receive, and the timing of receipt of, any marketing approvals from applicable regulatory authorities; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">establishing commercial manufacturing capabilities or making arrangements with third-party manufacturers; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">obtaining and maintaining patent and trade secret protection and non-patent exclusivity for our product candidates; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">launching commercial sales of our products, if and when approved, whether alone or in collaboration with others; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">acceptance of our products, if and when approved, by patients, the medical community and third-party payors; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">effectively competing with other therapies; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">a continued acceptable safety profile of our products following approval; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">enforcing and defending intellectual property rights and claims; and </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">achieving desirable medicinal properties for the intended indications. </font></p></td></tr></table></div>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">If we do not achieve one or more of these factors in a timely manner or at all, we could experience significant delays or an inability to successfully commercialize our product candidates, which would materially harm our business. </p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">31</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU32\"></a><font style=\"font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">Preclinical and clinical drug development involves a lengthy and</font><font style=\"font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\"> expensive process with an uncertain outcome, and observations and results from earlier studies and trials may not be applicable or predictive in future clinical trials. </font></p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Preclinical and clinical testing is expensive and can take many years to complete, and its outcome is inherently uncertain. Failure can occur at any time during the preclinical development or clinical trial process. The results of preclinical studies and early clinical trials of our product candidates may not be predictive of the results of later-stage clinical trials. For example, although our preclinical observations and data generated from our Phase 1 and Phase 2 clinical trials of mavacamten support our hypothesis that mavacamten has the potential to reduce cardiac muscle contractility and our belief that such data have demonstrated clinical proof of mechanism in both HCM patients and healthy volunteers, we have not completed placebo controlled clinical trials of mavacamten in larger populations using the current dosing strategy, inclusion/exclusion criteria, and endpoints of EXPLORER-HCM. In addition, our precision medicine platform is based on a translational medicine approach. Translational medicine, or the application of basic scientific findings to develop therapeutics that promote human health, is subject to a number of inherent risks. In particular, scientific hypotheses formed from preclinical or early clinical observations may prove to be incorrect, and the data generated in animal models or observed in limited patient populations may be of limited value, and may not be applicable in clinical trials conducted under the controlled conditions required by applicable regulatory requirements and our protocols. The initial clinical data from our Phase 1 and Phase 2 clinical trials of mavacamten are preliminary in nature, and the clinical development of mavacamten is not complete. Early positive data may not be repeated or observed in ongoing or future trials involving our product candidates. Product candidates in later stages of clinical trials may fail to show the desired safety and efficacy traits despite having progressed through preclinical studies and initial clinical trials. There is a high failure rate for drugs and biologics proceeding through clinical trials, particularly in the field of cardiovascular medicine. A number of companies in the pharmaceutical and biotechnology industries have suffered significant setbacks in clinical development even after achieving promising results in earlier studies, and any such setbacks in our clinical development could have a material adverse effect on our business and operating results. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">We may encounter substantial delays in our clinical trials or we may fail to demonstrate safety and efficacy to the satisfaction of applicable regulatory authorities. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Before obtaining marketing approval from regulatory authorities for the sale of our product candidates, we must conduct extensive clinical trials to demonstrate the safety and efficacy of the product candidates in humans. Clinical testing is expensive, time-consuming and uncertain as to outcome. We cannot guarantee that any clinical trials will be conducted as planned or completed on schedule, if at all. A failure of one or more clinical trials can occur at any stage of testing. We may experience delays in our ongoing clinical trials and we do not know whether planned clinical trials will begin on time, need to be redesigned, enroll patients on time or be completed on schedule, if at all. Additionally, although we believe that our precision medicine approach should eliminate the need for <font style=\"color:#000000;\">mavacamten</font> to undergo the large outcomes-based studies that are often required for cardiovascular drugs as a condition to regulatory approval by the FDA or other regulatory authorities, regulatory authorities may nevertheless require us to conduct additional trials or generate additional data, including potential trials studying the interaction of our product candidates with other therapeutics commonly administered in the patient populations we are seeking to treat, which would increase the time and cost of our clinical development process.\u00a0\u00a0Furthermore, we will need to conduct larger clinical trials, and the FDA may subsequently require us to evaluate a larger number of patients than we presently anticipate, or to assess other endpoints besides those presently contemplated, in order to support regulatory approval.</p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Clinical trials can be delayed for a variety of reasons, including: </p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">delays in reaching a consensus with regulatory agencies on trial design; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">delays in reaching agreement on acceptable terms with prospective CROs and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and clinical trial sites; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><a name=\"_cp_text_1_177\"></a><a name=\"_cp_text_1_179\"></a><font style=\"font-family:Times New Roman;\">delays in obtaining required <a name=\"_cp_text_1_177\"></a>Institutional Review Board (\u201c<a name=\"_cp_text_1_179\"></a>IRB\u201d) approval at each clinical trial site; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">delays in recruiting suitable patients to participate in our clinical trials; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">imposition of a clinical hold by regulatory agencies, including after an inspection of our clinical trial operations or trial sites; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">failure by our CROs, other third parties or us to adhere to clinical trial requirements; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><a name=\"_cp_text_1_181\"></a><a name=\"_cp_text_1_183\"></a><font style=\"font-family:Times New Roman;\">failure by us or our CROs or other third-party contractors to perform clinical trials in accordance with the FDA\u2019s good clinical pr<a name=\"_cp_text_1_181\"></a>actice (\u201c<a name=\"_cp_text_1_183\"></a>GCP\u201d) requirements or applicable regulatory guidelines in other countries; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">delays in the testing, validation, manufacturing and delivery of our product candidates to the clinical sites; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">delays in having patients complete participation in a study or return for post-treatment follow-up; </font></p></td></tr></table></div>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">32</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU33\"></a><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"></font><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"></font><font style=\"font-family:Times New Roman;\">clinical trial sites deviating from a trial protocol or dropping out of a trial; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">clinical trial subjects failing to comply with the trial regimen or dropping out of a trial; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">adding new clinical trial sites; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">failure to manufacture or supply sufficient quantities of product candidates for use in clinical trials; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;letter-spacing:-0.1pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';letter-spacing:-0.1pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';letter-spacing:-0.1pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;letter-spacing:-0.1pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">occurrence of serious adverse events associated with the product candidate that are viewed to outweigh its potential benefits;\u00a0or </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">changes in regulatory requirements and guidance that require amending or submitting new clinical protocols. </font></p></td></tr></table></div>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_cp_text_1_185\"></a><a name=\"_cp_text_1_187\"></a>We could encounter delays if a clinical trial is suspended or terminated by us, by the IRBs of the institutions in which such trials are being cond<a name=\"_cp_text_1_185\"></a>ucted, or suspension or termination is recommended by the Data Safety Monitoring Board (\u201c<a name=\"_cp_text_1_187\"></a>DSMB\u201d) for such trial or by the FDA or other regulatory authorities. Such authorities may impose such a suspension or termination due to a number of factors, including failure to conduct the clinical trial in accordance with regulatory requirements or our clinical protocols, inspection of the clinical trial operations or trial site by the FDA or other regulatory authorities resulting in the imposition of a clinical hold, unforeseen safety issues or adverse side effects, failure to demonstrate a benefit from using a drug, changes in governmental regulations or administrative actions or lack of adequate funding to continue the clinical trial. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"Background-color:#FFFFFF;\">Moreover, principal investigators for our clinical trials may serve as scientific advisors or consultants to us from time to time and receive compensation in connection with such services. Under certain circumstances, we may be required to report some of these relationships to the FDA or other regulatory authorities. The FDA or other regulatory authorities may conclude that a financial relationship between us and a principal investigator has created a conflict of interest or otherwise affected interpretation of the study. The FDA or other regulatory authorities may therefore question the integrity of the data generated at the applicable clinical trial site and the utility of the clinical trial itself may be jeopardized. This could result in a delay in approval, or rejection, of our marketing applications by the FDA or other regulatory authorities, as the case may be, and may ultimately lead to the denial of marketing approval of one or more of our product candidates.</font></p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Any inability to successfully complete preclinical and clinical development could result in additional costs to us or impair our ability to generate revenues from product sales, regulatory and commercialization milestones and royalties. In addition, if we make manufacturing or formulation changes to our product candidates, we may need to conduct additional studies to bridge our modified product candidates to earlier versions. Clinical trial delays could also shorten any periods during which we may have the exclusive right to commercialize our product candidates or allow our competitors to bring products to market before we do, which could impair our ability to successfully commercialize our product candidates and may harm our business and results of operations. In addition, many of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of our product candidates. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">If the results of our clinical trials are inconclusive or if there are safety concerns or adverse events associated with our product candidates, we may: </p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">be delayed in obtaining marketing approval for our product candidates, if at all; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">obtain approval for indications or patient populations that are not as broad as intended or desired; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">obtain approval with labeling that includes significant restrictions on use or distribution of the drug; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">require safety warnings in the label and/or require risk management plan post-approval; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">be required to perform additional clinical trials to support approval or be subject to additional post-marketing testing requirements; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><a name=\"_cp_text_1_189\"></a><a name=\"_cp_text_1_190\"></a><font style=\"font-family:Times New Roman;\">have regulatory authorities withdraw their approval of the product or impose restrictions on its distribution in the form of a modified risk evaluation and <a name=\"_cp_text_1_189\"></a>mitigation strategy (\u201c<a name=\"_cp_text_1_190\"></a>REMS\u201d); </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">be subject to the addition of labeling statements, such as warnings or contraindications; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">be sued;\u00a0or </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">experience damage to our reputation. </font></p></td></tr></table></div>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">33</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU34\"></a><font style=\"font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">We may find it difficult to enroll patients in our clinical trials, which could delay or prevent clinical trials of our product candidates. </font></p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Identifying and qualifying patients to participate in clinical trials of our product candidates is critical to our success. The timing to commence and complete our clinical trials depends on the speed at which we can recruit patients to participate in testing our product candidates. If patients are unwilling to participate in our clinical trials because of a lack of familiarity with our approach to the treatment of cardiovascular diseases, negative publicity from adverse events in biotechnology or the fields of precision medicine or cardiovascular disease or for other reasons, including competitive clinical trials for similar patient populations, our timelines for recruiting patients, conducting clinical trials and obtaining regulatory approval of potential products may be delayed. These delays could result in increased costs, delays in advancing our product development, delays in testing the effectiveness of our technology or termination of our clinical trials altogether. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We may not be able to identify, recruit and enroll a sufficient number of patients, or those with required or desired characteristics to achieve diversity in a study, to complete our clinical trials in a timely manner. Patient enrollment is affected by factors including: </p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">severity of the disease under investigation; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">design of the clinical trial protocol; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">size and nature of the patient population; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">eligibility criteria for the clinical trial in question; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">perceived risks and benefits of the product candidate under study in relation to other available therapies, including any new drugs that may be approved for the indications we are investigating; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">proximity and availability of clinical trial sites for prospective patients; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">availability of competing therapies and clinical trials; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">efforts to facilitate timely enrollment in clinical trials; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">patient referral practices of physicians; and </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">ability to monitor patients adequately during and after treatment. </font></p></td></tr></table></div>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">In particular, each of the conditions in which we plan to evaluate our current product candidates is a rare genetic disorder with limited patient pools from which to draw for clinical trials. To date, the HCM and DCM patient populations have not been extensively evaluated in clinical trials. As a result, enrollment in our ongoing and planned clinical trials is difficult to predict and may take longer or cost more than we anticipate. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We plan to seek initial marketing approval in the United States. We may not be able to initiate or continue clinical trials if we cannot enroll a sufficient number of eligible patients to participate in the clinical trials required by the FDA or other regulatory agencies. Our ability to successfully initiate, enroll and complete a clinical trial in any foreign country is subject to numerous risks unique to conducting business in foreign countries, including: </p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">difficulty in establishing or managing relationships with CROs and physicians; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">different standards for the conduct of clinical trials; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">our inability to locate qualified local consultants, physicians and partners; and </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the potential burden of complying with a variety of foreign laws, medical standards and regulatory requirements, including the regulation of pharmaceutical and biotechnology products and treatment. </font></p></td></tr></table></div>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">If we have difficulty enrolling a sufficient number of patients to conduct our clinical trials as planned, we may need to delay, limit or terminate ongoing or planned clinical trials, any of which would have an adverse effect on our business. </p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">34</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU35\"></a><font style=\"font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">We may not be successful in our efforts to identify or discover potential product candidates. </font></p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The success of our business depends primarily upon our ability to identify, develop and commercialize therapeutics for the treatment of genetic cardiovascular diseases based on our precision medicine approach. A key element of our strategy is to use our precision medicine platform to identify and study compounds that can be used to correct or offset the abnormal contraction caused by HCM and DCM. Our research programs may initially show promise in identifying potential product candidates, yet fail to yield product candidates for clinical development for a number of reasons, including: </p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the research methodology used may not be successful in identifying appropriate biomarkers or potential product candidates; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">our initial hypotheses based on our preclinical or early clinical observations may not be supported by later clinical results; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">potential product candidates may, on further study, be shown to have harmful side effects or may have other characteristics that may make the products unmarketable or unlikely to receive marketing approval; or </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">research programs to identify new product candidates require substantial technical, financial and human resources. We may choose to focus our efforts and resources on a potential product candidate that ultimately proves to be unsuccessful. </font></p></td></tr></table></div>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">If we are unable to identify suitable compounds for preclinical and clinical development, we may be forced to abandon our development efforts for a research program or programs and we will not be able to obtain product revenues in future periods, which likely would result in significant harm to our financial position and adversely impact our stock price. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">We may not be able to successfully use the Sarcomeric Human Cardiomyopathy Registry, or SHaRe, to identify or recruit patients for our clinical trials or to develop targeted precision therapeutics for the treatment of heritable cardiomyopathies. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We rely, and expect to continue to rely, on genetic and clinical data gathered through SHaRe to provide us with insight into risk profiles and disease progression in heritable cardiomyopathies. Although the body of information in SHaRe is growing, we may face challenges collecting additional data through SHaRe in the future for a variety of reasons, including: </p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">insufficient funding to support the research necessary to generate patient data for SHaRe; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">our failure to maintain existing relationships and establish new relationships with clinical investigators and research institutions whose activities support SHaRe and provide us with access to patient data; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">our failure to maintain or increase interest in SHaRe within our target patient communities; and </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">third parties may generate competing databases to which we do not have access. </font></p></td></tr></table></div>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Additionally, the predictive value of the information generated through SHaRe to date may be limited. Although we expect to use these data to define and identify patient subgroups most likely to respond to our product candidates, our initial hypotheses regarding these data may prove to be incorrect, or our patient selection strategies based on our analysis of these data may fail to yield suitable patients for evaluation in our clinical trials or suitable indications and product candidates for clinical development. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;\">Any of our product candidates may cause adverse effects or have other properties that could delay or prevent their regulatory approval, limit the scope of any approved label or market acceptance or result in other significant negative consequences following marketing approval, if any<font style=\"font-weight:normal;font-style:normal;\">.</font></p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Adverse events or other unintended side effects or safety signals caused by our product candidates could cause us, IRBs or ethics committees, clinical trial sites or regulatory authorities to interrupt, delay or halt clinical trials and could result in the denial of regulatory approval. For example, through additional studies, we may determine that although <font style=\"color:#000000;\">mavacamten</font> has been shown to be specific to striated muscle, which includes both skeletal and cardiac muscle, and selective for cardiac muscle, it may target myosin in skeletal muscle, which could result in unintended adverse effects. We have observed adverse events in our clinical trials of <font style=\"color:#000000;\">mavacamten</font>. Results of our ongoing and planned trials could reveal a high and unacceptable severity and prevalence of these or other adverse events in subjects treated with our product candidates. Additionally, if the adverse events we have observed are deemed to be unacceptable or other unacceptable side effects or safety signals are observed in any ongoing or subsequent preclinical studies or clinical trials of our product candidates, our trials could be suspended or terminated and the FDA or comparable foreign regulatory authorities could order us to cease further development of or deny approval of our product candidates for any or all targeted indications. Any adverse effects encountered in our preclinical studies or clinical trials, whether or not drug-related, could affect patient recruitment or the ability of enrolled patients to complete the trial or result in potential product liability claims.\u00a0\u00a0Additionally, adverse effects may represent safety signals that could influence the benefit-risk assessment for further development or commercialization of a product candidate and may warrant further clinical or nonclinical investigation, consultation with health authorities, changes to product labeling or guidelines for its safe use, or other scientific or regulatory actions.\u00a0\u00a0Any of these occurrences may harm our business, financial condition and prospects significantly.</p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">35</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU36\"></a><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Further, if any of our future products, if and when approved for commercial sale, cause serious or unexpected adverse events, a number of potentially significant negative consequences could result, including:</font></p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">regulatory authorities may withdraw their approval of the product or impose restrictions on its distribution in the form of a REMS or provide a medication guide outlining the risks of such side effects for distribution to patients;</font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">regulatory authorities may require the addition of labeling statements, such as warnings or contraindications;</font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">we may be required to change the way the product is administered or conduct additional clinical trials;</font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">we could be sued and held liable for harm caused to patients; or</font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">our reputation may suffer.</font></p></td></tr></table></div>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Any of these events could prevent us or our partners from achieving or maintaining market acceptance of the affected product and could substantially increase the costs of commercializing our future products and impair our ability to generate revenues from the commercialization of these products.</p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Risks Related to Government Regulation </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">We currently do not have regulatory approval to market any of our product candidates. The regulatory approval processes of the FDA and comparable foreign authorities are lengthy, time consuming and inherently unpredictable, and if we are ultimately unable to obtain regulatory approval for our product candidates, our business will be substantially harmed. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The time required to obtain approval by the FDA, EMA and comparable foreign authorities is unpredictable but typically takes many years following the commencement of clinical trials and depends upon numerous factors, including the substantial discretion of the regulatory authorities. In addition, approval policies, regulations, or the type and amount of clinical data necessary to gain approval may change during the course of a product candidate\u2019s clinical development and may vary among jurisdictions. We have not obtained regulatory approval for any product candidate and it is possible that none of our existing product candidates or any product candidates we may seek to develop in the future will ever obtain regulatory approval. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Our product candidates could fail to receive regulatory approval for many reasons, including the following: </p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the FDA or comparable foreign regulatory authorities may disagree with the design or implementation of our clinical trials; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">we may be unable to demonstrate to the satisfaction of the FDA or comparable foreign regulatory authorities that a product candidate is safe and effective for its proposed indication; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the results of clinical trials may not meet the level of statistical significance required by the FDA or comparable foreign regulatory authorities for approval; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">we may be unable to demonstrate that a product candidate\u2019s clinical and other benefits outweigh its safety risks; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the FDA or comparable foreign regulatory authorities may disagree with our interpretation of data from preclinical studies or clinical trials; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><a name=\"_cp_text_1_192\"></a><a name=\"_cp_text_1_194\"></a><font style=\"font-family:Times New Roman;\">the data collected from clinical trials of our product candidates may not be sufficient to support the submission of a <a name=\"_cp_text_1_192\"></a>New Drug Application (\u201c<a name=\"_cp_text_1_194\"></a>NDA\u201d) or other submission or to obtain regulatory approval in the United States or elsewhere; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the FDA or comparable foreign regulatory authorities may find deficiencies with or fail to approve the manufacturing processes or facilities of third-party manufacturers with which we contract for clinical and commercial supplies; or</font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the approval policies or regulations of the FDA or comparable foreign regulatory authorities may significantly change in a manner rendering our clinical data insufficient for approval. </font></p></td></tr></table></div>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">This lengthy approval process as well as the unpredictability of future clinical trial results may result in our failing to obtain regulatory approval to market <font style=\"color:#000000;\">mavacamten</font>, MYK-491 or any other product candidate we may develop, which would significantly harm our business, results of operations and prospects. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">In addition, even if we were to obtain approval, regulatory authorities may approve any of our product candidates for fewer or more limited indications than we request, may not approve the price we intend to charge for our products, may grant approval contingent on the performance of costly post-marketing clinical trials, or may approve a product candidate with a label that does not include the labeling claims necessary or desirable for the successful commercialization of that product candidate. Any of the foregoing scenarios could materially harm the commercial prospects for our product candidates. </p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">36</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU37\"></a><font style=\"font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">Even if we complete the necessary preclinical studies and clinical trials, we cannot predict when or if we will obtain regulatory approval to commercialize a product candida</font><font style=\"font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">te or the approval may be for a more limited indication than we expect. </font></p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We cannot commercialize a product until the appropriate regulatory authorities have reviewed and approved the product candidate. Even if our product candidates demonstrate safety and efficacy in clinical trials, the regulatory agencies may not complete their review processes in a timely manner, or we may not be able to obtain regulatory approval. Additional delays may result if an FDA Advisory Committee or other regulatory authority recommends non-approval or restrictions on approval. In addition, we may experience delays or rejections based upon additional government regulation from future legislation or administrative action, or changes in regulatory agency policy during the period of product development, clinical trials and the review process. Regulatory agencies also may approve a treatment candidate for fewer or more limited indications than requested or may grant approval subject to the performance of post-marketing studies. In addition, regulatory agencies may not approve the labeling claims that are necessary or desirable for the successful commercialization of our treatment candidates. If we are unable to obtain regulatory approval for our product candidates for use in the treatment of heritable cardiomyopathies, our business may suffer. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">Failure to obtain marketing approval in international jurisdictions would prevent our products from being marketed in such jurisdictions. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">In order to market and sell our products in the European Union and many other jurisdictions, we or our third-party collaborators must obtain separate marketing approvals and comply with numerous and varying regulatory requirements. The approval procedure varies among countries and can involve additional testing. The time required to obtain approval may differ substantially from that required to obtain FDA approval. The regulatory approval process outside the United\u00a0States generally includes all of the risks associated with obtaining FDA approval. In addition, in many countries outside the United States, it is required that the product be approved for reimbursement before the product can be approved for sale in that country. We or these third parties may not obtain approvals from regulatory authorities outside the United States on a timely basis, if at all. Approval by the FDA does not ensure approval by regulatory authorities in other countries or jurisdictions, and approval by one regulatory authority outside the United States does not ensure approval by regulatory authorities in other countries or jurisdictions or by the FDA. However, the failure to obtain approval in one jurisdiction may negatively impact our ability to obtain approval in other jurisdictions. We may not be able to file for marketing approvals, and even if we do, we may not obtain necessary approvals to commercialize our medicines in any market. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">Even if we receive regulatory approval for any of our product candidates, we will be subject to ongoing obligations and continued regulatory review, which may result in significant additional expense. Additionally, our product candidates, if approved, could be subject to labeling and other restrictions and market withdrawal and we may be subject to penalties if we fail to comply with regulatory requirements or experience unanticipated problems with our products. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_cp_text_1_197\"></a><a name=\"_cp_text_1_199\"></a>Any product candidate for which we obtain marketing approval, along with the manufacturing processes, post-approval clinical data, labeling, advertising and promotional activities for such product, will be subject to extensive and ongoing regulatory requirements and review by the FDA and other regulatory authorities. These requirements include submissions of safety and other post-marketing information and reports, registration and listing requirements, <a name=\"_cp_text_1_197\"></a>current Good Manufacturing Practice (\u201c<a name=\"_cp_text_1_199\"></a>cGMP\u201d) requirements relating to quality control, quality assurance and corresponding maintenance of records and documents, and requirements regarding the distribution of samples to physicians and recordkeeping. For example, the holder of an approved NDA is obligated to monitor and report adverse events and any failure of a product to meet the specifications in the NDA. The holder of an approved NDA must also submit new or supplemental applications and obtain FDA approval for certain changes to the approved product, product labeling or manufacturing process. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">In addition, product manufacturers and their facilities are subject to payment of user fees and continual review and periodic inspections by the FDA and other regulatory authorities for compliance with cGMP and adherence to commitments made in the NDA and other marketing authorizations. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Even if marketing approval of a product candidate is granted, the approval may be subject to limitations on the indicated uses for which the product may be marketed or to the conditions of approval, or contain requirements for costly post-marketing testing and surveillance to monitor the safety or efficacy of the medicine. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The FDA closely regulates the post-approval marketing and promotion of medicines to ensure that they are marketed only for the approved indications and in accordance with the provisions of the approved labeling. The FDA imposes stringent restrictions on manufacturers\u2019 communications regarding off-label use and if we do not market our medicines for their approved indications, we may be subject to enforcement action for off-label marketing. </p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">37</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU38\"></a><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">In addition, later discovery of previously unknown problems with our medicines, manufacturers or manufacturing processes, or failure to comply with regulatory requirements, may result in various nega</font><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">tive consequences, including: </font></p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">restrictions on the labeling, marketing or manufacturing of the product; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">restrictions on distribution or use of the product; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">requirements to conduct post-marketing clinical trials or holds on ongoing or planned clinical trials; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">warning or untitled letters; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">withdrawal of the medicines from the market; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">refusal by the FDA or comparable foreign regulatory authorities to approve pending applications or supplements to approved applications that we submit; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">mandatory or voluntary recalls; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">fines, restitution or disgorgement of profits or revenue; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">suspension or withdrawal of marketing approvals; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">refusal to permit the import or export of our medicines; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">product seizure or detention; and </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">injunctions or the imposition of civil or criminal penalties. </font></p></td></tr></table></div>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The FDA\u2019s policies may change and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our product candidates. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval that we may have obtained, which would adversely affect our business, prospects and ability to achieve or sustain profitability. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Any government investigation of alleged violations of law could require us to expend significant time and resources in response and could generate negative publicity. The occurrence of any event or penalty described above may inhibit our ability to commercialize our product candidates and generate revenues. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">We may seek one or more special designations from regulatory authorities for our product candidates, including Breakthrough Therapy Designation, Fast Track Designation or Orphan Drug Designation. These designations may not lead to a faster development or regulatory review or approval process, and it does not increase the likelihood that our product candidates will receive marketing approval.</p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We may seek one or more special designations from regulatory authorities for our product candidates, including Breakthrough Therapy Designation, Fast Track Designation or Orphan Drug Designation. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">A breakthrough therapy is defined as a product that is intended, alone or in combination with one or more other products, to treat a serious or life-threatening disease or condition, and preliminary clinical evidence indicates that the product may demonstrate substantial improvement over existing therapies on one or more clinically important endpoints, such as substantial treatment effects observed early in clinical development. For products that have been designated as breakthrough therapies, interaction and communication between the FDA and the sponsor of the trial can help to identify the most efficient path for clinical development while minimizing the number of patients placed in ineffective control regimens. Products designated as breakthrough therapies by the FDA can also be eligible for accelerated approval. If a product is intended for the treatment of a serious or life-threatening condition and the product demonstrates the potential to address unmet medical needs for this condition, the product sponsor may apply for Fast Track Designation.</p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The FDA has broad discretion whether or not to grant these designations, so even if we believe a particular product candidate is eligible for a particular designation, we cannot assure you that the FDA would decide to grant it. Accordingly, even if we believe one of our product candidates meets the criteria for a designation, the FDA may disagree and instead determine not to make such designation. In any event, the receipt of a particular designation for a product candidate may not result in a faster development process, review or approval compared to products considered for approval under conventional FDA procedures and does not assure ultimate approval by the FDA. In addition, even if one or more of our product candidates qualify as breakthrough therapies, the FDA may later decide that the products no longer meet the conditions for qualification and rescind the breakthrough designation. Further, the FDA may withdraw Fast Track Designation if it believes that the designation is no longer supported by data from a clinical development program.</p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">38</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU39\"></a><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Regulatory authorities in some jurisdictions, including the United States and Eu</font><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">rope, may designate drugs for relatively small patient populations as orphan drugs. Under the Orphan Drug Act, the FDA may designate a drug as an orphan drug if it is a drug intended to treat a rare disease or condition, which is generally defined as a pat</font><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">ient population of fewer than 200,000 individuals annually in the United States, or a patient population greater than 200,000 in the United States where there is no reasonable expectation that the cost of developing the drug will be recovered from sales in</font><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"> the United States. In the United States, Orphan Drug Designation entitles a party to incentives such as tax advantages and user-fee waivers. \u00a0In April 2016, the FDA granted Orphan Drug Designation for </font><font style=\"color:#000000;\">mavacamten</font><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"> for use in the treatment of symptomatic obs</font><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">tructive HCM.</font></p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"Background-color:#FFFFFF;\">In addition, if a product that has Orphan Drug Designation subsequently receives the first approval for the disease for which it has such designation, the product is entitled to orphan drug exclusivity, which in the United States means that the FDA may not approve any other applications to market the same drug for the same indication for seven years, except in limited circumstances.</font><font style=\"Background-color:#FFFFFF;font-size:12pt;\">\u00a0</font><font style=\"color:#000000;\">The exclusivity granted under any Orphan Drug Designations that we have received or may receive may not effectively protect the product candidate from competition.\u00a0\u00a0</font><font style=\"Background-color:#FFFFFF;\">Although we have received Orphan Drug Designation from the FDA for </font>mavacamten<font style=\"Background-color:#FFFFFF;\"> for use in the treatment of symptomatic obstructive HCM, we may not be the first to obtain marketing approval of this drug for the orphan-designated indication due to the uncertainties associated with developing pharmaceutical products. In addition, exclusive marketing rights in the United States may be limited if we seek approval for an indication broader than the orphan-designated indication or may be lost if the FDA later determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient quantities of the product to meet the needs of patients with the rare disease or condition. Further, even if we obtain orphan drug exclusivity, that exclusivity may not effectively protect the product from competition </font><font style=\"color:#000000;\">because different drugs </font><font style=\"Background-color:#FFFFFF;\">with different active moieties</font><font style=\"Background-color:#FFFFFF;font-size:12pt;\">\u00a0</font><font style=\"color:#000000;\">can be approved for the same condition. Even after an orphan drug is approved, the FDA can subsequently approve another drug </font><font style=\"Background-color:#FFFFFF;\">with the same active moiety </font><font style=\"color:#000000;\">for the same condition if the FDA concludes that the later drug is clinically superior, in that it is shown to be safer, more effective or makes a major contribution to patient care. </font><font style=\"Background-color:#FFFFFF;\">Orphan Drug Designation neither shortens the development time or regulatory review time of a drug nor gives the drug any advantage in the regulatory review or approval process.</font><font style=\"Background-color:#FFFFFF;font-size:12pt;\">\u00a0 </font><font style=\"color:#000000;\">Any inability to secure or maintain Orphan Drug Designation or the exclusivity benefits of this designation would have an adverse impact on our ability to develop and commercialize our product candidates.</font></p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Risks Related to Our Reliance on Third Parties </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">We are substantially dependent upon our collaboration agreement with Sanofi for the development and eventual commercialization of mavacamten, MYK-491 and any product candidates from our HCM-2 program. If this collaboration is unsuccessful or is terminated, we may be unable to commercialize certain product candidates and we will not receive additional funding from this relationship<font style=\"font-style:normal;\">.</font> </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We depend upon our license and collaboration agreement with Aventis Inc., a wholly-owned subsidiary of Sanofi S.A., which we refer to as the Collaboration Agreement, for financial and scientific resources related to the clinical development and commercialization of product candidates under our <font style=\"color:#000000;\">mavacamten</font>, MYK-491 and HCM-2 programs. While Sanofi has obligations to fund various research and development activities under the collaboration and with respect to the commercialization of product candidates in selected territories under certain programs under the Collaboration Agreement, our ability to receive funding from this relationship will depend upon the ability and willingness of Sanofi to successfully meet its responsibilities under our Collaboration Agreement and continue the collaboration. We may not receive some or all of the financial and scientific resources that we currently expect to receive under our Collaboration Agreement. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Our ability to generate additional funding from our Collaboration Agreement may be impaired by several factors including: </p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">Sanofi may shift its priorities and resources away from our programs due to a change in business strategies, or a merger, acquisition, sale or downsizing of its company or business unit; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">Sanofi may cease development and commercialization activities in therapeutic areas which are the subject of our collaboration; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">Sanofi may change the success criteria for a particular program or potential product candidate, thereby delaying or ceasing development of such program or candidate; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">Sanofi may exercise its rights to terminate the collaboration; or </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">a dispute may arise between us and Sanofi concerning financial obligations or the research, development or commercialization of a program or product candidate, resulting in a delay in payments or termination of a program and possibly resulting in costly litigation or arbitration which may divert management attention and resources. </font></p></td></tr></table></div>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">39</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU40\"></a><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Specifically, with respect to termination, the initial term of the research program under our Collaboration Agreement with Sanofi is set to end on December\u00a031, 2018. At any time after December\u00a031, 2018, Sanofi may, upon</font><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"> prior written notice to us, terminate the Collaboration Agreement for convenience in its entirety or on a region-by-region or program-by-program basis with respect to selected regions or programs. The Collaboration Agreement is also subject to termination</font><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"> by either party upon a material breach by the other party, subject to a notice and cure period, or upon a bankruptcy, insolvency or similar event affecting the other party. </font></p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">If our Collaboration Agreement with Sanofi is terminated, then, depending on the event: </p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the development of our product candidates subject to the Collaboration Agreement may be terminated or significantly delayed; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">our cash expenditures could increase significantly if it is necessary for us to hire additional employees and allocate internal resources to the development and commercialization of product candidates that were previously funded, or expected to be funded, by Sanofi; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">we would bear all of the risks and costs related to the further development and commercialization of product candidates that were previously the subject of the Collaboration Agreement; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">in order to fund further development and commercialization, we may need to seek out and establish alternative strategic collaborations with third-party partners, which may not be possible; or </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">we may not be able to do so on terms which are acceptable to us, in which case it may be necessary for us to limit the size or scope of one or more of our programs or increase our expenditures and seek additional funding by other means. </font></p></td></tr></table></div>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Any of these events would have a material adverse effect on our results of operations and financial condition. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">We expect to rely on third parties to conduct some or all aspects of our protocol development, research and preclinical and clinical testing, and these third parties may not perform satisfactorily. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We do not expect to independently conduct all aspects of our protocol development, research and preclinical and clinical testing. We currently rely, and expect to continue to rely, on third parties with respect to these items. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_cp_text_1_203\"></a><a name=\"_cp_text_1_204\"></a>Any of these third parties may terminate their engagements with us at any time. If we need to enter into alternative arrangements, it could delay our product development activities. Our reliance on these third parties for research and development activities will reduce our control over these activities but will not relieve us of our responsibility to ensure compliance with all required regulations and study protocols. For product candidates that we develop and commercialize on our own, we will remain responsible for ensuring that each of our preclinical studies and clinical trials are conducted in accordance with the study plan and protocols. We and our third-party contractors and CROs are required to comply with GCP regulations, which are regulations and guidelines enforced by the FDA, the Competent Authorities of the Member States of the <a name=\"_cp_text_1_203\"></a>European Economic Area (\u201c<a name=\"_cp_text_1_204\"></a>EEA\u201d), and comparable foreign regulatory authorities for all products in clinical development. Regulatory authorities enforce these GCP requirements through periodic inspections of trial sponsors, principal investigators and trial sites. If we or any of our third-party contractors or CROs fail to comply with applicable GCP requirements, the clinical data generated in our clinical trials may be deemed unreliable and the FDA, EMA or comparable foreign regulatory authorities may require us to perform additional clinical trials before approving our marketing applications. We cannot assure that upon inspection by a given regulatory authority, such regulatory authority will determine that any of our clinical trials complies with GCP regulations. In addition, our clinical trials must be conducted with product produced under cGMP regulations. Our failure to comply with these regulations may require us to repeat clinical trials, which would delay the regulatory approval process. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">If these third parties do not successfully carry out their contractual duties, meet expected deadlines or conduct our studies in accordance with regulatory requirements or our stated study plans and protocols, we will be delayed in completing, or may not be able to complete, the preclinical and clinical studies required to support future Investigational New Drug Application (IND) submissions and approval of our product candidates. Any of these events could lead to clinical study delays or failure to obtain regulatory approval, or impact our ability to successfully commercialize future products. Some of these events could be the basis for FDA action, including injunction, request for voluntary recall, seizure or total or partial suspension of production. </p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">40</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU41\"></a><font style=\"font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">We contract with third parties for the manufacture of our product candidates for preclinical and clinical testing and expect to continue to do so for commercialization. This reliance on third parties increases the risk that we will not have sufficient q</font><font style=\"font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">uantities of our product candidates or medicines or that such supply will not be available to us at an acceptable cost, which could delay, prevent or impair our development or commercialization efforts. </font></p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We do not have any manufacturing facilities. We currently rely, and expect to continue to rely, on third-party manufacturers for the manufacture of our product candidates for preclinical and clinical testing and for the commercial supply of any of these product candidates for which we or our collaborators obtain marketing approval. To date, we have obtained materials for mavacamten for our clinical trials from third-party manufacturers, <font style=\"Background-color:#FFFFFF;color:#000000;\">and we intend to rely on third-party manufacturers for our planned Phase 2 and Phase 3 clinical development activities for mavacamten and Phase 1b and Phase 2 clinical trials of MYK-491</font>. We do not have a long-term supply agreement with the third-party manufacturers, and we purchase our required drug supply on a purchase order basis. We may be unable to establish any agreements with third-party manufacturers or to do so on acceptable terms.\u00a0\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Reliance on third-party manufacturers entails risks to which we would not be subject if we manufactured the product candidates ourselves, including: </p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the inability to negotiate manufacturing agreements with third parties under commercially reasonable terms; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">reduced control as a result of using third-party manufacturers for all aspects of manufacturing activities; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">reliance on the third party for regulatory compliance, quality assurance, and safety and pharmacovigilance reporting; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the possible breach of the manufacturing agreement by the third party; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the possible termination or nonrenewal of the agreement by the third party at a time that is costly or inconvenient for us;\u00a0and </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">disruptions to the operations of our third-party manufacturers or suppliers caused by conditions unrelated to our business or operations, including the bankruptcy of the manufacturer or supplier. </font></p></td></tr></table></div>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The facilities used by our contract manufacturers to manufacture any of our future products must be evaluated by the FDA pursuant to inspections that will be conducted after we submit an NDA to the FDA. We do not control the manufacturing process of, and are completely dependent on, our contract manufacturing partners for compliance with the cGMP regulation for manufacture of both active drug substances and finished drug products. If our contract manufacturers cannot successfully manufacture material that conforms to our specifications and the strict regulatory requirements of the FDA or others, they will not be able to secure and/or maintain regulatory approval for their manufacturing facilities or our marketing applications will not be approved. In addition, we have no control over the ability of our contract manufacturers to maintain adequate quality control, quality assurance and qualified personnel. If the FDA or a comparable foreign regulatory authority finds deficiencies with or does not approve these facilities for the manufacture of our product candidates or if it finds deficiencies or withdraws any such approval in the future, we may need to find alternative manufacturing facilities, which would significantly impact our ability to develop, obtain regulatory approval for or market our product candidates, if approved. Third-party manufacturers may not be able to comply with cGMP regulations or similar regulatory requirements outside the United States. Our failure, or the failure of our third-party manufacturers, to comply with applicable regulations could result in sanctions being imposed on us, including fines, injunctions, civil penalties, delays, suspension or withdrawal of approvals, license revocation, seizures or voluntary recalls of product candidates or medicines, operating restrictions and criminal prosecutions, any of which could significantly and adversely affect supplies of our medicines and harm our business and results of operations. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Any products that we may develop may compete with our other product candidates and products and the products of third parties for access to manufacturing facilities. There are a limited number of manufacturers that operate under cGMP regulations and that might be capable of manufacturing for us. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Any performance failure on the part of our existing or future manufacturers could delay clinical development or marketing approval. We do not currently have arrangements in place for a redundant supply of bulk drug substances. If any one of our current contract manufacturers cannot perform as agreed, we may be required to replace that manufacturer. Although we believe that there are several potential alternative manufacturers who could manufacture our product candidates, we may incur added costs and delays in identifying and qualifying any such replacement. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Our current and anticipated future dependence upon others for the manufacture of our product candidates or medicines may adversely affect our future profit margins and our ability to commercialize any medicines that receive marketing approval on a timely and competitive basis. </p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">41</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU42\"></a><font style=\"font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Risks Related to Our Intellectual Property </font></p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">If we are unable to obtain and maintain patent protection for our medicines and technology, or if the scope of the patent protection obtained is not sufficiently broad, our competitors could develop and commercialize medicines and technology similar or identical to ours, and our ability to successfully commercialize our medicines and technology may be adversely affected. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Our commercial success will depend, in part, on our ability to obtain and maintain patent protection in the United States and other countries with respect to our proprietary products and technology. We seek to protect our proprietary position by filing patent applications in the United States and abroad related to our novel technologies and medicines that are important to our business. To date, we own three issued United States patents that cover our proprietary technology or product candidates. We cannot be certain that we will secure any additional rights to any issued patents with claims that cover any of our proprietary technology or product candidates. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The patent prosecution process is expensive and time-consuming, and we may not be able to file and prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner. It is also possible that we will fail to identify patentable aspects of our research and development output before it is too late to obtain patent protection. Although we enter into non-disclosure and confidentiality agreements with parties who have access to patentable aspects of our research and development output, such as our employees, corporate collaborators, outside scientific collaborators, CROs, contract manufacturers, consultants, advisors and other third parties, any of these parties may breach the agreements and disclose such output before a patent application is filed, thereby jeopardizing our ability to seek patent protection.</p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">In addition to seeking patents for some of our technology and medicines, we also rely on trade secrets, including unpatented know-how, technology and other proprietary information, to maintain our competitive position. With respect to our proprietary molecularly targeted small molecule drugs, we consider trade secrets and know-how to be our primary intellectual property. Trade secrets and know-how can be difficult to protect. In particular, we anticipate that with respect to our precision medicine platform, these trade secrets and know-how will over time be disseminated within the industry through independent development, the publication of journal articles describing the methodology, and the movement of personnel skilled in the art from academic to industry scientific positions. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We seek to protect these trade secrets, in part, by entering into non-disclosure and confidentiality agreements with parties who have access to them, such as our employees, corporate collaborators, outside scientific collaborators, CROs, contract manufacturers, consultants, advisors and other third parties. We also enter into confidentiality and invention or patent assignment agreements with our employees and consultants. Despite these efforts, any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets, and we may not be able to obtain adequate remedies for such breaches. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, some courts inside and outside the United States are less willing or unwilling to protect trade secrets. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor or other third party, we would have no right to prevent them from using that technology or information to compete with us. If any of our trade secrets were to be disclosed to or independently developed by a competitor or other third party, our competitive position would be harmed. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">Third-party claims of intellectual property infringement may prevent or delay our development and commercialization efforts. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_cp_text_1_206\"></a>Our commercial success depends in part on our avoiding infringement of the patents and proprietary rights of third parties. There is a substantial amount of litigation, both within and outside the United States, involving patent and other intellectual property rights in the biotechnology and pharmaceutical industries, including patent infringement lawsuits, interferences, oppositions and\u00a0<font style=\"font-style:italic;\">inter partes</font>\u00a0reexamination proceedings before the <a name=\"_cp_text_1_206\"></a>U.S. Patent and Trademark Office, or the U.S. PTO, and corresponding foreign patent offices. Numerous U.S. and foreign issued patents and pending patent applications, which are owned by third parties, exist in the fields in which we are pursuing development candidates. As the biotechnology and pharmaceutical industries expand and more patents are issued, the risk increases that our product candidates may be subject to claims of infringement of the patent rights of third parties. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Third parties may assert that we are employing their proprietary technology without authorization. There may be third-party patents or patent applications with claims to materials, formulations, methods of manufacture or methods for treatment related to the use or manufacture of our product candidates. Because patent applications can take many years to issue, there may be currently pending patent applications which may later result in issued patents that our product candidates may infringe. In addition, third parties may obtain patents in the future and claim that use of our technologies infringes upon these patents. If any third-party patents were held by a court of competent jurisdiction to cover the manufacturing process of any of our product candidates, any molecules formed during the manufacturing process or any final product itself, the holders of any such patents may be able to block our ability to commercialize such product candidate unless we obtained a license under the applicable patents, or until such patents expire. </p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">42</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU43\"></a><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Similarly, if any third-party patents were held by a court of competent jurisdiction to cover aspects of our formulations, processes for manufacture or methods of use, including combina</font><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">tion therapy, the holders of any such patents may be able to block our ability to develop and commercialize the applicable product candidate unless we obtained a license or until such patent expires. In either case, such a license may not be available on c</font><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">ommercially reasonable terms or at all. </font></p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Parties making claims against us may obtain injunctive or other equitable relief, which could effectively block our ability to further develop and commercialize one or more of our product candidates. Defense of these claims, regardless of their merit, would involve substantial litigation expense and would be a substantial diversion of employee resources from our business. In the event of a successful claim of infringement against us, we may have to pay substantial damages, including treble damages and attorneys\u2019 fees for willful infringement, pay royalties, redesign our infringing products or obtain one or more licenses from third parties, which may be impossible or require substantial time and monetary expenditure. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Parties making claims against us may be able to sustain the costs of complex patent litigation more effectively than we can because they have substantially greater resources. In addition, any uncertainties resulting from the initiation and continuation of any litigation could have material adverse effect on our ability to raise additional funds or otherwise have a material adverse effect on our business, results of operations, financial condition and prospects. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">We may be involved in lawsuits to protect or enforce our patents or the patents of our licensors, which could be expensive, time-consuming and unsuccessful. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Competitors may infringe our patents or the patents of our licensors. To counter infringement or unauthorized use, we may be required to file infringement claims, which can be expensive and time-consuming. In addition, in an infringement proceeding, a court may decide that a patent of ours or our licensors is not valid, is unenforceable and/or is not infringed, or may refuse to stop the other party from using the technology at issue on the grounds that our patents do not cover the technology in question. Interference proceedings provoked by third parties or brought by us may be necessary to determine the priority of inventions with respect to our patents or patent applications or those of our licensors. An adverse result in any litigation or defense proceedings could put one or more of our patents at risk of being invalidated or interpreted narrowly and could put our patent applications at risk of not issuing. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">An unfavorable outcome could require us to cease using the related technology or to attempt to license rights to it from the prevailing party. Our business could be harmed if the prevailing party does not offer us a license on commercially reasonable terms. Our defense of litigation or interference proceedings may fail and, even if successful, may result in substantial costs and distract our management and other employees. We may not be able to prevent, alone or with our licensors, misappropriation of our intellectual property rights, particularly in countries where the laws may not protect those rights as fully as in the United States. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. There could also be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a material adverse effect on the price of our common stock. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">We may be subject to claims challenging the inventorship or ownership of our patents and other intellectual property. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We may also be subject to claims that former employees, collaborators or other third parties have an ownership interest in our patents or other intellectual property. In the future, we may have ownership disputes arising, for example, from conflicting obligations of consultants or others who are involved in developing our product candidates. Litigation may be necessary to defend against these and other claims challenging inventorship or ownership. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, valuable intellectual property. Such an outcome could have a material adverse effect on our business. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">Issued patents covering our product candidates could be found invalid or unenforceable if challenged in court. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU44\"></a>If we or one of our licensing partners initiated legal proceedings against a third party to enforce a patent covering one of our product candidates, the defendant could counterclaim that the patent covering our product candidate is invalid and/or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity and/or unenforceability are commonplace. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including lack of novelty, obviousness or non-enablement. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant information from the U.S. PTO, or made a misleading statement, during prosecution. Third parties may also raise similar claims before administrative bodies in the United States or abroad, even outside the context of litigation. </p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">43</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Such mechanisms include re-examination, post grant review, and equivalent proceedings in foreign jurisd</font><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">ictions (e.g., opposition proceedings). Such proceedings could result in revocation or amendment to our patents in such a way that they no longer cover our product candidates. The outcome following legal assertions of invalidity and unenforceability is unp</font><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">redictable. With respect to the validity question, for example, we cannot be certain that there is no invalidating prior art, of which we and the patent examiner were unaware during prosecution. If a defendant were to prevail on a legal assertion of invali</font><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">dity and/or unenforceability, we would lose at least part, and perhaps all, of the patent protection on our product candidates. Such a loss of patent protection would have a material adverse impact on our business. </font></p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">We may be subject to claims that our employees, consultants or independent contractors have wrongfully used or disclosed confidential information of third parties or that our employees have wrongfully used or disclosed alleged trade secrets of their former employers. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">As is common in the biotechnology and pharmaceutical industry, we employ individuals who were previously employed at universities or other biotechnology or pharmaceutical companies, including our competitors or potential competitors. Although we try to ensure that our employees, consultants and independent contractors do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or our employees, consultants or independent contractors have inadvertently or otherwise used or disclosed intellectual property, including trade secrets or other proprietary information, of any of our employee\u2019s former employer or other third parties. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel, which could adversely impact our business. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Risks Related to Commercialization and the Market for Our Product Candidates </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">If the market opportunities for our product candidates are smaller than we believe they are or if we are unable to market our products to expanded patient populations, our revenues may be adversely affected and our business may suffer. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We focus our research and product development efforts on treatments for heritable cardiomyopathies, and our targeted indications are rare genetic diseases. In particular, we estimate that approximately 630,000 people in the United States have a form of HCM, and that approximately 360,000 people in the United States have a form of genetic DCM. Our projections of both the number of people who have these diseases, as well as the subset of people with these diseases who have the potential to benefit from treatment with our product candidates, are based on estimates derived from primary research with physicians and payors, analysis of medical journals and peer-reviewed literature, the work of third-party consultants and other publicly- or non-publicly-available data sources. These estimates may prove to be incorrect and new studies may change the estimated incidence or prevalence of our targeted disease indications. The number of patients in the United States, Europe and elsewhere may turn out to be lower than expected, may not be otherwise amenable to treatment with our products, and new patients may become increasingly difficult to identify or gain access to, all of which would adversely affect our results of operations and our business. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Additionally, because the target patient populations of our product candidates are small, we must be able to successfully identify patients and achieve a significant market share to achieve or maintain profitability and growth. Although we plan to use SHaRe to identify and select patients who are suitable for treatment with our products, if approved, we may not be able to identify or target a sufficient number of patients through SHaRe or our sales and marketing efforts to achieve the necessary market share. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">Even if any of our product candidates receive marketing approval, they may fail to achieve the degree of market acceptance by physicians, patients, healthcare payors and others in the medical community necessary for commercial success. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">If any of our product candidates receive marketing approval, they may nonetheless fail to gain sufficient market acceptance by physicians, patients, healthcare payors and others in the medical community. For example, current cardiovascular disease treatments such as beta blockers, non-dihydropyridine calcium channel blockers and disopyramide are well-established in the medical community, and doctors may continue to rely on these treatments. If our product candidates do not achieve an adequate level of acceptance, we may not generate significant product revenues and we may not become profitable. The degree of market acceptance of our product candidates, if approved for commercial sale, will depend on a number of factors, including: </p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">efficacy and potential advantages compared to alternative treatments; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the ability to offer our medicines for sale at competitive prices; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">convenience and ease of administration compared to alternative treatments; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the willingness of the target patient population to try new therapies and of physicians to prescribe these therapies; </font></p></td></tr></table></div>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">44</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU45\"></a><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"></font><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"></font><font style=\"font-family:Times New Roman;\">the strength of marketing and distribution support; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">sufficient third-party coverage or reimbursement; and </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the prevalence and severity of any side effects. </font></p></td></tr></table></div>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Any failure to achieve or maintain sufficient market acceptance of <font style=\"color:#000000;\">mavacamten</font>, MYK-491 or any of our other product candidates, if approved, could significantly harm our business, prospects, financial condition and results of operations.</p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">If we are unable to establish sales and marketing capabilities or enter into agreements with third parties to market and sell our product candidates, we may be unable to generate any revenues. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We have no experience marketing or selling our product candidates. To successfully commercialize any products that may result from our development programs, we will need to develop these capabilities, either on our own or with others. We may enter into collaborations with other entities to utilize their mature marketing and distribution capabilities, but we may be unable to enter into marketing agreements on favorable terms, if at all. If our future collaborations do not commit sufficient resources to commercialize our future products, if any, and we are unable to develop the necessary marketing capabilities on our own, we will be unable to generate sufficient product revenue to sustain our business. We will be competing with many companies that currently have extensive and well-funded marketing and sales operations. Without an internal team or the support of a third party to perform marketing and sales functions, we may be unable to compete successfully against these more established companies. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">The insurance coverage and reimbursement status of newly-approved products targeting small patient populations is uncertain. Failure to obtain or maintain adequate coverage and reimbursement for our product candidates, if approved, could limit our ability to market those products and decrease our ability to generate revenue. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The availability and extent of reimbursement by governmental and private payors is essential for most patients to be able to afford expensive treatments, such as endothelin receptor antagonists used in the treatment of certain cardiovascular diseases. Sales of our product candidates will depend substantially, both domestically and abroad, on the extent to which the costs of our product candidates will be paid by health maintenance, managed care, pharmacy benefit and similar healthcare management organizations, or reimbursed by government health administration authorities, private health coverage insurers and other third-party payors. Additionally, therapies directed at small patient populations, such as our product candidates, may be more expensive, and reimbursement options for these therapies may be more limited. If reimbursement or coverage is not available, or is available only to limited levels, we may not be able to successfully commercialize our product candidates. Even if coverage is provided, the approved reimbursement amount may not be high enough to allow us to establish or maintain pricing sufficient to realize a sufficient return on our investment. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_cp_text_1_208\"></a><a name=\"_cp_text_1_209\"></a>There is significant uncertainty related to the insurance coverage and<a name=\"_cp_text_1_208\"></a> reimbursement of newly approved products and for products whose targeted patient populations are small. In the United States, the principal decisions about reimbursement for new medicines are typically made by the Centers for Medicare\u00a0&amp; Medicaid Services (\u201c<a name=\"_cp_text_1_209\"></a>CMS\u201d), an agency within the U.S. Department of Health and Human Services, as CMS decides whether and to what extent a new medicine will be covered and reimbursed under Medicare. Private payors tend to follow CMS to a substantial degree. It is difficult to predict what CMS or third-party payors will decide with respect to reimbursement and coverage for fundamentally novel products such as ours, as there is no body of established practices and precedents for these new products. Reimbursement agencies in Europe may be more conservative than CMS. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Outside the United States, international operations are generally subject to extensive governmental price controls and other market regulations, and we believe the increasing emphasis on cost-containment initiatives in Europe, Canada, and other countries may put pressure on the pricing and usage of our product candidates. In many countries, the prices of medical products are subject to varying price control mechanisms as part of national health systems. In general, the prices of medicines under such systems are substantially lower than in the United States. Other countries allow companies to fix their own prices for medicines, but monitor and control company profits. Additional foreign price controls or other changes in pricing regulation could restrict the amount that we are able to charge for our product candidates. Accordingly, in markets outside the United States, the reimbursement for our products may be reduced compared with the United States and may be insufficient to generate commercially reasonable revenues and profits. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Moreover, increasing efforts by governmental and third-party payors, in the United States and abroad, to cap or reduce healthcare costs may cause such organizations to limit both coverage and the level of reimbursement for new products approved and, as a result, they may not cover or provide adequate payment for our product candidates. We expect to experience pricing pressures in connection with the sale of any of our product candidates, due to the trend toward managed healthcare, the increasing influence of health maintenance organizations and additional legislative changes. The downward pressure on healthcare costs in general, particularly prescription drugs and surgical procedures and other treatments, has become very intense. As a result, increasingly high barriers are being erected to the entry of new products. </p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">45</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU46\"></a><font style=\"font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Risk Related to Our Business and Industry </font></p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">We may be subject to healthcare, health information privacy and security laws, regulation and enforcement, and our failure to comply with these laws could harm our results of operations and financial conditions. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Although we do not currently have any products on the market, if we obtain FDA approval for any of our product candidates and begin commercializing those products in the United States, our operations may be directly, or indirectly through our customers and third-party payors, subject to various U.S. federal and state fraud and abuse, patient privacy laws and other healthcare regulatory laws, and to additional healthcare, statutory and regulatory requirements and enforcement by foreign regulatory authorities in jurisdictions in which we conduct our business. Healthcare providers, physicians and others play a primary role in the recommendation and prescription of any products for which we obtain marketing approval. These laws may impact, among other things, our proposed sales, marketing and education programs and constrain the business of financial arrangements and relationships with healthcare providers, physicians and other parties through which we market, sell and distribute our products for which we obtain marketing approval. The laws that may affect our ability to operate include: </p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the U.S. federal Anti-Kickback Statute, which prohibits, among other things, persons or entities from knowingly and willfully soliciting, offering, receiving or paying any remuneration (including any kickback, bribe, or certain rebate), directly or indirectly, overtly or covertly, in cash or in kind, to induce or reward either the referral of an individual for, or the purchase, lease, order or recommendation of, any good, facility, item or service, for which payment may be made, in whole or in part, under U.S. federal and state healthcare programs such as Medicare and Medicaid. A person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the U.S. federal False Claims Act, which imposes civil penalties, including through civil whistleblower or qui tam actions, against individuals or entities for knowingly presenting, or causing to be presented, to the U.S. federal government, claims for payment or approval that are false or fraudulent or from knowingly making a false statement to avoid, decrease or conceal an obligation to pay money to the U.S. federal government. In addition, the government may assert that a claim including items and services resulting from a violation of the U.S. federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the False Claims Act; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><a name=\"_cp_text_1_211\"></a><a name=\"_cp_text_1_213\"></a><font style=\"font-family:Times New Roman;\">the U.S. federal Health Insurance Portability and Accountability <a name=\"_cp_text_1_211\"></a>Act of 1996 (\u201c<a name=\"_cp_text_1_213\"></a>HIPAA\u201d) which imposes criminal and civil liability for knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, or knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false statement, in connection with the delivery of, or payment for, healthcare benefits, items or services; similar to the U.S. federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><a name=\"_cp_text_1_215\"></a><a name=\"_cp_text_1_217\"></a><font style=\"font-family:Times New Roman;\">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health <a name=\"_cp_text_1_215\"></a>Act of 2009 (\u201c<a name=\"_cp_text_1_217\"></a>HITECH\u201d) and its implementing regulations, and as amended again by the final HIPAA omnibus rule, Modifications to the HIPAA Privacy, Security, Enforcement and Breach Notification Rules Under HITECH and the Genetic Information Nondiscrimination Act; Other Modifications to the HIPAA Rules, published in January 2013, which imposes certain obligations, including mandatory contractual terms, with respect to safeguarding the privacy, security and transmission of individually identifiable health information without appropriate authorization on covered entities subject to the rule, such as health plans, healthcare clearinghouses and healthcare providers as well as their business associates that perform certain services involving the use or disclosure of individually identifiable health information; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><a name=\"_cp_text_1_219\"></a><a name=\"_cp_text_1_221\"></a><font style=\"font-family:Times New Roman;\">the U. S. Federal Food, Drug, and <a name=\"_cp_text_1_219\"></a>Cosmetic Act (\u201c<a name=\"_cp_text_1_221\"></a>FDCA\u201d) which prohibits, among other things, the adulteration or misbranding of drugs, biologics and medical devices; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><a name=\"_cp_text_1_226\"></a><font style=\"font-family:Times New Roman;\">the U. S. legislation commonly referred to as the Physician Payments Sunshine Act, <a name=\"_cp_text_1_226\"></a>enacted as part of the ACA and its implementing regulations, which requires certain manufacturers of drugs, devices, biologics and medical supplies that are reimbursable under Medicare, Medicaid, or the Children\u2019s Health Insurance Program to report annually to CMS, information related to payments and other transfers of value to physicians and teaching hospitals, as well as ownership and investment interests held by physicians\u00a0\u00a0and their immediate family members; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">Federal consumer protection and unfair competition laws, which broadly regulate marketplace activities and activities that potentially harm consumers;</font></p></td></tr></table></div>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">46</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU47\"></a><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"></font><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"></font><font style=\"font-family:Times New Roman;\">analogous state laws and regulations, including: state anti-kickback and false claims laws, which may apply to our business practices, including but not limited to, research, distribution, sales and marketing arrangements and claim</font><font style=\"font-family:Times New Roman;\">s involving healthcare items or services reimbursed by any third-party payor, including private insurers; state laws that require pharmaceutical companies to comply with the pharmaceutical industry\u2019s voluntary compliance guidelines and the relevant complia</font><font style=\"font-family:Times New Roman;\">nce guidance promulgated by the U.S. federal government, or otherwise restrict payments that may be made to healthcare providers and other potential referral sources; and state laws and regulations that require drug manufacturers to file reports relating t</font><font style=\"font-family:Times New Roman;\">o pricing and marketing information, which requires tracking gifts and other remuneration and items of value provided to healthcare professionals and entities, and state laws governing the privacy and security of health information in certain circumstances</font><font style=\"font-family:Times New Roman;\">, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts; and </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">European and other foreign law equivalents of each of the laws, including reporting requirements detailing interactions with and payments to healthcare providers. </font></p></td></tr></table></div>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">In addition, regulators globally are also imposing greater monetary fines for privacy violations. For example, in 2016, the European Union adopted a new regulation governing data practices and privacy called the General Data Protection Regulation, or GDPR, which became effective on May 25, 2018. The GDPR applies to any company established in the European Union as well as to those outside the European Union if they collect and use personal data in connection with the offering goods or services to individuals in the European Union or the monitoring of their behavior.\u00a0The GDPR enhances data protection obligations for processors and controllers of personal data, including, for example, special protections for \u201csensitive information\u201d such as health and genetic information, expanded disclosures about how personal information is to be used, limitations on retention of information, mandatory data breach notification requirements and onerous new obligations on service providers. Non-compliance with the GDPR may result in monetary penalties of up to \u20ac20 million or 4% of worldwide revenue, whichever is higher. The GDPR and other changes in laws or regulations associated with the enhanced protection of certain types of personal data, such as healthcare data or other sensitive information, could greatly increase our cost of developing or commercializing our product candidates or impair our ability to collect data from patients resident in the European Union.</p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Efforts to ensure that our business arrangements with third parties will comply with applicable healthcare laws and regulations will involve substantial costs. It is possible that governmental authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our operations are found to be in violation of any of the laws described above or any other governmental laws and regulations that may apply to us, we may be subject to significant penalties, including civil, criminal and administrative penalties, damages, fines, exclusion from U.S. government funded healthcare programs, such as Medicare and Medicaid, and the curtailment or restructuring of our operations. If any of the physicians or other providers or entities with whom we expect to do business is found not to be in compliance with applicable laws, they may be subject to criminal, civil or administrative sanctions, including exclusions from government funded healthcare programs and imprisonment. If any of the above occur, it could adversely affect our ability to operate our business and our results of operations. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">We face significant competition from other biotechnology and pharmaceutical companies, and our operating results will suffer if we fail to compete effectively. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Our competitors may develop drugs that are less expensive, safer, or more effective, which may diminish or eliminate the commercial success of any drugs that we may commercialize. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Our competitors may: </p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">develop drug candidates and market drugs that are less expensive or more effective than our future drugs; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">commercialize competing drugs before we or our partners can launch any drugs developed from our drug candidates; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">initiate or withstand substantial price competition more successfully than we can; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">have greater success in recruiting skilled scientific workers from the limited pool of available talent; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">more effectively negotiate third-party licenses and strategic collaborations; and </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">take advantage of acquisition or other opportunities more readily than we can. </font></p></td></tr></table></div>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">47</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU48\"></a><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We will compete for market share against large pharmaceutical and biotechnology compan</font><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">ies and smaller companies that are collaborating with larger pharmaceutical companies, new companies, academic institutions, government agencies and other public and private research organizations. Many of these competitors, either alone or together with t</font><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">heir partners, may develop new drug candidates that will compete with ours, as these competitors may, and in certain cases do, operate larger research and development programs or have substantially greater financial resources than we do. Our competitors ma</font><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">y also have significantly greater experience in: </font></p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">developing product candidates; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">undertaking preclinical testing and clinical trials; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">building relationships with key customers and opinion-leading physicians; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">obtaining and maintaining FDA and other regulatory approvals of product candidates; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">formulating and manufacturing drugs; and </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">launching, marketing and selling drugs. </font></p></td></tr></table></div>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">If our competitors market drugs that are less expensive, safer or more effective than our potential drugs, or that reach the market sooner than our potential drugs, we may not achieve commercial success. In addition, the life sciences industry is characterized by rapid technological change. Because our research approach integrates many technologies, it may be difficult for us to stay abreast of the rapid changes in each technology. If we fail to stay at the forefront of technological change, we may be unable to compete effectively. Our competitors may render our technologies obsolete by advances in existing technological approaches or the development of new or different approaches, potentially eliminating the advantages in our drug discovery process that we believe we derive from our research approach and proprietary technologies. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">Public opinion and heightened regulatory scrutiny of precision medicine for the treatment of cardiovascular disease may impact public perception of our product candidates or adversely affect our ability to conduct our business or obtain regulatory approvals for our product candidates. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Precision medicine remains a novel technology, particularly in the field of cardiovascular disease, with no products approved to date in the United\u00a0States that are specifically targeted at correcting the underlying biomechanical defects in cardiac contractility associated with HCM and DCM. Public perception may be influenced by claims that these therapies are unproven or unsafe, and our product candidates may not gain the acceptance of the public or the medical community. In particular, our success will depend upon physicians, who specialize in the treatment of those diseases that our product candidates target, prescribing treatments that involve the use of our product candidates in lieu of, or in addition to, existing treatments they are already familiar with and for which greater clinical data may be available. More restrictive government regulations or negative public opinion could have an adverse effect on our business or financial condition and may delay or impair the development and commercialization of our product candidates or demand for any products we may develop. Adverse events in our clinical trials, even if not ultimately attributable to our product candidates, and the resulting publicity, could result in increased governmental regulation, unfavorable public perception, potential regulatory delays in the testing or approval of our product candidates, stricter labeling requirements for those product candidates that are approved and a decrease in demand for any such product candidates. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">Healthcare legislative reform measures may have a material adverse effect on our business and results of operations. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">In the United States, the EU, and other foreign jurisdictions, there have been a number of legislative and regulatory changes to the healthcare system that could affect our future results of operations. In particular, there have been and continue to be a number of initiatives at the United States federal and state levels that seek to reduce healthcare costs and improve the quality of healthcare. For example, ACA changes the way healthcare is financed by both governmental and private insurers and significantly impacts the U.S. pharmaceutical and biotechnology industries. ACA, among other things, subjects biologic products to potential competition by lower-cost biosimilars, addresses a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted or injected, increases the minimum Medicaid rebates owed by manufacturers under the Medicaid Drug Rebate Program and extends the rebate program to individuals enrolled in Medicaid managed care organizations, establishes annual fees and taxes on manufacturers of certain branded prescription drugs and biologic products, and a new Medicare Part\u00a0D coverage gap discount program, in which manufacturers must agree to offer 50% point-of-sale discounts off negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage gap period, as a condition for the manufacturer\u2019s outpatient drugs to be covered under Medicare Part\u00a0D. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU49\"></a>The new presidential administration has indicated that enacting change to the ACA is a legislative priority, and has alternatively discussed repealing and replacing the ACA. In January 2017, Congress voted to adopt a budget resolution for fiscal year 2017, that </p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">48</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">while not a law, is widely viewed as the first step toward the pa</font><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">ssage of legislation that would repeal certain aspects of the ACA.\u00a0\u00a0The 2017 Tax Reform Act includes a provision repealing the individual mandate, effective January 1, 2019.\u00a0\u00a0Further, on January 20, 2017, U.S. President Donald Trump signed an Executive Ord</font><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">er directing federal agencies with authorities and responsibilities under the ACA to waive, defer, grant exemptions from, or delay the implementation of any provision of the ACA that would impose a fiscal burden on states or a cost, fee, tax, penalty or re</font><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">gulatory burden on individuals, healthcare providers, health insurers, or manufacturers of pharmaceuticals or medical devices. On October 13, 2017, President Trump signed an Executive Order terminating the cost-sharing subsidies that reimburse the insurers</font><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"> under the ACA.\u00a0\u00a0Several state Attorneys General filed suit to stop the administration from terminating the subsidies, but their request for a restraining order was denied by a federal judge in California on October 25, 2017.\u00a0\u00a0In addition, CMS has recently</font><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"> proposed regulations that would give states greater flexibility in setting benchmarks for insurers in the individual and small group marketplaces, which may have the effect of relaxing the essential health benefits required under the ACA for plans sold th</font><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">rough these marketplaces.\u00a0\u00a0Thus, there may be further action to repeal, replace, or modify the ACA. While any further legislative and regulatory changes will likely take time to develop, and may or may not have an impact on the regulatory regime to which w</font><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">e are subject, we cannot predict the ultimate content, timing or effect of any healthcare reform legislation or the impact of potential legislation on us.</font></p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">In addition, other legislative changes have been proposed and adopted in the United States since ACA was enacted. On August\u00a02, 2011, the Budget Control Act of 2011, among other things, created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, was unable to reach required goals, thereby triggering the legislation\u2019s automatic reduction to several government programs. This includes aggregate reductions of Medicare payments to providers of 2%\u00a0per fiscal year. These reductions went into effect on April\u00a01, 2013 and, due to subsequent legislative amendments to the statute, will remain in effect through 2025 unless additional Congressional action is taken. On January\u00a02, 2013, the American Taxpayer Relief Act of 2012 was signed into law, which, among other things, further reduced Medicare payments to several types of providers, including hospitals, imaging centers and cancer treatment centers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. These new laws may result in additional reductions in Medicare and other health care funding, which could have a material adverse effect on our customers and accordingly, our financial operations. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Moreover, payment methodologies may be subject to changes in healthcare legislation and regulatory initiatives. For example, CMS may develop new payment and delivery models, such as bundled payment models. The U.S. federal government has set a goal of moving 50% of Medicare payments into these \u201cAlternative Payment Models\u201d by the end of 2018. <font style=\"Background-color:#FFFFFF;color:#000000;\">In addition, recently there has been heightened governmental scrutiny over the manner in which drug manufacturers set prices for their commercial products.</font><font style=\"Background-color:#FFFFFF;color:#000000;font-size:12pt;\">\u00a0</font>We expect that additional U.S. federal healthcare reform measures will be adopted in the future, any of which could limit the amounts that the U.S. federal government will pay for healthcare products and services, which could result in reduced demand for our product candidates or additional pricing pressures. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">Our future success depends on our ability to retain key employees and consultants, including our scientific advisors and founders, and to attract, retain and motivate qualified personnel. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We are highly dependent on our scientific advisors and founders and the principal members of our executive team, the loss of whose services may adversely impact the achievement of our objectives. While we have entered into employment agreements with each of our executive officers, any of them could leave our employment at any time, as all of our employees are \u201cat will\u201d employees. Recruiting and retaining other qualified employees, consultants and advisors for our business, including scientific and technical personnel, will also be critical to our success. There is currently a shortage of skilled executives and scientific experts in our industry, which is likely to continue. As a result, competition for skilled personnel is intense and the turnover rate can be high. We may not be able to attract and retain personnel on acceptable terms given the competition among numerous pharmaceutical and biotechnology companies, as well as from academic and research institutions, for individuals with similar skill sets. In addition, any failure of our programs to succeed in preclinical studies or clinical trials may make it more challenging to recruit and retain qualified personnel. The inability to recruit or the loss of the services of any executive, key employee, consultant or advisor may impede the progress of our research, development and commercialization objectives. </p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">49</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU50\"></a><font style=\"font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">We will need to expand our organization and we may experience difficulties in managing this growth, which could disrupt our operations. </font></p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">As of June 30, 2018, we had 147 full-time employees. As we mature, we expect to expand our full-time employee base and to hire more consultants and contractors. Our management may need to divert a disproportionate amount of its attention away from our day-to-day activities and devote a substantial amount of time to managing these growth activities. We may not be able to effectively manage the expansion of our operations, which may result in weaknesses in our infrastructure, operational mistakes, loss of business opportunities, loss of employees and reduced productivity among remaining employees. Our expected growth could require significant capital expenditures and may divert financial resources from other projects, such as the development of additional product candidates. If our management is unable to effectively manage our growth, our expenses may increase more than expected, our ability to generate and/or grow revenues could be reduced, and we may not be able to implement our business strategy. Our future financial performance and our ability to commercialize product candidates and compete effectively will depend, in part, on our ability to effectively manage any future growth. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">We may expend our limited resources to pursue a particular product candidate or indication and fail to capitalize on product candidates or indications that may be more profitable or for which there is a greater likelihood of success. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Because we have limited financial and managerial resources, we focus on research programs and product candidates that we identify for specific indications. As a result, we may forego or delay pursuit of opportunities with other product candidates or for other indications that later prove to have greater commercial potential. Our resource allocation decisions may cause us to fail to capitalize on viable commercial medicines or profitable market opportunities. Our spending on current and future research and development programs and product candidates for specific indications may not yield any commercially viable medicines. If we do not accurately evaluate the commercial potential or target market for a particular product candidate, we may relinquish valuable rights to that product candidate through collaboration, licensing or other royalty arrangements in cases in which it would have been more advantageous for us to retain sole development and commercialization rights to such product candidate. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">Our anticipated international operations may expose us to business, regulatory, political, operational, financial, pricing and reimbursement and economic risks associated with doing business outside of the United States. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We have a wholly-owned Australian subsidiary through which we conduct clinical trials in Australia. Our business strategy also contemplates potential additional international operations as we seek to continue the development of <font style=\"color:#000000;\">mavacamten</font>, MYK-491 and other product candidates that we have or may identify, seek regulatory approval for our product candidates, and commercialize any product candidates that are approved outside the United States. If any product candidates for which we have retained worldwide commercial rights are approved, we may hire sales representatives and conduct physician and patient group outreach activities outside of the United States. Doing business internationally involves a number of risks, including but not limited to: </p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">multiple, conflicting, and changing laws and regulations such as privacy regulations, tax laws, export and import restrictions, employment laws, regulatory requirements, and other governmental approvals, permits, and licenses; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">failure by us to obtain and maintain regulatory approvals for the use of our products in various countries; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">complexities and difficulties in obtaining protection for and enforcing our intellectual property rights; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">difficulties in staffing and managing foreign operations; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">complexities associated with managing multiple payor reimbursement regimes, government payors, or patient self-pay systems; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">limits in our ability to penetrate international markets; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">financial risks, such as exposure to foreign currency exchange rate fluctuations and their impact on payments required in local currency; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">natural disasters, political and economic instability, including wars, terrorism, and political unrest, outbreak of disease, boycotts, curtailment of trade, and other business restrictions; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">certain expenses including, among others, expenses for travel, translation, and insurance; and </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">regulatory and compliance risks that relate to maintaining accurate information and control over sales and activities that may fall within the purview of the U.S. Foreign Corrupt Practices Act, its books and records provisions, or its anti-bribery provisions. </font></p></td></tr></table></div>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Any of these factors could significantly harm our future international expansion and operations and, consequently, our results of operations. </p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">50</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU51\"></a><font style=\"font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">If we fail to comply with environmental, health and safety laws and regulations, we could become subject to </font><font style=\"font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">fines or penalties or incur costs that could have a material adverse effect on the success of our business. </font></p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We are subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment and disposal of hazardous materials and wastes. Our operations involve the use of hazardous and flammable materials, including chemicals and biological materials. Our operations also produce hazardous waste products. We generally contract with third parties for the disposal of these materials and wastes. We cannot eliminate the risk of contamination or injury from these materials. In the event of contamination or injury resulting from our use of hazardous materials, we could be held liable for any resulting damages, and any liability could exceed our resources. We also could incur significant costs associated with civil or criminal fines and penalties. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Although we maintain workers\u2019 compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees resulting from the use of hazardous materials or other work-related injuries, this insurance may not provide adequate coverage against potential liabilities. In addition, we may incur substantial costs in order to comply with current or future environmental, health and safety laws and regulations. These current or future laws and regulations may impair our research, development or production efforts. Failure to comply with these laws and regulations also may result in substantial fines, penalties or other sanctions. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">Our employees, independent contractors, principal investigators, CROs, consultants, vendors and collaboration partners may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements, which could have a material adverse effect on our business. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We are exposed to the risk that our employees, independent contractors, principal investigators, CROs, consultants, vendors and collaboration partners may engage in fraudulent conduct or other illegal activities. Misconduct by these parties could include intentional, reckless and/or negligent conduct or unauthorized activities that violate: (i)\u00a0the regulations of the FDA, EMA and other regulatory authorities, including those laws that require the reporting of true, complete and accurate information to such authorities; (ii)\u00a0manufacturing standards; (iii)\u00a0federal and state data privacy, security, fraud and abuse and other healthcare laws and regulations in the United States and abroad; or (iv)\u00a0laws that require the reporting of true, complete and accurate financial information and data. In particular, sales, marketing and business arrangements in the healthcare industry are subject to extensive laws and regulations intended to prevent fraud, misconduct, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. Activities subject to these laws could also involve the improper use of information obtained in the course of clinical trials or creating fraudulent data in our preclinical studies or clinical trials, which could result in regulatory sanctions and cause serious harm to our reputation. It is not always possible to identify and deter misconduct by employees and other third parties, and the precautions we take to detect and prevent misconduct may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to comply with such laws or regulations. Additionally, we are subject to the risk that a person could allege such fraud or other misconduct, even if none occurred. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business and results of operations, including the imposition of significant civil, criminal and administrative penalties, damages, monetary fines, possible exclusion from participation in Medicare, Medicaid and other U.S. federal healthcare programs, contractual damages, reputational harm, diminished profits and future earnings, and curtailment of our operations, any of which could adversely affect our ability to operate our business and our results of operations. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">Unfavorable global economic and political conditions could adversely affect our business, financial condition or results of operations. </p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Our ability to invest in and expand our business and meet our financial obligations, to attract and retain third-party contractors and collaboration partners and to raise additional capital depends on our operating and financial performance, which, in turn, is subject to numerous factors, including the prevailing economic and political conditions and financial, business and other factors beyond our control, such as the rate of unemployment, the number of uninsured persons in the United States, political influences and inflationary pressures. For example, an overall decrease in or loss of insurance coverage among individuals in the United States as a result of unemployment, underemployment or the potential repeal of certain provisions of the ACA, may decrease the demand for healthcare services and pharmaceuticals. If fewer patients are seeking medical care because they do not have insurance coverage, we may experience difficulties in any eventual commercialization of our product candidates and our business, results of operations, financial condition and cash flows could be adversely affected. </p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">51</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU52\"></a><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">In addition, our results of operations could be adversely affected by general conditions in t</font><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">he global economy and in the global financial markets upon which biopharmaceutical companies such as us are dependent for sources of capital. In the past, global financial crises have caused extreme volatility and disruptions in the capital and credit mark</font><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">ets. A severe or prolonged economic downturn could result in a variety of risks to our business, including a reduced ability to raise additional capital when needed on acceptable terms, if at all, and weakened demand for our product candidates. A weak or d</font><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">eclining economy could also strain our suppliers, possibly resulting in supply disruption. Any of the foregoing could harm our business and we cannot anticipate all of the ways in which the current economic climate and financial market conditions could adv</font><font style=\"font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">ersely impact our business. </font></p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">We or the third parties upon whom we depend may be adversely affected by earthquakes or other natural disasters and our business continuity and disaster recovery plans may not adequately protect us from a serious disaster. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Earthquakes or other natural disasters could severely disrupt our operations, and have a material adverse effect on our business, results of operations, financial condition and prospects. If a natural disaster, power outage or other event occurred that prevented us from using all or a significant portion of our headquarters, that damaged critical infrastructure, such as the manufacturing facilities of our third-party contract manufacturers, or that otherwise disrupted operations, it may be difficult or, in certain cases, impossible for us to continue our business for a substantial period of time. The disaster recovery and business continuity plans we have in place currently are limited and are unlikely to prove adequate in the event of a serious disaster or similar event. We may incur substantial expenses as a result of the limited nature of our disaster recovery and business continuity plans, which, particularly when taken together with our lack of earthquake insurance, could have a material adverse effect on our business. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">Product liability lawsuits against us could cause us to incur substantial liabilities and could limit commercialization of any medicines that we may develop. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We face an inherent risk of product liability exposure related to the testing of our product candidates in human clinical trials and will face an even greater risk if we commercially sell any medicines that we may develop. If we cannot successfully defend ourselves against claims that our product candidates or medicines caused injuries, we could incur substantial liabilities. Regardless of merit or eventual outcome, liability claims may result in: </p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">decreased demand for any product candidates or medicines that we may develop; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">injury to our reputation and significant negative media attention; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">withdrawal of clinical trial participants; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">significant costs to defend the related litigation; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">substantial monetary awards to trial participants or patients; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">loss of revenue; and </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the inability to commercialize </font><font style=\"color:#000000;font-family:Times New Roman;\">mavacamten</font><font style=\"font-family:Times New Roman;\">, MYK-491 or any other product candidates that we may develop. </font></p></td></tr></table></div>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Although we maintain product liability insurance, including coverage for clinical trials that we sponsor, it may not be adequate to cover all liabilities that we may incur. We anticipate that we will need to increase our insurance coverage as we commence additional clinical trials and if we successfully commercialize any product candidates. The market for insurance coverage is increasingly expensive, and the costs of insurance coverage will increase as our clinical programs increase in size. We may not be able to maintain insurance coverage at a reasonable cost or in an amount adequate to satisfy any liability that may arise. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">Our internal computer systems, or those of our third-party CROs or other contractors or consultants, may fail or suffer security breaches, which could result in a material disruption of our operations. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Despite the implementation of security measures, our internal computer systems and those of our third-party CROs and other contractors and consultants are vulnerable to damage from computer viruses, unauthorized access, natural disasters, terrorism, war and telecommunication and electrical failures. While we have not experienced any such system failure, accident or security breach to date, if such an event were to occur and cause interruptions in our operations, it could result in a material disruption of our programs. For example, the loss of clinical trial data for our product candidates could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. To the extent that any disruption or security breach results in a loss of or damage to our data or applications or other data or applications relating to our technology or product candidates, or inappropriate disclosure of confidential or proprietary information, we could incur liabilities and experience delays or disruptions to various aspects of our operations, including our financial reporting and the development of our product candidates. </p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">52</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU53\"></a><font style=\"font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">Our ability to utilize our net operating loss carryforwards and certain other tax attributes may be limited. </font></p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_cp_text_1_228\"></a><a name=\"_cp_text_1_229\"></a><a name=\"_cp_text_1_230\"></a><a name=\"_cp_text_1_232\"></a><a name=\"_cp_text_1_234\"></a>We have incurred substantial losses during our history and do not expect to become profitable in the near future. To the extent that we continue to generate taxable losses, unused losses will carry forward to offset future taxable income, if any, until suc<a name=\"_cp_text_1_228\"></a>h unused losses expire. Under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended (<a name=\"_cp_text_1_229\"></a>the \u201c<a name=\"_cp_text_1_230\"></a>Code\u201d) if a corporation undergoes an \u201cownership change,\u201d generally defined as a greater than 50 percentage point change (by value) in its equity owner<a name=\"_cp_text_1_232\"></a>ship over a rolling three-year period, the corporation\u2019s ability to use its pre-change net operating loss carryforwards (\u201c<a name=\"_cp_text_1_234\"></a>NOLs\u201d) and other pre-change tax attributes (such as research tax credits) to offset its post-change income or taxes may be limited. While we have determined that an ownership change occurred in April 2015 in connection with our Series\u00a0B redeemable convertible preferred stock financing and in August 14, 2017 due to a subsequent stock offering, we do not believe that these ownership changes will result in the expiration of any of our existing NOLs prior to utilization. We may experience subsequent shifts in our stock ownership, some of which are outside our control. As a result, if we earn net taxable income, our ability to use our pre-change net operating loss carryforwards to offset U.S. federal taxable income may be subject to limitations, which could potentially result in increased future tax liability to us. In addition, at the state level, there may be periods during which the use of NOLs is suspended or otherwise limited, which could accelerate or permanently increase state taxes owed. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">In addition, under the Tax Cuts and Jobs Act (the \u201cTax Act\u201d), the amount of post 2017 NOLs that we are permitted to deduct in any taxable year is limited to 80% of our taxable income in such year, where taxable income is determined without regard to the NOL deduction itself.\u00a0 The Tax Act generally eliminates the ability to carry back any NOL to prior taxable years, while allowing post 2017 unused NOLs to be carried forward indefinitely.\u00a0 There is a risk that due to changes under the Tax Act, regulatory changes or other unforeseen reasons, our existing NOLs could expire or otherwise be unavailable to offset future income tax liabilities.</p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Risks Related to Our Common Stock </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">The market price of our common stock has been and may continue to be highly volatile. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The market price of our common stock has experienced volatility since our IPO in October 2015 and is likely to continue to be volatile. Our stock price could be subject to wide fluctuations in response to a variety of factors, including the following: </p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">adverse results or delays in preclinical studies or clinical trials; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">reports of adverse events in clinical trials of our product candidates or in other products for the treatment of cardiovascular diseases or clinical trials of such products; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">inability to obtain additional funding; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">any delay in filing an IND or NDA for any of our product candidates and any adverse development or perceived adverse development with respect to the FDA\u2019s review of that IND or NDA; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">failure to develop successfully and commercialize our product candidates; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">any adverse developments relating to our Collaboration Agreement with Sanofi, or any failure to maintain our existing strategic collaborations or enter into new collaborations; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">failure by us or our licensors and strategic collaborators to prosecute, maintain or enforce our intellectual property rights; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">changes in laws or regulations applicable to future products; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">inability to obtain adequate product supply for our product candidates or the inability to do so at acceptable prices; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">adverse regulatory decisions affecting our product candidates or development programs; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">introduction of new products, services or technologies by our competitors; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">failure to meet or exceed financial projections we may provide to the public or to the investment community; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the perception of the pharmaceutical industry by the public, legislatures, regulators and the investment community; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">announcements of significant acquisitions, strategic partnerships, joint ventures or capital commitments by us, our strategic collaboration partner or our competitors; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">disputes or other developments relating to proprietary rights, including patents, litigation matters and our ability to obtain patent protection for our technologies; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">additions or departures of key scientific or management personnel; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">significant lawsuits, including patent or stockholder litigation; </font></p></td></tr></table></div>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">53</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU54\"></a><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"></font><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"></font><font style=\"font-family:Times New Roman;\">changes in the market valuations of similar companies; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">sales of our common stock by us or our stockholders in the future; and </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">trading volume of our common stock. </font></p></td></tr></table></div>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_cp_text_1_237\"></a><a name=\"_cp_text_1_239\"></a>In addition<a name=\"_cp_text_1_237\"></a>, companies trading in the stock market in general, and The NASDAQ Global Select Market (\u201c<a name=\"_cp_text_1_239\"></a>NASDAQ\u201d) in particular, have experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of these companies. Broad market and industry factors may negatively affect the market price of our common stock, regardless of our actual operating performance.\u00a0\u00a0In the past, following periods of volatility in the market, securities class-action litigation has often been instituted against companies. Such litigation, if instituted against us, could result in substantial costs and diversion of management\u2019s attention and resources, which could materially and adversely affect our business, financial condition, results of operations and growth prospects.</p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">Future sales and issuances of our common stock or rights to purchase common stock, including pursuant to our equity incentive plans, could result in additional dilution of the percentage ownership of our stockholders and could cause our stock price to fall. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Additional capital will be needed in the future to continue our planned operations. To the extent we raise additional capital by issuing equity securities, our stockholders may experience substantial dilution. We may sell common stock, convertible securities or other equity securities in one or more transactions at prices and in a manner we determine from time to time. If we sell common stock, convertible securities or other equity securities in more than one transaction, investors may be materially diluted by subsequent sales. These sales may also result in material dilution to our existing stockholders, and new investors could gain rights superior to our existing stockholders.</p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">In addition, sales of a substantial number of shares of our outstanding common stock in the public market could occur at any time. These sales, or the perception in the market that the holders of a large number of shares of common stock intend to sell shares, could reduce the market price of our common stock. Persons who were our stockholders prior to our IPO continue to hold a substantial number of shares of our common stock that many of them are now able to sell in the public market.\u00a0\u00a0Significant portions of these shares are held by a relatively small number of stockholders.\u00a0\u00a0Sales by our stockholders of a substantial number of shares, or the expectation that such sales may occur, could significantly reduce the market price of our common stock.\u00a0\u00a0 </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We have also registered all shares of our common stock subject to options or other equity awards issued or reserved for future issuance under our equity incentive plans. As a result, these shares will be eligible for sale in the public market to the extent permitted by any applicable vesting requirements and the exercise of options, and restrictions under applicable securities laws. In addition, our directors, executive officers and certain affiliates have established or may in the future establish programmed selling plans under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, for the purpose of effecting sales of our common stock.\u00a0\u00a0If any of these events cause a large number of our shares to be sold in the public market, the sales could reduce the trading price of our common stock and impede our ability to raise future capital.\u00a0\u00a0Moreover, certain holders of our common stock have rights, subject to certain conditions, to require us to file registration statements covering their shares or to include their shares in registration statements that we may file for ourselves or other stockholders.\u00a0\u00a0In particular, we have filed a registration statement on Form S-3 registering for resale 9,184,352 shares of common stock held by entities affiliated with our major shareholder, Third Rock Ventures, which was declared effective by the SEC on July 21, 2017. These shares, together with any additional shares that we may register for resale, can be freely sold in the public market. If these additional shares are sold, or if it is perceived that they will be sold, in the public market, the trading price of our common stock could decline. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_cp_text_1_241\"></a><a name=\"_cp_text_1_242\"></a><a name=\"_cp_text_1_243\"></a><a name=\"_cp_text_1_245\"></a><a name=\"_cp_text_1_246\"></a><a name=\"_cp_text_1_248\"></a><a name=\"_cp_text_1_241\"></a>Pursuant to our 2015 Stock Option and Incentive Plan (<a name=\"_cp_text_1_242\"></a>the \u201c<a name=\"_cp_text_1_243\"></a>2015 Plan\u201d), we are authorized to grant stock options and other equity-based awards to our employees, directors and consultants. Beginning on January 1, 2017, the number of shares available for future grant under the 2015 Plan will automatically increase each year by up to 4% of all shares of our capital stock outstanding as of December\u00a031 of the prior calendar year, subject to the ability of our board of directors to take action to reduce the size of the increase in any given year. In addition, pursuant to our 2015 E<a name=\"_cp_text_1_245\"></a>mployee Stock Purchase Plan (<a name=\"_cp_text_1_246\"></a>the \u201c<a name=\"_cp_text_1_248\"></a>2015 ESPP\u201d), we have initially reserved 255,000 shares for purchase by eligible employees. Beginning on January 1, 2017 and ending on January 1, 2025, the number of shares available for future issuance under the 2015 ESPP will automatically increase each year by up to the lesser of 3,000,000 shares of common stock or 1% of all shares of our capital stock outstanding as of December 31 of the prior calendar year, subject to the ability of our board of directors to take action to reduce the size of the increase in any given year. Currently, we plan to register the increased number of shares available for issuance under the 2015 Plan and the 2015 ESPP each year. If our board of directors elects to increase the number of shares available for future grant under these plans by the maximum amount each year, our stockholders may experience additional dilution, which could cause our stock price to fall. </p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">54</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU55\"></a><font style=\"font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">Our principal stockholders and management own a significant percentage of our stoc</font><font style=\"font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">k and will be able to exert significant control over matters subject to stockholder approval. </font></p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_Hlk508059787\"></a>As of June 30, 2018, our executive officers, directors, five percent or greater stockholders and their affiliates beneficially own approximately 33.3% of our outstanding voting stock. These stockholders will have the ability to influence us through their ownership positions. These stockholders may be able to determine all matters requiring stockholder approval. For example, these stockholders, acting together, may be able to control elections of directors, amendments of our organizational documents, or approval of any merger, sale of assets, or other major corporate transaction. This may prevent or discourage unsolicited acquisition proposals or offers for our common stock that you may believe are in your best interest as one of our stockholders. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">We have broad discretion in the use of our cash and cash equivalents and may not use them effectively. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Our management has broad discretion in the application of our existing cash and cash equivalents, and you will not have the opportunity to assess whether our existing cash and cash equivalents are being used appropriately. Because of the number and variability of factors that will determine our use of our existing cash and cash equivalents, their ultimate use may vary substantially from their currently intended use. The failure by our management to apply these funds effectively could harm our business. Pending their use, we may invest our cash and cash equivalents in short-term, investment-grade, interest-bearing securities. These investments may not yield a favorable return to our stockholders. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">If securities or industry analysts do not publish research, or publish inaccurate or unfavorable research, about our business, our stock price and trading volume could decline. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The trading market for our common stock will depend, in part, on the research and reports that securities or industry analysts publish about us or our business. Securities and industry analysts may not publish an adequate amount of research on our company, which may negatively impact the trading price for our stock. In addition, if one or more of the analysts who cover us downgrade our stock or publish inaccurate or unfavorable research about our business, our stock price would likely decline. Further, if our operating results fail to meet the forecasts of analysts, our stock price would likely decline. If one or more of these analysts cease coverage of our company or fail to publish reports on us regularly, demand for our stock could decrease, which might cause our stock price and trading volume to decline. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">We are an \u201cemerging growth company,\u201d and we cannot be certain if the reduced reporting requirements applicable to emerging growth companies will make our common stock less attractive to investors.</p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_cp_text_1_250\"></a><a name=\"_cp_text_1_251\"></a><a name=\"_cp_text_1_252\"></a><a name=\"_cp_text_1_253\"></a><a name=\"_cp_text_1_255\"></a><a name=\"_cp_text_1_257\"></a><a name=\"_cp_text_1_258\"></a>We are an \u201cemerging growth company,\u201d as defined in the JOBS Act. For as long as we continue to be an emerging growth company, we may take advantage of exemptions from various reporting requirements that are applic<a name=\"_cp_text_1_250\"></a>able to other public companies that are not emerging growth companies, including not being required to comply with the auditor attestation requirements of Section\u00a0404 of the Sarbanes-Oxley Act of 2002 (<a name=\"_cp_text_1_251\"></a>the \u201c<a name=\"_cp_text_1_252\"></a>Sarbanes-Oxley Act\u201d), reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously <a name=\"_cp_text_1_253\"></a>approved. We will remain an emerging growth company until the earliest of (i)\u00a0December 31, 2020, (ii)\u00a0the last day of the fiscal year in which we have total annual gross revenue of $1.07 billion or more, (iii)\u00a0the last day of the fiscal year in which we ar<a name=\"_cp_text_1_255\"></a>e deemed to be a large accelerated filer, which means the market value of our common stock that is held by non-affiliates exceeds $700.0 million as of the prior June 30<sup style=\"font-size:85%; vertical-align:top\">th</sup> and (iv)\u00a0the date on which we have issued more than $1.0\u00a0billion in non-convertible debt during any three-year period before that time. Even after we no longer qualify as an emerging growth company, we may still qualify as a \u201csmaller reporting company\u201d which would allow us to take advantage of many of the same exemptions from disclosure re<a name=\"_cp_text_1_257\"></a>quirements, including not being required to comply with the auditor attestation requirements of Section\u00a0404 of the Sarbanes-Oxley Act (\u201c<a name=\"_cp_text_1_258\"></a>Section\u00a0404\u201d), and reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements. We cannot predict if investors will find our common stock less attractive because we may rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Under the JOBS Act, emerging growth companies can also delay adopting new or revised accounting standards until such time as those standards apply to private companies. We have irrevocably elected not to avail ourselves of this exemption from new or revised accounting standards and, therefore, are subject to the same new or revised accounting standards as other public companies that are not emerging growth companies. </p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">55</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU56\"></a><font style=\"font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">We will continue to incur increased costs as a </font><font style=\"font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">result of operating as a public company, and our management is required to devote substantial time to new compliance initiatives. </font></p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">As a public company, and particularly after we are no longer an emerging growth company, we incur and will continue to incur significant legal, accounting and other expenses that we did not incur as a private company. In addition, the Sarbanes-Oxley Act and rules subsequently implemented by the SEC and NASDAQ have imposed various requirements on public companies, including establishment and maintenance of effective disclosure and financial controls and corporate governance practices. Our management and other personnel will need to devote a substantial amount of time to these compliance initiatives. Moreover, these rules and regulations will increase our legal and financial compliance costs and will make some activities more time-consuming and costly. For example, we expect that these rules and regulations may make it more difficult and more expensive for us to obtain director and officer liability insurance. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Pursuant to Section\u00a0404, we are required to furnish a report by our management on our internal control over financial reporting starting with our Annual Report on Form 10-K for the fiscal year ending December 31, 2017. However, while we remain an emerging growth company, we will not be required to obtain an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. To achieve compliance with Section\u00a0404 within the prescribed period, we will be engaged in a process to document and evaluate our internal control over financial reporting, which is both costly and challenging. In this regard, we will need to continue to dedicate internal resources, engage outside consultants and adopt a detailed work plan to assess and document the adequacy of internal control over financial reporting, continue steps to improve control processes as appropriate, validate through testing that controls are functioning as documented and implement a continuous reporting and improvement process for internal control over financial reporting. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Despite our efforts, there is a risk that neither we nor our independent registered public accounting firm will be able to conclude within the prescribed timeframe that our internal control over financial reporting is effective as required by Section\u00a0404. This could impair our ability to produce timely and accurate consolidated financial statements and result in an adverse reaction in the financial markets due to a loss of confidence in the reliability of our consolidated financial statements. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">Our operating results may fluctuate significantly or may fall below the expectations of investors or securities analysts, each of which may cause our stock price to fluctuate or decline. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Our quarterly and annual operating results may fluctuate significantly in the future, which makes it difficult to predict our future operating results. Our net loss and other operating results will be affected by numerous factors, many of which are outside of our control and may be difficult to predict, including: </p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">variations in the level of expenses related to our clinical development programs, our precision medicine platform or our preclinical research and development programs; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">the timing and success or failure of preclinical studies and clinical trials for our product candidates or competing product candidates;</font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">our ability to obtain regulatory approval for our product candidates, and the timing and scope of any such approvals we may receive;</font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">if any of our product candidates receives regulatory approval, the level of underlying demand for these product candidates and our ability to successfully commercialize any approved product; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">addition or termination of clinical trials or funding support; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">our execution of any new collaborative, licensing or similar arrangements, and the timing of payments we may make or receive under these arrangements. </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">any intellectual property infringement or other lawsuits in which we may become involved; and </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">regulatory developments affecting our product candidates or those of our competitors. </font></p></td></tr></table></div>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">If our operating results fall below the expectations of investors or securities analysts, the price of our common stock could decline substantially. Furthermore, any fluctuations in our operating results may, in turn, cause the price of our stock to fluctuate substantially. Additionally, due to the unpredictability of our quarterly and annual operating results, we believe that period-to-period comparisons of our financial results are not necessarily meaningful and should not be relied upon as an indication of our future performance. </p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">56</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU57\"></a><font style=\"font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">Because we do not anticipate paying any cash dividends on our capital stock in the foreseeable future, capital appreciation, if any, will be</font><font style=\"font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\"> your sole source of gain. </font></p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">We have never declared or paid cash dividends on our capital stock. We currently intend to retain all of our future earnings, if any, to finance the growth and development of our business. In addition, the terms of any future debt agreements may preclude us from paying dividends. As a result, capital appreciation, if any, of our common stock will be your sole source of gain for the foreseeable future. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">We could be subject to securities class action litigation. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">In the past, securities class action litigation has often been brought against a company following a decline in the market price of its securities. This risk is especially relevant for us because biotechnology and pharmaceutical companies have experienced significant stock price volatility in recent years. If we face such litigation, it could result in substantial costs and a diversion of management\u2019s attention and resources, which could harm our business. </p>\n<p style=\"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;\">Provisions in our amended and restated certificate of incorporation and amended and restated bylaws, as well as provisions of Delaware law, could make it more difficult for a third party to acquire us or increase the cost of acquiring us, even if doing so would benefit our stockholders or remove our current management. </p>\n<p style=\"margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Our amended and restated certificate of incorporation, amended and restated bylaws and Delaware law contain provisions that may have the effect of delaying or preventing a change in control of us or changes in our management. Our amended and restated certificate of incorporation and amended and restated bylaws include provisions that: </p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">authorize \u201cblank check\u201d preferred stock, which could be issued by our board of directors without stockholder approval and may contain voting, liquidation, dividend and other rights superior to our common stock; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">create a classified board of directors whose members serve staggered three-year terms; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">specify that special meetings of our stockholders can be called only by our board of directors, the chairperson of our board of directors, our chief executive officer or our president; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">prohibit stockholder action by written consent; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">establish an advance notice procedure for stockholder approvals to be brought before an annual meeting of our stockholders, including proposed nominations of persons for election to our board of directors; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">provide that our directors may be removed only for cause and with the vote of the holders of 75% or more of our outstanding capital stock then entitled to vote at an election of directors; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">provide that vacancies on our board of directors may be filled only by a majority of directors then in office, even if less than a quorum; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">specify that no stockholder is permitted to cumulate votes at any election of directors; </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">expressly authorize our board of directors to modify, alter or repeal our amended and restated bylaws; and </font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2022</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;\"><font style=\"font-family:Times New Roman;\">require supermajority votes of the holders of our common stock to amend specified provisions of our amended and restated certificate of incorporation and amended and restated bylaws. </font></p></td></tr></table></div>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">These provisions, alone or together, could delay or prevent hostile takeovers and changes in control or changes in our management. </p>\n<p style=\"margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">In addition, because we are incorporated in Delaware, we are governed by the provisions of Section\u00a0203 of the Delaware General Corporation Law, which limits the ability of stockholders owning in excess of 15% of our outstanding voting stock to merge or combine with us. </p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Any provision of our amended and restated certificate of incorporation or amended and restated bylaws or Delaware law that has the effect of delaying or deterring a change in control could limit the opportunity for our stockholders to receive a premium for their shares of our common stock, and could also affect the price that some investors are willing to pay for our common stock.</p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">57</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:10.27%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Item\u00a02.</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU58\"></a><a name=\"ITEM_2_UNREGISTERED_SALES_EQUITY_SECURIT\"></a><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"></font><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"ITEM_2_UNREGISTERED_SALES_EQUITY_SECURIT\"></a>Unregistered Sales of Equi</font><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">ty Securities and Use of Proceeds</font></p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:2.27%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-style:italic;font-weight:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\"><font style=\"font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">(a)</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-style:italic;font-weight:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;\">Recent Sales of Unregistered Equity Securities</p></td></tr></table></div>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">None.</p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:2.27%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:18pt;margin-bottom:0pt;font-style:italic;font-weight:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:18pt;margin-bottom:0pt;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\"><font style=\"font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">(b)</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-top:18pt;margin-bottom:0pt;font-style:italic;font-weight:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;\">Use of Proceeds</p></td></tr></table></div>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Not applicable.</p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:2.27%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:18pt;margin-bottom:0pt;font-style:italic;font-weight:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:18pt;margin-bottom:0pt;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\"><font style=\"font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">(c)</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-top:18pt;margin-bottom:0pt;font-style:italic;font-weight:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;\">Issuer Repurchases of Company Equity Securities.</p></td></tr></table></div>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">None.</p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:10.27%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Item\u00a03.</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;\"><a name=\"ITEM_3_DEFAULTS_UPON_SENIOR_SECURITIES\"></a><a name=\"ITEM_3_DEFAULTS_UPON_SENIOR_SECURITIES\"></a>Defaults Upon Senior Securities</p></td></tr></table></div>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">None.</p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:10.27%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Item\u00a04.</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;\"><a name=\"ITEM_4_MINE_SAFETY_DISCLOSURES\"></a><a name=\"ITEM_4_MINE_SAFETY_DISCLOSURES\"></a>Mine Safety Disclosures</p></td></tr></table></div>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Not applicable.</p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:10.27%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Item\u00a05.</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;\"><a name=\"ITEM_5_OR_INFORMATION\"></a><a name=\"ITEM_5_OR_INFORMATION\"></a>Other Information</p></td></tr></table></div>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">None.</p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">58</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:10.27%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Item\u00a06.</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU59\"></a><a name=\"ITEM_6_EXHIBITS\"></a><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"></font><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"ITEM_6_EXHIBITS\"></a></font><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Exhibits</font></p></td></tr></table></div>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The following exhibits are filed or furnished as part of this Quarterly Report on Form 10-Q: </p>\n<p style=\"text-align:center;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"EXHIBIT_INDEX\"></a><a name=\"EXHIBIT_INDEX\"></a>EXHIBIT INDEX</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.62%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Exhibit</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Number</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.72%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Exhibit Description</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:12.92%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Incorporated\u00a0by</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Reference\u00a0From</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:9.14%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Date</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Number</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Filed</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Herewith</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.62%; border-top:solid 0.75pt #000000;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.72%; border-top:solid 0.75pt #000000;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:12.92%; border-top:solid 0.75pt #000000;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:9.14%; border-top:solid 0.75pt #000000;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%; border-top:solid 0.75pt #000000;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;\" valign=\"middle\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.62%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0\u00a0\u00a03.1</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.72%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a style=\"text-decoration:underline;\">Restated Certificate of Incorporation.</font></a> </p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:12.92%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_cp_text_1_265\"></a>10-Q</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:9.14%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_cp_text_1_266\"></a>11/18/2015</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;\" valign=\"middle\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_cp_text_1_267\"></a> 3.1</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.62%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.72%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:12.92%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:9.14%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;\" valign=\"middle\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.62%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_cp_text_1_754\"></a>\u00a0\u00a0 3.2</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.72%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a style=\"text-decoration:underline;\">Amended and Restated Bylaws.</font></a></p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:12.92%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_cp_table_18_757\"></a>S-1/A</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:9.14%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_cp_table_18_759\"></a>10/13/2015</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;\" valign=\"middle\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_cp_text_1_760\"></a>3.4</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.62%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.72%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:12.92%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:9.14%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.62%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0\u00a0\u00a04.1</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.72%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a style=\"text-decoration:underline;\">Specimen Common Stock Certificate.</font></a> </p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:12.92%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">S-1/A</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:9.14%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">10/19/2015</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">4.1</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.62%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.72%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:12.92%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:9.14%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.62%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0\u00a031.1</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.72%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a style=\"text-decoration:underline;\">Certification of Principal Executive Officer Required Under Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended.</font></a></p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:12.92%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:9.14%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">X</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.62%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.72%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:12.92%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:9.14%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.62%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0\u00a031.2</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.72%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a style=\"text-decoration:underline;\">Certification of Principal Financial Officer Required Under Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended.</font></a></p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:12.92%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:9.14%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">X</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.62%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.72%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:12.92%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:9.14%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.62%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0\u00a032.1*</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.72%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a style=\"text-decoration:underline;\">Certification of Principal Executive Officer and Principal Financial Officer Required Under Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. \u00a71350.</font></a></p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:12.92%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:9.14%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">X</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.62%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.72%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:12.92%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:9.14%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.62%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">101.INS</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.72%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">XBRL Instance Document.</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:12.92%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:9.14%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">X</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.62%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.72%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:12.92%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:9.14%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.62%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">101.SCH</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.72%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">XBRL Taxonomy Extension Schema Document.</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:12.92%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:9.14%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">X</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.62%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.72%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:12.92%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:9.14%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.62%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">101.CAL</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.72%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">XBRL Taxonomy Extension Calculation Linkbase Document.</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:12.92%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:9.14%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">X</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.62%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.72%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:12.92%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:9.14%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.62%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">101.DEF</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.72%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">XBRL Taxonomy Extension Definition Linkbase Document.</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:12.92%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:9.14%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">X</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.62%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.72%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:12.92%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:9.14%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.62%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">101.LAB</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.72%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">XBRL Taxonomy Extension Label Linkbase Document.</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:12.92%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:9.14%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">X</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.62%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.72%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:12.92%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:9.14%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.62%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">101.PRE</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.72%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">XBRL Taxonomy Extension Presentation Linkbase Document.</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:12.92%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:9.14%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"width:1.06%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.16%;\" valign=\"top\">\n<p style=\"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">X</p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">#</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;\">Represents management compensation plan, contract or arrangement.</p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">*</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;\">The certification attached as Exhibit\u00a032.1 that accompanies this Quarterly Report on Form\u00a010-Q is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of MyoKardia, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form\u00a010-Q, irrespective of any general incorporation language contained in such filing.</p></td></tr></table></div>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">59</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU60\"></a><a name=\"SIGNATURES\"></a><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"SIGNATURES\"></a>SIGNA</font><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">TURES</font></p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:48%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Date: August 8, 2018</p></td>\n<td colspan=\"3\" style=\"width:52%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">MYOKARDIA, INC.</p></td>\n</tr>\n<tr>\n<td style=\"width:48%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;\">\u00a0</p></td>\n<td style=\"width:2%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;\">\u00a0</p></td>\n<td style=\"width:2%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;\">\u00a0</p></td>\n<td style=\"width:48%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;\">\u00a0</p></td>\n</tr>\n<tr>\n<td style=\"width:48%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td colspan=\"2\" style=\"width:4%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">By:</p></td>\n<td style=\"width:48%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">/s/ Tassos Gianakakos</p></td>\n</tr>\n<tr>\n<td style=\"width:48%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:2%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:2%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:48%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Tassos Gianakakos</p></td>\n</tr>\n<tr>\n<td style=\"width:48%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:2%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:2%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:48%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">President, Chief Executive Officer</p></td>\n</tr>\n<tr>\n<td style=\"width:48%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:2%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:2%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:48%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">(Principal Executive Officer)</p></td>\n</tr>\n<tr>\n<td style=\"width:48%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td style=\"width:2%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td style=\"width:2%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td style=\"width:48%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n</tr>\n<tr>\n<td style=\"width:48%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td style=\"width:2%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td style=\"width:2%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td style=\"width:48%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n</tr>\n<tr>\n<td style=\"width:48%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Date: August 8, 2018</p></td>\n<td colspan=\"2\" style=\"width:4%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">By:</p></td>\n<td style=\"width:48%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">/s/ Taylor Harris</p></td>\n</tr>\n<tr>\n<td style=\"width:48%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:2%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:2%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:48%; border-top:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Taylor Harris</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">Chief Financial Officer </p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;\">(Principal Financial and Accounting Officer)</p></td>\n</tr>\n<tr>\n<td style=\"width:48%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:2%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:2%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:48%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"></p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<p style=\"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">60</p>\n\n\n\n"}, "reportNo8": {"reportType": "8-K", "url": "https://www.sec.gov/Archives/edgar/data/1552451/000156459018020475/myok-8k_20180808.htm", "dateOfReport": "2018-08-08", "content": "On August 8, 2018, MyoKardia, Inc. announced its financial results for the first quarter ended June 30, 2018. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.The information in Item2.02 of this Form 8-K (including Exhibit 99.1) shall not be deemed \u201cfiled\u201d for purposes of Section18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such a filing.", "htmlOfReport": " <document>\n<type>8-K\n<sequence>1\n<filename>myok-8k_20180808.htm\n<description>8-K\n<text>\n<!DOCTYPE HTML PUBLIC \"-//W3C//DTD HTML 4.01 Transitional//EN\" \"http://www.w3.org/TR/html4/loose.dtd\">\n\n<html>\n<head>\n<title>\nmyok-8k_20180808.htm\n</title>\n</head>\n<!-- NG Converter v5.0.18157.137 -->\n<body>\n<p style=\"border-bottom:Double 2.25pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;\">\u00a0</p>\n<p style=\"text-align:center;margin-top:4pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">UNITED STATES</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">SECURITIES AND EXCHANGE COMMISSION</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Washington, D.C. 20549</p>\n<p style=\"text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:12pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:12pt;font-family:Times New Roman;\">\u00a0</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">FORM 8-K</p>\n<p style=\"text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:12pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:12pt;font-family:Times New Roman;\">\u00a0</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">CURRENT REPORT</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Pursuant to Section\u00a013 or 15(d)</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">of the Securities Exchange Act of 1934</p>\n<p style=\"text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Date of Report (Date of earliest event reported): August 8, 2018</p>\n<p style=\"text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:12pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:12pt;font-family:Times New Roman;\">\u00a0</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">MYOKARDIA,\u00a0INC.</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(Exact name of registrant as specified in its charter)</p>\n<p style=\"margin-bottom:0pt;text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:12pt;font-family:Times New Roman;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:33.34%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Delaware</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:33.34%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">001-37609</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:33.32%;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">44-5500552</p></td>\n</tr>\n<tr>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:33.34%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">(State or other jurisdiction</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">of incorporation)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:33.34%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">(Commission</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">File Number)</p></td>\n<td bgcolor=\"#FFFFFF\" style=\"padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:33.32%;\" valign=\"top\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">(I.R.S. Employer</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Identification No.)</p></td>\n</tr>\n</table></div>\n<p style=\"text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">333 Allerton Ave.</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">South San Francisco, CA 94080</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">(Address of principal executive offices, including zip code)</p>\n<p style=\"text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">(650) 741-0900</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">(Registrant\u2019s telephone number, including area code)</p>\n<p style=\"text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Not Applicable</p>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">(Former Name or Former Address, if Changed Since Last Report)</p>\n<p style=\"text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:12pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:12pt;font-family:Times New Roman;\">\u00a0</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Check the appropriate box below if the Form\u00a08-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2610</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;\">Written communications pursuant to Rule\u00a0425 under the Securities Act (17 CFR 230.425)</p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2610</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;\">Soliciting material pursuant to Rule\u00a014a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2610</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;\">Pre-commencement communications pursuant to Rule\u00a014d-2(b)\u00a0under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr></table></div>\n<div align=\"left\">\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:4.54%;white-space:nowrap\" valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><font style=\"font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u2610</font></p></td>\n<td valign=\"top\">\n<p style=\"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;\">Pre-commencement communications pursuant to Rule\u00a013e-4(c)\u00a0under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table></div>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (\u00a7\u2009230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (\u00a7\u2009240.12b-2 of this chapter).</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Emerging growth company\u00a0<font style=\"color:#000000;font-size:9pt;font-family:'Times New Roman';\"><font style=\"font-size:9pt;font-family:'Times New Roman'\">\u2612</font></font></p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_gjdgxs\"></a>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.\u00a0<font style=\"color:#000000;font-size:9pt;font-family:'Times New Roman';\"><font style=\"font-size:9pt;font-family:'Times New Roman'\">\u2612</font></font></p>\n<p style=\"border-bottom:Double 2.25pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;\">\u00a0</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU2\"></a><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Item\u00a02.02\u00a0Results of Operations and Financial Condition.</font></p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">On August 8, 2018, MyoKardia, Inc. announced its financial results for the first quarter ended June 30, 2018. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">The information in Item\u00a02.02 of this Form 8-K (including Exhibit 99.1) shall not be deemed \u201cfiled\u201d for purposes of Section\u00a018 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such a filing.</p>\n<p style=\"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">Item\u00a09.01\u00a0Financial Statements and Exhibits</p>\n<p style=\"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">(d)\u00a0Exhibits.</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Exhibit\u00a0No.</p></td>\n<td style=\"width:1%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td style=\"width:90%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Description</p></td>\n</tr>\n<tr>\n<td style=\"width:9%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td style=\"width:1%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td style=\"width:90%; border-top:solid 0.75pt #000000;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n</tr>\n<tr>\n<td style=\"width:9%;white-space:nowrap;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">99.1</p></td>\n<td style=\"width:1%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:90%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a style=\"text-decoration:none;\">Press Release issued by MyoKardia, Inc. on August 8, 2018, furnished herewith</font></a></p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU3\"></a><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">EXHIBIT\u00a0INDEX</font></p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Exhibit\u00a0No.</p></td>\n<td style=\"width:1%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;\">\u00a0</p></td>\n<td style=\"width:90%; border-bottom:solid 0.75pt #000000;\" valign=\"bottom\">\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;\">Description</p></td>\n</tr>\n<tr>\n<td style=\"width:9%; border-top:solid 0.75pt #000000;white-space:nowrap;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td style=\"width:1%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n<td style=\"width:90%; border-top:solid 0.75pt #000000;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;\">\u00a0</p></td>\n</tr>\n<tr>\n<td style=\"width:9%;white-space:nowrap;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">99.1</p></td>\n<td style=\"width:1%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">\u00a0\u00a0</p></td>\n<td style=\"width:90%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\"><a style=\"text-decoration:none;\">Press Release issued by MyoKardia, Inc. on August 8, 2018, furnished herewith</font></a></p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;\">\u00a0</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;\">\u00a0</p>\n<hr style=\"page-break-after:always;width:100%;\"/>\n<p style=\"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\"><a name=\"_AEIOULastRenderedPageBreakAEIOU4\"></a><font style=\"font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">SIGNATURES</font></p>\n<p style=\"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p>\n<div>\n<table align=\"center\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%;\">\n<tr>\n<td style=\"width:48%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Date: August 8, 2018</p></td>\n<td style=\"width:1%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:1%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td colspan=\"3\" style=\"width:2%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;\">MyoKardia, Inc.</p></td>\n</tr>\n<tr>\n<td style=\"width:48%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;\">\u00a0</p></td>\n<td style=\"width:1%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;\">\u00a0</p></td>\n<td colspan=\"4\" style=\"width:1%;\" valign=\"middle\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;\">\u00a0</p></td>\n</tr>\n<tr>\n<td style=\"width:48%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:1%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:1%; border-bottom:solid 0.75pt transparent;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:2%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">By:</p></td>\n<td style=\"width:1%; border-bottom:solid 0.75pt transparent;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:47%; border-bottom:solid 0.75pt #000000;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">/s/ Taylor Harris</p></td>\n</tr>\n<tr>\n<td style=\"width:48%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:1%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:1%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:2%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:1%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:47%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Taylor Harris</p></td>\n</tr>\n<tr>\n<td style=\"width:48%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:1%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:1%;\" valign=\"bottom\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:2%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:1%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></td>\n<td style=\"width:47%;\" valign=\"top\">\n<p style=\"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;\">Chief Financial Officer <font style=\"font-weight:bold;\">(principal\u00a0financial\u00a0officer)</font></p></td>\n</tr>\n</table></div>\n<p style=\"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;\">\u00a0</p></body>\n</html>\n</text>\n</description></filename></sequence></type></document>\n"}, "reportNo9": {"reportType": "Form 4", "url": ["https://www.sec.gov/Archives/edgar/data/1552451/000089924318020579/xslF345X03/doc4.xml", "2018-07-25"], "content": {"nameOfOwner": "Bauer Jake", "position": "Chief Business Officer", "dateOfReport": "2018-07-23", "transaction1": {"classOfStock": "Common Stock", "transactionDate": "2018-07-23", "amount": "7500", "price": "13.90", "buyOrSell": "A", "ownershipAfterTransaction": "68106"}, "transaction2": {"classOfStock": "Common Stock", "transactionDate": "2018-07-23", "amount": "4399", "price": "56.59", "buyOrSell": "D", "ownershipAfterTransaction": "63707"}, "transaction3": {"classOfStock": "Common Stock", "transactionDate": "2018-07-23", "amount": "3101", "price": "57.28", "buyOrSell": "D", "ownershipAfterTransaction": "60606"}, "transaction4": {"classOfStock": "Stock Option (Right to Buy)", "transactionDate": "2018-07-23", "amount": "7500", "price": "0.00", "buyOrSell": "D", "ownershipAfterTransaction": "7500"}}, "dateOfReport": "2018-07-23", "htmlOfReport": " <!DOCTYPE html PUBLIC \"-//W3C//DTD HTML 4.01 Transitional//EN\" \"http://www.w3.org/TR/html4/loose.dtd\">\n\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<title>SEC FORM \n            4</title>\n<style type=\"text/css\">\n              .FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;}\n              .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;}\n              .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;}\n              .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;}\n              .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;}\n              .FormNumText {font-size: small; font-weight: bold; font-family: arial, helvetica, sans-serif;}\n              .FormAttention {font-size: medium; font-weight: bold; font-family: helvetica;}\n              .FormText {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left;}\n              .FormTextR {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right;}\n              .FormTextC {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center;}\n              .FormEMText {font-size: medium; font-style: italic; font-weight: normal; font-family: arial, helvetica, sans-serif;}\n              .FormULText {font-size: medium; text-decoration: underline; font-weight: normal; font-family: arial, helvetica, sans-serif;}\n              .SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: left;}\n              .SmallFormTextR {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: right;}\n              .SmallFormTextC {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: center;}\n              .MedSmallFormText {font-size: x-small; font-family: arial, helvetica, sans-serif; text-align: left;}\n              .FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold;}\n              .FormTitle1 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; border-top: black thick solid;}\n              .FormTitle2 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold;}\n              .FormTitle3 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; padding-top: 2em; padding-bottom: 1em;}\n              .SectionTitle {font-size: small; text-align: left; font-family: arial, helvetica, sans-serif; \n              \t\tfont-weight: bold; border-top: gray thin solid; border-bottom: gray thin solid;}\n              .FormName {font-size: large; font-family: arial, helvetica, sans-serif; font-weight: bold;}\n              .CheckBox {text-align: center; width: 5px; cell-spacing: 0; padding: 0 3 0 3; border-width: thin; border-style: solid;  border-color: black:}\n              body {background: white;}\n      </style>\n</head>\n<body>SEC Form 4 \n   <table border=\"0\" cellpadding=\"4\" cellspacing=\"0\" width=\"100%\">\n<tr>\n<td align=\"center\" class=\"FormName\" colspan=\"2\" valign=\"top\" width=\"20%\">FORM 4</td>\n<td align=\"center\" rowspan=\"2\" valign=\"middle\" width=\"60%\">\n<span class=\"FormTitle\">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span><br/><span class=\"MedSmallFormText\">Washington, D.C. 20549</span><br/><br/><span class=\"FormTitle\">STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP</span><br/><br/><span class=\"MedSmallFormText\">Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934</span><br/><span class=\"MedSmallFormText\">or Section 30(h) of the Investment Company Act of 1940</span>\n</td>\n<td align=\"center\" rowspan=\"2\" valign=\"top\" width=\"20%\"><table border=\"1\" summary=\"OMB Approval Status Box\" width=\"100%\">\n<tr><td class=\"FormTextC\">OMB APPROVAL</td></tr>\n<tr><td><table border=\"0\" summary=\"OMB Interior Box\" width=\"100%\">\n<tr>\n<td class=\"SmallFormText\" colspan=\"3\">OMB Number:</td>\n<td class=\"SmallFormTextR\">3235-0287</td>\n</tr>\n<tr><td class=\"SmallFormText\" colspan=\"4\">Estimated average burden</td></tr>\n<tr>\n<td class=\"SmallFormText\" colspan=\"3\">hours per response:</td>\n<td class=\"SmallFormTextR\">0.5</td>\n</tr>\n</table></td></tr>\n</table></td>\n</tr>\n<tr valign=\"middle\">\n<td><table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\"><tr><td>\u00a0\u00a0</td></tr></table></td>\n<td class=\"SmallFormText\">Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. \n         <i>See</i>\n\n         Instruction 1(b).</td>\n</tr>\n</table>\n<table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" width=\"100%\">\n<tr>\n<td rowspan=\"3\" valign=\"top\" width=\"35%\">\n<span class=\"MedSmallFormText\">1. Name and Address of Reporting Person<sup>*</sup></span><table border=\"0\" width=\"100%\"><tr><td><a Jake</a></td></tr></table>\n<hr width=\"98%\"/>\n<table border=\"0\" width=\"100%\"><tr>\n<td class=\"MedSmallFormText\" width=\"33%\">(Last)</td>\n<td class=\"MedSmallFormText\" width=\"33%\">(First)</td>\n<td class=\"MedSmallFormText\" width=\"33%\">(Middle)</td>\n</tr></table>\n<table border=\"0\" width=\"100%\">\n<tr><td><span class=\"FormData\">C/O MYOKARDIA, INC.</span></td></tr>\n<tr><td><span class=\"FormData\">333 ALLERTON AVENUE</span></td></tr>\n</table>\n<hr width=\"98%\"/>\n<span class=\"MedSmallFormText\">(Street)</span><table border=\"0\" width=\"100%\"><tr>\n<td width=\"33%\"><span class=\"FormData\">SOUTH SAN FRANCISCO</span></td>\n<td width=\"33%\"><span class=\"FormData\">CA</span></td>\n<td width=\"33%\"><span class=\"FormData\">94080</span></td>\n</tr></table>\n<hr width=\"98%\"/>\n<table border=\"0\" width=\"100%\"><tr>\n<td class=\"MedSmallFormText\" width=\"33%\">(City)</td>\n<td class=\"MedSmallFormText\" width=\"33%\">(State)</td>\n<td class=\"MedSmallFormText\" width=\"33%\">(Zip)</td>\n</tr></table>\n</td>\n<td valign=\"top\" width=\"35%\">\n<span class=\"MedSmallFormText\">2. Issuer Name <b>and</b> Ticker or Trading Symbol\n      </span><br/><a Inc</a>\n     [ <span class=\"FormData\">MYOK</span> ]\n   </td>\n<td rowspan=\"2\" valign=\"top\">\n<span class=\"MedSmallFormText\">5. Relationship of Reporting Person(s) to Issuer\n      </span><br/><span class=\"MedSmallFormText\">(Check all applicable)</span><table border=\"0\" width=\"100%\">\n<tr>\n<td align=\"center\" width=\"15%\"></td>\n<td class=\"MedSmallFormText\" width=\"35%\">Director</td>\n<td align=\"center\" width=\"15%\"></td>\n<td class=\"MedSmallFormText\" width=\"35%\">10% Owner</td>\n</tr>\n<tr>\n<td align=\"center\"><span class=\"FormData\">X</span></td>\n<td class=\"MedSmallFormText\">Officer (give title below)</td>\n<td align=\"center\"></td>\n<td class=\"MedSmallFormText\">Other (specify below)</td>\n</tr>\n<tr><td align=\"center\" colspan=\"4\"><span class=\"FormData\">Chief Business Officer</span></td></tr>\n</table>\n</td>\n</tr>\n<tr><td valign=\"top\">\n<span class=\"MedSmallFormText\">3. Date of Earliest Transaction\n         (Month/Day/Year)</span><br/><span class=\"FormData\">07/23/2018</span>\n</td></tr>\n<tr>\n<td valign=\"top\">\n<span class=\"MedSmallFormText\">4. If Amendment, Date of Original Filed\n         (Month/Day/Year)</span><br/>\n</td>\n<td valign=\"top\">\n<span class=\"MedSmallFormText\">6. Individual or Joint/Group Filing (Check Applicable Line)\n      </span><table border=\"0\" width=\"100%\">\n<tr>\n<td align=\"center\" width=\"15%\"><span class=\"FormData\">X</span></td>\n<td class=\"MedSmallFormText\" width=\"85%\">Form filed by One Reporting Person</td>\n</tr>\n<tr>\n<td align=\"center\" width=\"15%\"></td>\n<td class=\"MedSmallFormText\" width=\"85%\">Form filed by More than One Reporting Person</td>\n</tr>\n</table>\n</td>\n</tr>\n</table>\n<table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" width=\"100%\">\n<thead>\n<tr><th align=\"center\" class=\"FormTextC\" colspan=\"11\" valign=\"top\" width=\"100%\"><b>Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned</b></th></tr>\n<tr>\n<th align=\"left\" class=\"MedSmallFormText\" rowspan=\"2\" valign=\"top\" width=\"36%\">1. Title of Security (Instr. \n      3)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"6%\">2. Transaction Date\n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"5%\">2A. Deemed Execution Date, if any\n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"7%\">3. Transaction Code (Instr. \n      8)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"3\" valign=\"top\" width=\"19%\">4. Securities Acquired (A) or Disposed Of (D) (Instr. \n      3, 4 and 5)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"11%\">5. \n      Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. \n      3 and 4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"9%\">6. Ownership Form: Direct (D) or Indirect (I) (Instr. \n      4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"8%\">7. Nature of Indirect Beneficial Ownership (Instr. \n      4)\n   </th>\n</tr>\n<tr>\n<th align=\"center\" class=\"SmallFormText\" width=\"4%\">Code</th>\n<th align=\"center\" class=\"SmallFormText\" width=\"3%\">V</th>\n<th align=\"center\" class=\"SmallFormText\" width=\"8%\">Amount</th>\n<th align=\"center\" class=\"SmallFormText\" width=\"5%\">(A) or (D)</th>\n<th align=\"center\" class=\"SmallFormText\" width=\"6%\">Price</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"><span class=\"FormData\">07/23/2018</span></td>\n<td align=\"center\"><span class=\"FormData\"></span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">M</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">7,500</span></td>\n<td align=\"center\"><span class=\"FormData\">A</span></td>\n<td align=\"center\">\n<span class=\"FormText\">$</span><span class=\"FormData\">13.9</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"><span class=\"FormData\">68,106</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"left\"></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"><span class=\"FormData\">07/23/2018</span></td>\n<td align=\"center\"><span class=\"FormData\"></span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">S</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">4,399</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"center\">\n<span class=\"FormText\">$</span><span class=\"FormData\">56.59</span><span class=\"FootnoteData\"><sup>(2)</sup></span>\n</td>\n<td align=\"center\"><span class=\"FormData\">63,707</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"left\"></td>\n</tr>\n<tr>\n<td align=\"left\"><span class=\"FormData\">Common Stock</span></td>\n<td align=\"center\"><span class=\"FormData\">07/23/2018</span></td>\n<td align=\"center\"><span class=\"FormData\"></span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">S</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"FormData\">3,101</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"center\">\n<span class=\"FormText\">$</span><span class=\"FormData\">57.28</span><span class=\"FootnoteData\"><sup>(3)</sup></span>\n</td>\n<td align=\"center\"><span class=\"FormData\">60,606</span></td>\n<td align=\"center\"><span class=\"FormData\">D</span></td>\n<td align=\"left\"></td>\n</tr>\n</tbody>\n</table>\n<table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" width=\"100%\">\n<thead>\n<tr><th align=\"center\" class=\"FormTextC\" colspan=\"16\" valign=\"top\" width=\"100%\">\n<b>Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned</b><br/><b>(e.g., puts, calls, warrants, options, convertible securities)</b>\n</th></tr>\n<tr>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"13%\">1. Title of Derivative Security (Instr. \n      3)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"5%\">2. Conversion or Exercise Price of Derivative Security\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"5%\">3. Transaction Date\n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"5%\">3A. Deemed Execution Date, if any\n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"9%\">4. Transaction Code (Instr. \n      8)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"10%\">5. \n      Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. \n      3, 4 and 5)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"9%\">6. Date Exercisable and Expiration Date \n      (Month/Day/Year)</th>\n<th align=\"left\" class=\"SmallFormText\" colspan=\"2\" valign=\"top\" width=\"17%\">7. Title and Amount of Securities Underlying Derivative Security (Instr. \n      3 and 4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"6%\">8. Price of Derivative Security (Instr. \n      5)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"6%\">9. \n      Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. \n      4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"6%\">10. Ownership Form: Direct (D) or Indirect (I) (Instr. \n      4)\n   </th>\n<th align=\"left\" class=\"SmallFormText\" rowspan=\"2\" valign=\"top\" width=\"7%\">11. Nature of Indirect Beneficial Ownership (Instr. \n      4)\n   </th>\n</tr>\n<tr>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"4%\">Code</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"4%\">V</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"5%\">(A)</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"5%\">(D)</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"5%\">Date Exercisable</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"4%\">Expiration Date</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"10%\">Title</th>\n<th align=\"center\" class=\"SmallFormText\" valign=\"bottom\" width=\"7%\">Amount or Number of Shares</th>\n</tr>\n</thead>\n<tbody><tr>\n<td align=\"left\"><span class=\"SmallFormData\">Stock Option (Right to Buy)</span></td>\n<td align=\"center\">\n<span class=\"SmallFormText\">$</span><span class=\"SmallFormData\">13.9</span>\n</td>\n<td align=\"center\"><span class=\"SmallFormData\">07/23/2018</span></td>\n<td align=\"center\"><span class=\"SmallFormData\"></span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">M</span><span class=\"FootnoteData\"><sup>(1)</sup></span>\n</td>\n<td align=\"center\"></td>\n<td align=\"center\"></td>\n<td align=\"center\"><span class=\"SmallFormData\">7,500</span></td>\n<td align=\"center\">\n<span class=\"SmallFormData\">\n</span><span class=\"FootnoteData\"><sup>(4)</sup></span>\n</td>\n<td align=\"center\"><span class=\"SmallFormData\">07/19/2027</span></td>\n<td align=\"center\"><span class=\"SmallFormData\">Common Stock</span></td>\n<td align=\"center\"><span class=\"FormData\">7,500</span></td>\n<td align=\"center\">\n<span class=\"SmallFormText\">$</span><span class=\"SmallFormData\">0.00</span>\n</td>\n<td align=\"center\"><span class=\"SmallFormData\">7,500</span></td>\n<td align=\"center\"><span class=\"SmallFormData\">D</span></td>\n<td align=\"left\"></td>\n</tr></tbody>\n</table>\n<table border=\"0\" width=\"100%\">\n<tr><td class=\"MedSmallFormText\"><b>Explanation of Responses:</b></td></tr>\n<tr><td class=\"FootnoteData\">1. This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.</td></tr>\n<tr><td class=\"FootnoteData\">2. Represents the weighted average sale price of the shares sold ranging from $56.00 to $56.95 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.</td></tr>\n<tr><td class=\"FootnoteData\">3. Represents the weighted average sale price of the shares sold ranging from $57.00 to $57.60 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.</td></tr>\n<tr><td class=\"FootnoteData\">4. The shares subject to this option vest and become exercisable in in two annual installments after July 20, 2017, so long as the Reporting Person continues to be an employee of the Issuer through each vesting date.</td></tr>\n<tr><td class=\"FormText\"><b>Remarks:</b></td></tr>\n<tr><td class=\"FootnoteData\">Exhibit 24.1 - Power of Attorney</td></tr>\n</table>\n<table border=\"0\" width=\"100%\">\n<tr>\n<td width=\"60%\"></td>\n<td width=\"20%\"><u><span class=\"FormData\">/s/ Cynthia J. Ladd, Attorney-in-Fact</span></u></td>\n<td width=\"20%\"><u><span class=\"FormData\">07/25/2018</span></u></td>\n</tr>\n<tr>\n<td></td>\n<td class=\"MedSmallFormText\">** Signature of Reporting Person</td>\n<td class=\"MedSmallFormText\">Date</td>\n</tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\">Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.</td></tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\">* If the form is filed by more than one reporting person, \n                  <i>see</i>\n\n                  Instruction \n                  4\n\n                  (b)(v).</td></tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\">** Intentional misstatements or omissions of facts constitute Federal Criminal Violations \n                  <i>See</i>\n\n                  18 U.S.C. 1001 and 15 U.S.C. 78ff(a).</td></tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\">Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, \n                  <i>see</i>\n\n                  Instruction 6 for procedure.</td></tr>\n<tr><td class=\"MedSmallFormText\" colspan=\"3\"><b>Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.</b></td></tr>\n</table>\n</body>\n</html>\n"}, "reportNo10": {"reportType": "SC 13G", "url": "https://www.sec.gov/Archives/edgar/data/1442756/000114420418038333/tv498513_sc13g.htm", "dateOfReport": "2018-07-13", "htmlOfReport": " <document>\n<type>SC 13G\n<sequence>1\n<filename>tv498513_sc13g.htm\n<description>SC 13G\n<text>\n<html>\n<head>\n<title></title>\n</head>\n<body style=\"font: 10pt Times New Roman, Times, Serif\">\n<p style=\"margin: 0\">\u00a0</p>\n<p style=\"margin: 0\"></p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse\">\n<tr style=\"vertical-align: top\">\n<td style=\"width: 100%; padding-right: 5.4pt; padding-left: 0.5in; text-align: justify; text-indent: -0.5in; font-size: 10pt\">\u00a0</td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><b>UNITED STATES</b></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><b>SECURITIES AND EXCHANGE COMMISSION</b></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><b>Washington, D.C.\u00a0\u00a020549</b></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\">\u00a0</td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\">\u00a0</td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><font style=\"font-size: 18pt\">SCHEDULE 13G</font></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><b>(Rule 13d-102)</b></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\">\u00a0</td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><b>Information Statement Pursuant to Rules 13d-1 and 13d-2</b></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><b>Under the Securities Exchange Act of 1934</b></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><font style=\"font-size: 10pt\"><b>(Amendment No. <u>\u00a0\u00a0\u00a0\u00a0\u00a0</u>)*</b></font></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\">\u00a0</td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\">\u00a0</td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\">Myokardia, Inc.</td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\">(Name of Issuer)</td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\">\u00a0</td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\">Common stock, par value $0.0001 per share</td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\">(Title of Class of Securities)</td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\">\u00a0</td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\">\u00a0</td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid\">62857M105</p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\">(CUSIP Number)</td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\">\u00a0</td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\">\u00a0</td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid\">July 3,\n        2018</p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\">Date of Event Which Requires Filing of the Statement</td></tr>\n</table>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify\">Check the appropriate box to designate\nthe rule pursuant to which this Schedule is filed:</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse\">\n<tr style=\"vertical-align: top\">\n<td style=\"width: 10%; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; font-size: 10pt; layout-grid-mode: line\">[\u00a0\u00a0\u00a0]</td>\n<td style=\"width: 90%; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; font-size: 10pt; layout-grid-mode: line\">Rule 13d-1(b)</td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; font-size: 10pt; layout-grid-mode: line\">[X]</td>\n<td style=\"padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; font-size: 10pt; layout-grid-mode: line\">Rule 13d-1(c)</td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; font-size: 10pt; layout-grid-mode: line\">[\u00a0\u00a0\u00a0]</td>\n<td style=\"padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; font-size: 10pt; layout-grid-mode: line\">Rule 13d-1(d)</td></tr>\n</table>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify\">*The remainder of this cover page shall\nbe filled out for a reporting person\u2019s initial filing on this form with respect to the subject class of securities, and for\nany subsequent amendment containing information which would alter disclosures provided in a prior cover page.</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify\">The information required on the remainder\nof this cover page shall not be deemed to be \u201cfiled\u201d for the purpose of Section 18 of the Securities Exchange Act of\n1934 (\u201cAct\u201d) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions\nof the Act (however, see the Notes).</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify\">\u00a0</p>\n<!-- Field: Page; Sequence: 1 -->\n<div style=\"margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid\"><p style=\"margin: 0pt\">\u00a0</p></div>\n<div style=\"page-break-before: always; margin-top: 6pt; margin-bottom: 12pt\"><p style=\"margin: 0pt\"></p><table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse\"><tr><td style=\"width: 24%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><br style=\"clear: both\"/> <font style=\"font-size: 10pt; font-variant: small-caps\">Cusip No.</font><font style=\"font-size: 10pt\">\u00a0\u00a062857M105</font></td><td style=\"width: 49%; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><font style=\"font-size: 10pt\"><b>13G</b></font></td><td style=\"width: 27%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">Page <!-- Field: Sequence; Type: Arabic; Value: 2; Name: PageNo -->2<!-- Field: /Sequence --> of <font style=\"font-family: Times New Roman, Times, Serif\">13 Pages</font></font></td></tr></table><p style=\"margin: 0pt\"></p></div>\n<!-- Field: /Page -->\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify\"></p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse\">\n<tr style=\"vertical-align: top\">\n<td style=\"border: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">1.</p></td>\n<td colspan=\"3\" style=\"border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">NAME OF REPORTING PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\"><b>Partner Fund Management, L.P.</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">2.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 324.7pt; text-indent: -36.7pt\"><font style=\"font-size: 10pt\">(a)\u00a0\u00a0\u00a0</font>[_]</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 324.6pt; text-indent: -36.6pt\"><font style=\"font-size: 10pt\">(b)\u00a0\u00a0\u00a0</font>[X]</p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">3.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SEC USE ONLY</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">4.</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">CITIZENSHIP OR PLACE OF ORGANIZATION</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>Delaware</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td colspan=\"2\" rowspan=\"4\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">NUMBER OF</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">SHARES</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">BENEFICIALLY</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">OWNED BY</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">EACH</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">REPORTING</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">WITH</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">5.</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SOLE VOTING POWER</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>0</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">6.</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SHARED VOTING POWER</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\"><b>\u00a0</b></p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>1,998,484 </b></p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">7.</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SOLE DISPOSITIVE POWER</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>0</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">8.</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SHARED DISPOSITIVE POWER</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>See Row 6 above</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">9.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>See Row 6 above</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">10.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in\">CHECK BOX\n        IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">CERTAIN SHARES</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right\">[_]</p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">11.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>5.0%<u><sup>1</sup></u></b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">12.</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">TYPE OF REPORTING PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>IA; PN</b></p></td></tr>\n<tr>\n<td style=\"width: 7%\">\u00a0</td>\n<td style=\"width: 23%\">\u00a0</td>\n<td style=\"width: 7%\">\u00a0</td>\n<td style=\"width: 63%\">\u00a0</td></tr>\n</table>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 0\"></td><td style=\"width: 0.5in\">________________</td><td></td></tr></table>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 0\"></td><td style=\"width: 0.5in\"><u><sup>1</sup></u></td><td style=\"text-align: left\">The percentages reported in this Schedule 13G are based upon 39,672,982 shares of common stock outstanding\naccording to the prospectus filed by the issuer with the Securities and Exchange Commission on May 23, 2018. All of the other numbers\nand percentages reported in this Schedule 13G are as of 9:00 a.m. (ET) on the date of filing.</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in\">\u00a0</p>\n<!-- Field: Page; Sequence: 2 -->\n<div style=\"margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid\"><p style=\"margin: 0pt\">\u00a0</p></div>\n<div style=\"page-break-before: always; margin-top: 6pt; margin-bottom: 12pt\"><p style=\"margin: 0pt\"></p><table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse\"><tr><td style=\"width: 24%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><br style=\"clear: both\"/> <font style=\"font-size: 10pt; font-variant: small-caps\">Cusip No.</font><font style=\"font-size: 10pt\">\u00a0\u00a062857M105</font></td><td style=\"width: 49%; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><font style=\"font-size: 10pt\"><b>13G</b></font></td><td style=\"width: 27%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> of <font style=\"font-family: Times New Roman, Times, Serif\">13 Pages</font></font></td></tr></table><p style=\"margin: 0pt\"></p></div>\n<!-- Field: /Page -->\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse\">\n<tr style=\"vertical-align: top\">\n<td style=\"border: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">1.</p></td>\n<td colspan=\"3\" style=\"border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">NAME OF REPORTING PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\"><b>Partner Fund Management GP, LLC</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">2.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 324.7pt; text-indent: -36.7pt\"><font style=\"font-size: 10pt\">(a)\u00a0\u00a0\u00a0</font>[_]</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 324.6pt; text-indent: -36.6pt\"><font style=\"font-size: 10pt\">(b)\u00a0\u00a0\u00a0</font>[X]</p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">3.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SEC USE ONLY</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">4.</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">CITIZENSHIP OR PLACE OF ORGANIZATION</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>Delaware</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td colspan=\"2\" rowspan=\"4\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">NUMBER OF</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">SHARES</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">BENEFICIALLY</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">OWNED BY</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">EACH</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">REPORTING</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">WITH</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">5.</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SOLE VOTING POWER</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>0</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">6.</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SHARED VOTING POWER</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\"><b>\u00a0</b></p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>1,998,484 </b></p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">7.</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SOLE DISPOSITIVE POWER</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>0</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">8.</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SHARED DISPOSITIVE POWER</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>See Row 6 above</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">9.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>See Row 6 above</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">10.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in\">CHECK BOX\n        IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">CERTAIN SHARES</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right\">[_]</p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">11.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>5.0%</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">12.</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">TYPE OF REPORTING PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>OO</b></p></td></tr>\n<tr>\n<td style=\"width: 7%\">\u00a0</td>\n<td style=\"width: 23%\">\u00a0</td>\n<td style=\"width: 7%\">\u00a0</td>\n<td style=\"width: 63%\">\u00a0</td></tr>\n</table>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in\">\u00a0</p>\n<!-- Field: Page; Sequence: 3 -->\n<div style=\"margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid\"><p style=\"margin: 0pt\">\u00a0</p></div>\n<div style=\"page-break-before: always; margin-top: 6pt; margin-bottom: 12pt\"><p style=\"margin: 0pt\"></p><table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse\"><tr><td style=\"width: 24%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><br style=\"clear: both\"/> <font style=\"font-size: 10pt; font-variant: small-caps\">Cusip No.</font><font style=\"font-size: 10pt\">\u00a0\u00a062857M105</font></td><td style=\"width: 49%; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><font style=\"font-size: 10pt\"><b>13G</b></font></td><td style=\"width: 27%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> of <font style=\"font-family: Times New Roman, Times, Serif\">13 Pages</font></font></td></tr></table><p style=\"margin: 0pt\"></p></div>\n<!-- Field: /Page -->\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse\">\n<tr style=\"vertical-align: top\">\n<td style=\"border: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">1.</p></td>\n<td colspan=\"3\" style=\"border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">NAME OF REPORTING PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\"><b>Partner Investment Management, L.P.</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">2.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 324.7pt; text-indent: -36.7pt\"><font style=\"font-size: 10pt\">(a)\u00a0\u00a0\u00a0</font>[_]</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 324.6pt; text-indent: -36.6pt\"><font style=\"font-size: 10pt\">(b)\u00a0\u00a0\u00a0</font>[X]</p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">3.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SEC USE ONLY</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">4.</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">CITIZENSHIP OR PLACE OF ORGANIZATION</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>Delaware</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td colspan=\"2\" rowspan=\"4\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">NUMBER OF</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">SHARES</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">BENEFICIALLY</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">OWNED BY</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">EACH</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">REPORTING</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">WITH</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">5.</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SOLE VOTING POWER</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>0</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">6.</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SHARED VOTING POWER</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\"><b>\u00a0</b></p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>22,431 </b></p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">7.</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SOLE DISPOSITIVE POWER</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>0</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">8.</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SHARED DISPOSITIVE POWER</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>See Row 6 above</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">9.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>See Row 6 above</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">10.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in\">CHECK BOX\n        IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">CERTAIN SHARES</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right\">[_]</p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">11.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>0.1%</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">12.</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">TYPE OF REPORTING PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>IA; PN</b></p></td></tr>\n<tr>\n<td style=\"width: 7%\">\u00a0</td>\n<td style=\"width: 23%\">\u00a0</td>\n<td style=\"width: 7%\">\u00a0</td>\n<td style=\"width: 63%\">\u00a0</td></tr>\n</table>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<!-- Field: Page; Sequence: 4 -->\n<div style=\"margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid\"><p style=\"margin: 0pt\">\u00a0</p></div>\n<div style=\"page-break-before: always; margin-top: 6pt; margin-bottom: 12pt\"><p style=\"margin: 0pt\"></p><table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse\"><tr><td style=\"width: 24%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><br style=\"clear: both\"/> <font style=\"font-size: 10pt; font-variant: small-caps\">Cusip No.</font><font style=\"font-size: 10pt\">\u00a0\u00a062857M105</font></td><td style=\"width: 49%; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><font style=\"font-size: 10pt\"><b>13G</b></font></td><td style=\"width: 27%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> of <font style=\"font-family: Times New Roman, Times, Serif\">13 Pages</font></font></td></tr></table><p style=\"margin: 0pt\"></p></div>\n<!-- Field: /Page -->\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse\">\n<tr style=\"vertical-align: top\">\n<td style=\"border: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">1.</p></td>\n<td colspan=\"3\" style=\"border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">NAME OF REPORTING PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\"><b>Partner Investment Management GP, LLC</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">2.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 324.7pt; text-indent: -36.7pt\"><font style=\"font-size: 10pt\">(a)\u00a0\u00a0\u00a0</font>[_]</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 324.6pt; text-indent: -36.6pt\"><font style=\"font-size: 10pt\">(b)\u00a0\u00a0\u00a0</font>[X]</p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">3.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SEC USE ONLY</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">4.</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">CITIZENSHIP OR PLACE OF ORGANIZATION</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>Delaware</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td colspan=\"2\" rowspan=\"4\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">NUMBER OF</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">SHARES</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">BENEFICIALLY</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">OWNED BY</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">EACH</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">REPORTING</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">WITH</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">5.</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SOLE VOTING POWER</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>0</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">6.</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SHARED VOTING POWER</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\"><b>\u00a0</b></p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>22,431 </b></p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">7.</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SOLE DISPOSITIVE POWER</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>0</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">8.</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SHARED DISPOSITIVE POWER</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>See Row 6 above</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">9.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>See Row 6 above</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">10.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in\">CHECK BOX\n        IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">CERTAIN SHARES</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right\">[_]</p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">11.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>0.1%</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">12.</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">TYPE OF REPORTING PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>OO</b></p></td></tr>\n<tr>\n<td style=\"width: 7%\">\u00a0</td>\n<td style=\"width: 23%\">\u00a0</td>\n<td style=\"width: 7%\">\u00a0</td>\n<td style=\"width: 63%\">\u00a0</td></tr>\n</table>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<!-- Field: Page; Sequence: 5 -->\n<div style=\"margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid\"><p style=\"margin: 0pt\">\u00a0</p></div>\n<div style=\"page-break-before: always; margin-top: 6pt; margin-bottom: 12pt\"><p style=\"margin: 0pt\"></p><table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse\"><tr><td style=\"width: 24%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><br style=\"clear: both\"/> <font style=\"font-size: 10pt; font-variant: small-caps\">Cusip No.</font><font style=\"font-size: 10pt\">\u00a0\u00a062857M105</font></td><td style=\"width: 49%; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><font style=\"font-size: 10pt\"><b>13G</b></font></td><td style=\"width: 27%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> of <font style=\"font-family: Times New Roman, Times, Serif\">13 Pages</font></font></td></tr></table><p style=\"margin: 0pt\"></p></div>\n<!-- Field: /Page -->\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse\">\n<tr style=\"vertical-align: top\">\n<td style=\"border: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">1.</p></td>\n<td colspan=\"3\" style=\"border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">NAME OF REPORTING PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\"><b>Brian D. Grossman</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">2.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 324.7pt; text-indent: -36.7pt\"><font style=\"font-size: 10pt\">(a)\u00a0\u00a0\u00a0</font>[_]</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 324.6pt; text-indent: -36.6pt\"><font style=\"font-size: 10pt\">(b)\u00a0\u00a0\u00a0</font>[X]</p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">3.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SEC USE ONLY</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">4.</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">CITIZENSHIP OR PLACE OF ORGANIZATION</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>U.S. Citizen</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td colspan=\"2\" rowspan=\"4\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">NUMBER OF</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">SHARES</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">BENEFICIALLY</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">OWNED BY</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">EACH</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">REPORTING</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">WITH</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">5.</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SOLE VOTING POWER</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>0</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">6.</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SHARED VOTING POWER</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\"><b>\u00a0</b></p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>2,020,915 </b></p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">7.</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SOLE DISPOSITIVE POWER</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>0</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">8.</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SHARED DISPOSITIVE POWER</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>See Row 6 above</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">9.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>See Row 6 above</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">10.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in\">CHECK BOX\n        IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">CERTAIN SHARES</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right\">[_]</p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">11.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>5.1%</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">12.</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">TYPE OF REPORTING PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>IN</b></p></td></tr>\n<tr>\n<td style=\"width: 7%\">\u00a0</td>\n<td style=\"width: 23%\">\u00a0</td>\n<td style=\"width: 7%\">\u00a0</td>\n<td style=\"width: 63%\">\u00a0</td></tr>\n</table>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in\">\u00a0</p>\n<!-- Field: Page; Sequence: 6 -->\n<div style=\"margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid\"><p style=\"margin: 0pt\">\u00a0</p></div>\n<div style=\"page-break-before: always; margin-top: 6pt; margin-bottom: 12pt\"><p style=\"margin: 0pt\"></p><table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse\"><tr><td style=\"width: 24%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><br style=\"clear: both\"/> <font style=\"font-size: 10pt; font-variant: small-caps\">Cusip No.</font><font style=\"font-size: 10pt\">\u00a0\u00a062857M105</font></td><td style=\"width: 49%; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><font style=\"font-size: 10pt\"><b>13G</b></font></td><td style=\"width: 27%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> of <font style=\"font-family: Times New Roman, Times, Serif\">13 Pages</font></font></td></tr></table><p style=\"margin: 0pt\"></p></div>\n<!-- Field: /Page -->\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse\">\n<tr style=\"vertical-align: top\">\n<td style=\"border: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">1.</p></td>\n<td colspan=\"3\" style=\"border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">NAME OF REPORTING PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\"><b>Christopher M. James</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">2.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 324.7pt; text-indent: -36.7pt\"><font style=\"font-size: 10pt\">(a)\u00a0\u00a0\u00a0</font>[_]</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 324.6pt; text-indent: -36.6pt\"><font style=\"font-size: 10pt\">(b)\u00a0\u00a0\u00a0</font>[X]</p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">3.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SEC USE ONLY</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">4.</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.35pt; padding-left: 6.35pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">CITIZENSHIP OR PLACE OF ORGANIZATION</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>U.S. Citizen</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td colspan=\"2\" rowspan=\"4\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">NUMBER OF</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">SHARES</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">BENEFICIALLY</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">OWNED BY</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">EACH</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">REPORTING</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">WITH</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">5.</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SOLE VOTING POWER</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>0</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">6.</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SHARED VOTING POWER</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\"><b>\u00a0</b></p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>2,020,915</b></p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">7.</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SOLE DISPOSITIVE POWER</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>0</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">8.</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p></td>\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.6pt; padding-left: 6.6pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">SHARED DISPOSITIVE POWER</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>See Row 6 above</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">9.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>See Row 6 above</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">10.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in\">CHECK BOX\n        IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">CERTAIN SHARES</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right\">[_]</p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">11.</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>5.1%</b></p></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">12.</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0</p></td>\n<td colspan=\"3\" style=\"border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 6.7pt; padding-left: 6.7pt\">\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">TYPE OF REPORTING PERSON</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in\"><b>IN</b></p></td></tr>\n<tr>\n<td style=\"width: 7%\">\u00a0</td>\n<td style=\"width: 23%\">\u00a0</td>\n<td style=\"width: 7%\">\u00a0</td>\n<td style=\"width: 63%\">\u00a0</td></tr>\n</table>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in\">\u00a0</p>\n<!-- Field: Page; Sequence: 7 -->\n<div style=\"margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid\"><p style=\"margin: 0pt\">\u00a0</p></div>\n<div style=\"page-break-before: always; margin-top: 6pt; margin-bottom: 12pt\"><p style=\"margin: 0pt\"></p><table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse\"><tr><td style=\"width: 24%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><br style=\"clear: both\"/> <font style=\"font-size: 10pt; font-variant: small-caps\">Cusip No.</font><font style=\"font-size: 10pt\">\u00a0\u00a062857M105</font></td><td style=\"width: 49%; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><font style=\"font-size: 10pt\"><b>13G</b></font></td><td style=\"width: 27%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> of <font style=\"font-family: Times New Roman, Times, Serif\">13 Pages</font></font></td></tr></table><p style=\"margin: 0pt\"></p></div>\n<!-- Field: /Page -->\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 0\"></td><td style=\"width: 1in\"><b>Item 1(a)</b></td><td><b>Name of Issuer</b></td></tr></table>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in\">Myokardia, Inc.</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\"><b>\u00a0</b></p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 0\"></td><td style=\"width: 1in\"><b>Item 1(b)</b></td><td><b>Address of Issuer\u2019s Principal Executive Offices</b></td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">333 Allerton Avenue, South San Francisco, California\n94080</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 0\"></td><td style=\"width: 1in\"><b>Item 2(a)</b></td><td><b>Name of Person Filing</b></td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">This Schedule 13G is being jointly filed by Partner\nFund Management, L.P. (\u201cPFM\u201d), Partner Fund Management GP, LLC (\u201cPFM-GP\u201d), Partner Investment Management,\nL.P. (\u201cPIM\u201d), Partner Investment Management GP, LLC (\u201cPIM-GP\u201d), Brian D. Grossman (\u201cGrossman\u201d)\nand Christopher M. James (\u201cJames\u201d and, collectively with PFM, PFM-GP, PIM, PIM-GP and Grossman, the \u201cReporting\nPersons\u201d) with respect to shares of common stock of the above-named issuer owned by Healthcare Emerging Growth Master Fund,\nL.P., a Cayman Islands limited partnership (\u201cHEGM\u201d), PFM Global Long Alpha Master Fund, L.P., a Cayman Islands limited\npartnership (\u201cGLAM\u201d), PFM Global Long Alpha Institutional Master Fund, L.P., a Cayman Islands limited partnership (\u201cGLAI\u201d),\nPFM Healthcare Master Fund, L.P., a Cayman Islands limited partnership (\u201cHCM\u201d), PFM Healthcare Long Master Fund, L.P.,\na Cayman Islands limited partnership (\u201cHCLM\u201d), PFM Thematic Growth Master Fund, L.P., a Cayman Islands limited partnership\n(\u201cTGM\u201d), PFM Thematic Growth Institutional Master Fund, L.P., a Cayman Islands limited partnership (\u201cTGIM\u201d),\nPFM Therapeutics Master Fund, L.P., a Cayman Islands limited partnership (\u201cTM\u201d), PFM Healthcare Principals Fund, L.P.,\na Delaware limited partnership (\u201cHCP\u201d), and PFM Thematic Growth Principals Fund, L.P. a Delaware limited partnership\n(\u201cTGP\u201d and, collectively with HEGM, GLAM, GLAI, HCM, HCLM, TGM, TGIM, TM and HCP, the \u201cFunds\u201d).</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">PFM is the investment advisor for the Funds other than\nHCP and TGP. PIM is the investment advisor for HCP and TGP. PFM-GP and PIM-GP are, respectively, the general partners of PFM and\nPIM. Grossman is the portfolio manager for the health care strategy for the Funds. James is the chief investment officer for PIM\nand PFM and member manager of PFM-GP and PIM-GP.</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">The filing of this statement shall not be construed\nas an admission that any of the Reporting Persons is the beneficial owner of any securities covered by the statement other than\nthe securities actually owned by such person (if any).</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 0\"></td><td style=\"width: 1in\"><b>Item 2(b)</b></td><td><b>Address of Principal Business Office</b></td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">The address of the principal business office of each\nof the Reporting Persons is c/o Partner Fund Management, L.P., 4 Embarcadero Center, Suite 3500, San Francisco, CA 94111.</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\"><tr style=\"vertical-align: top\">\n<td style=\"width: 0\"></td><td style=\"width: 1in\"><b>Item 2(c)</b></td><td><b>Citizenship</b></td></tr></table>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">Each of PFM and PIM is organized as a limited partnership\nunder the laws of the State of Delaware. Each of PFM-GP and PIM-GP is organized as a limited liability company under the laws of\nthe State of Delaware. Each of Grossman and James is a U.S. citizen.</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\"><tr style=\"vertical-align: top\">\n<td style=\"width: 0\"></td><td style=\"width: 1in\"><b>Item 2(d)</b></td><td><b>Title of Class of Securities</b></td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">Common stock, $0.0001 par value</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">\u00a0</p>\n<!-- Field: Page; Sequence: 8 -->\n<div style=\"margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid\"><p style=\"margin: 0pt\">\u00a0</p></div>\n<div style=\"page-break-before: always; margin-top: 6pt; margin-bottom: 12pt\"><p style=\"margin: 0pt\"></p><table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse\"><tr><td style=\"width: 24%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><br style=\"clear: both\"/> <font style=\"font-size: 10pt; font-variant: small-caps\">Cusip No.</font><font style=\"font-size: 10pt\">\u00a0\u00a062857M105</font></td><td style=\"width: 49%; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><font style=\"font-size: 10pt\"><b>13G</b></font></td><td style=\"width: 27%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> of <font style=\"font-family: Times New Roman, Times, Serif\">13 Pages</font></font></td></tr></table><p style=\"margin: 0pt\"></p></div>\n<!-- Field: /Page -->\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\"><tr style=\"vertical-align: top\">\n<td style=\"width: 0\"></td><td style=\"width: 1in\"><b>Item 2(e)</b></td><td><b>CUSIP Number</b></td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">62857M105</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 0\"></td><td style=\"width: 1in\"><b>Item 3</b></td><td style=\"text-align: justify\"><b>If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the\nperson filing is a:</b></td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 1in\"></td><td style=\"width: 0.5in\">(a)</td><td style=\"text-align: justify\">[__]\tBroker or dealer registered under Section 15 of the Exchange Act;</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 1in\"></td><td style=\"width: 0.5in\">(b)</td><td style=\"text-align: justify\">[__]\tBank as defined in Section 3(a)(6) of the Exchange Act;</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 1in\"></td><td style=\"width: 0.5in\">(c)</td><td style=\"text-align: justify\">[__]\tInsurance company as defined in Section 3(a)(19) of the Exchange Act;</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 1in\"></td><td style=\"width: 0.5in\">(d)</td><td style=\"text-align: justify\">[__]\tInvestment company registered under Section 8 of the Investment Company Act;</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 1in\"></td><td style=\"width: 0.5in\">(e)</td><td style=\"text-align: justify\">[__]\tAn investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 1in\"></td><td style=\"width: 0.5in\">(f)</td><td style=\"text-align: justify\">[__]\tAn employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 1in\"></td><td style=\"width: 0.5in\">(g)</td><td style=\"text-align: justify\">[__]\tA parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 1in\"></td><td style=\"width: 0.5in\">(h)</td><td style=\"text-align: justify\">[__]\tA savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 1in\"></td><td style=\"width: 0.5in\">(i)</td><td style=\"text-align: justify\">[__]\tA church plan that is excluded from the definition of an investment company under Section\n3(c)(14) of the Investment Company Act;</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 1in\"></td><td style=\"width: 0.5in\">(j)</td><td style=\"text-align: justify\">[__]\tA non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J);</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 1in\"></td><td style=\"width: 0.5in\">(k)</td><td style=\"text-align: justify\">[__]\tGroup, in accordance with Rule 13d-1(b)(1)(ii)(K).</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in\">If filing as\na non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution: ____________.</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in\">\u00a0</p>\n<!-- Field: Page; Sequence: 9 -->\n<div style=\"margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid\"><p style=\"margin: 0pt\">\u00a0</p></div>\n<div style=\"page-break-before: always; margin-top: 6pt; margin-bottom: 12pt\"><p style=\"margin: 0pt\"></p><table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse\"><tr><td style=\"width: 24%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><br style=\"clear: both\"/> <font style=\"font-size: 10pt; font-variant: small-caps\">Cusip No.</font><font style=\"font-size: 10pt\">\u00a0\u00a062857M105</font></td><td style=\"width: 49%; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><font style=\"font-size: 10pt\"><b>13G</b></font></td><td style=\"width: 27%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> of <font style=\"font-family: Times New Roman, Times, Serif\">13 Pages</font></font></td></tr></table><p style=\"margin: 0pt\"></p></div>\n<!-- Field: /Page -->\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 0\"></td><td style=\"width: 1in\"><b>Item 4</b></td><td><b>Ownership</b></td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\"><tr style=\"vertical-align: top; text-align: justify\">\n<td style=\"width: 1in\"></td><td style=\"width: 0.5in; text-align: left\">A.</td><td style=\"text-align: justify\">Partner Fund Management, L.P. and Partner Fund Management\nGP, LLC</td>\n</tr></table>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 1.5in\"></td><td style=\"width: 0.5in\">(a)</td><td style=\"text-align: left\">PFM and PFM-GP may be deemed to beneficially own 1,998,484 shares of Common Stock.</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 1.5in\"></td><td style=\"width: 0.5in\">(b)</td><td style=\"text-align: left\">The number of shares PFM and PFM-GP may be deemed to beneficially own constitutes approximately 5.0%\nof the Common Stock outstanding.</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\"><tr style=\"vertical-align: top; text-align: justify\">\n<td style=\"width: 1.5in\"></td><td style=\"width: 0.5in; text-align: left\">(c)</td><td style=\"text-align: justify\">Number of shares as to which such person has:</td>\n</tr></table>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 2in\"></td><td style=\"width: 0.5in\">(i)</td><td style=\"text-align: justify\">sole power to vote or to direct the vote: 0</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 2in\"></td><td style=\"width: 0.5in\">(ii)</td><td style=\"text-align: justify\">shared power to vote or to direct the vote: 1,998,484</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 2in\"></td><td style=\"width: 0.5in\">(iii)</td><td style=\"text-align: justify\">sole power to dispose or to direct the disposition of: 0</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 2in\"></td><td style=\"width: 0.5in\">(iv)</td><td style=\"text-align: justify\">shared power to dispose or to direct the disposition of: 1,998,484</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 1in\"></td><td style=\"width: 0.5in\">B.</td><td>Partner Investment Management, L.P. and Partner Investment Management GP, LLC</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 1.5in\"></td><td style=\"width: 0.5in\">(a)</td><td>PIM and PIM-GP may be deemed to beneficially own 22,431 shares of Common Stock.</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 1.5in\"></td><td style=\"width: 0.5in\">(b)</td><td style=\"text-align: left\">The number of shares PIM and PIM-GP may be deemed to beneficially own constitutes approximately 0.1%\nof the Common Stock outstanding.</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\"><tr style=\"vertical-align: top; text-align: justify\">\n<td style=\"width: 1.5in\"></td><td style=\"width: 0.5in; text-align: left\">(c)</td><td style=\"text-align: justify\">Number of shares as to which such person has:</td>\n</tr></table>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 2in\"></td><td style=\"width: 0.5in\">(i)</td><td style=\"text-align: justify\">sole power to vote or to direct the vote: 0</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 2in\"></td><td style=\"width: 0.5in\">(ii)</td><td style=\"text-align: justify\">shared power to vote or to direct the vote: 22,431</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 2in\"></td><td style=\"width: 0.5in\">(iii)</td><td style=\"text-align: justify\">sole power to dispose or to direct the disposition of: 0</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 2in\"></td><td style=\"width: 0.5in\">(iv)</td><td style=\"text-align: justify\">shared power to dispose or to direct the disposition of: 22,431</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<!-- Field: Page; Sequence: 10 -->\n<div style=\"margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid\"><p style=\"margin: 0pt\">\u00a0</p></div>\n<div style=\"page-break-before: always; margin-top: 6pt; margin-bottom: 12pt\"><p style=\"margin: 0pt\"></p><table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse\"><tr><td style=\"width: 24%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><br style=\"clear: both\"/> <font style=\"font-size: 10pt; font-variant: small-caps\">Cusip No.</font><font style=\"font-size: 10pt\">\u00a0\u00a062857M105</font></td><td style=\"width: 49%; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><font style=\"font-size: 10pt\"><b>13G</b></font></td><td style=\"width: 27%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> of <font style=\"font-family: Times New Roman, Times, Serif\">13 Pages</font></font></td></tr></table><p style=\"margin: 0pt\"></p></div>\n<!-- Field: /Page -->\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify; text-indent: -1in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify; text-indent: -1in\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\"><tr style=\"vertical-align: top; text-align: justify\">\n<td style=\"width: 1in\"></td><td style=\"width: 0.5in; text-align: left\">C.</td><td style=\"text-align: justify\">Brian D. Grossman</td>\n</tr></table>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 1.5in\"></td><td style=\"width: 0.5in\">(a)</td><td style=\"text-align: left\">Grossman may be deemed to beneficially own 2,020,915 shares of Common Stock.</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 1.5in\"></td><td style=\"width: 0.5in\">(b)</td><td style=\"text-align: left\">The number of shares Grossman may be deemed to beneficially own constitutes approximately 5.1% of\nthe Common Stock outstanding.</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\"><tr style=\"vertical-align: top; text-align: justify\">\n<td style=\"width: 1.5in\"></td><td style=\"width: 0.5in; text-align: left\">(c)</td><td style=\"text-align: justify\">Number of shares as to which such person has:</td>\n</tr></table>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 2in\"></td><td style=\"width: 0.5in\">(i)</td><td style=\"text-align: justify\">sole power to vote or to direct the vote: 0</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 2in\"></td><td style=\"width: 0.5in\">(ii)</td><td style=\"text-align: justify\">shared power to vote or to direct the vote: 2,020,915</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 2in\"></td><td style=\"width: 0.5in\">(iii)</td><td style=\"text-align: justify\">sole power to dispose or to direct the disposition of: 0</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 2in\"></td><td style=\"width: 0.5in\">(iv)</td><td style=\"text-align: justify\">shared power to dispose or to direct the disposition of: 2,020,915</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\"><tr style=\"vertical-align: top; text-align: justify\">\n<td style=\"width: 1in\"></td><td style=\"width: 0.5in; text-align: left\">D.</td><td style=\"text-align: justify\">Christopher M. James</td>\n</tr></table>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 1.5in\"></td><td style=\"width: 0.5in\">(a)</td><td style=\"text-align: left\">James may be deemed to beneficially own 2,020,915 shares of Common Stock.</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 1.5in\"></td><td style=\"width: 0.5in\">(b)</td><td style=\"text-align: left\">The number of shares James may be deemed to beneficially own constitutes approximately 5.1% of the\nCommon Stock outstanding.</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\"><tr style=\"vertical-align: top; text-align: justify\">\n<td style=\"width: 1.5in\"></td><td style=\"width: 0.5in; text-align: left\">(c)</td><td style=\"text-align: justify\">Number of shares as to which such person has:</td>\n</tr></table>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 2in\"></td><td style=\"width: 0.5in\">(i)</td><td style=\"text-align: justify\">sole power to vote or to direct the vote: 0</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 2in\"></td><td style=\"width: 0.5in\">(ii)</td><td style=\"text-align: justify\">shared power to vote or to direct the vote: 2,020,915</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 2in\"></td><td style=\"width: 0.5in\">(iii)</td><td style=\"text-align: justify\">sole power to dispose or to direct the disposition of: 0</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 2in\"></td><td style=\"width: 0.5in\">(iv)</td><td style=\"text-align: justify\">shared power to dispose or to direct the disposition of: 2,020,915</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 0\"></td><td style=\"width: 1in\"><b>Item 5</b></td><td><b>Ownership of Five Percent or Less of a Class</b></td></tr></table>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in\">\u00a0\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">If this statement is being filed to report the fact\nthat as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities,\ncheck the following [_].</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">\u00a0<b>\u00a0</b></p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 0\"></td><td style=\"width: 1in\"><b>Item 6</b></td><td><b>Ownership of More than Five Percent on Behalf of Another Person</b></td></tr></table>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">Not Applicable</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">\u00a0<b>\u00a0</b></p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 0\"></td><td style=\"width: 1in\"><b>Item 7</b></td><td><b>Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding\nCompany</b></td></tr></table>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">See Item 2 above</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">\u00a0\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 0\"></td><td style=\"width: 1in\"><b>Item 8</b></td><td><b>Identification and Classification of Members of the Group</b></td></tr></table>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">\u00a0\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">Not Applicable</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">\u00a0</p>\n<!-- Field: Page; Sequence: 11 -->\n<div style=\"margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid\"><p style=\"margin: 0pt\">\u00a0</p></div>\n<div style=\"page-break-before: always; margin-top: 6pt; margin-bottom: 12pt\"><p style=\"margin: 0pt\"></p><table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse\"><tr><td style=\"width: 24%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><br style=\"clear: both\"/> <font style=\"font-size: 10pt; font-variant: small-caps\">Cusip No.</font><font style=\"font-size: 10pt\">\u00a0\u00a062857M105</font></td><td style=\"width: 49%; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><font style=\"font-size: 10pt\"><b>13G</b></font></td><td style=\"width: 27%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> of <font style=\"font-family: Times New Roman, Times, Serif\">13 Pages</font></font></td></tr></table><p style=\"margin: 0pt\"></p></div>\n<!-- Field: /Page -->\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 0\"></td><td style=\"width: 1in\"><b>Item 9</b></td><td><b>Notice of Dissolution of Group</b></td></tr></table>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">\u00a0\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">Not Applicable</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">\u00a0\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\"><tr style=\"vertical-align: top\">\n<td style=\"width: 0\"></td><td style=\"width: 1in\"><b>Item 10</b></td><td><b>Certification</b></td></tr></table>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">By signing below I certify that, to the best of my knowledge\nand belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing\nor influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant\nin any transaction having that purpose or effect.</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in\">\u00a0\u00a0</p>\n<!-- Field: Page; Sequence: 12 -->\n<div style=\"margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid\"><p style=\"margin: 0pt\">\u00a0</p></div>\n<div style=\"page-break-before: always; margin-top: 6pt; margin-bottom: 12pt\"><p style=\"margin: 0pt\"></p><table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse\"><tr><td style=\"width: 24%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><br style=\"clear: both\"/> <font style=\"font-size: 10pt; font-variant: small-caps\">Cusip No.</font><font style=\"font-size: 10pt\">\u00a0\u00a062857M105</font></td><td style=\"width: 49%; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center\"><font style=\"font-size: 10pt\"><b>13G</b></font></td><td style=\"width: 27%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> of <font style=\"font-family: Times New Roman, Times, Serif\">13 Pages</font></font></td></tr></table><p style=\"margin: 0pt\"></p></div>\n<!-- Field: /Page -->\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in\">After reasonable inquiry\nand to the best of its knowledge and belief, the undersigned certify that the information set forth in this statement is true,\ncomplete and correct.</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">Dated this 13<sup>th</sup> day of July, 2018.</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse\">\n<tr style=\"vertical-align: top\">\n<td style=\"width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"width: 44%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"width: 4%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"width: 37%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td></tr>\n<tr style=\"vertical-align: top\">\n<td colspan=\"2\" style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\"><b>PARTNER FUND MANAGEMENT, L.P.</b></font></td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td colspan=\"2\" style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\"><b>PARTNER FUND MANAGEMENT GP, LLC</b></font></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">By:</font></td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">Partner Fund Management GP, LLC</font></td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">By:</font></td>\n<td style=\"border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">/s/ Darin Sadow<font style=\"font-family: Times New Roman, Times, Serif\"> </font></font></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">its general partner</font></td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">Darin Sadow, Authorized Signatory</font></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">By:</font></td>\n<td style=\"border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">/s/ Darin Sadow<font style=\"font-family: Times New Roman, Times, Serif\"> </font></font></td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">Darin Sadow, Authorized Signatory</font></td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td></tr>\n<tr style=\"vertical-align: top\">\n<td colspan=\"2\" style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\"><b>PARTNER INVESTMENT MANAGEMENT, L.P.</b></font></td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td colspan=\"2\" style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\"><b>PARTNER INVESTMENT MANAGEMENT GP, LLC</b></font></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">By:</font></td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">Partner Investment Management GP, LLC,</font></td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">By:</font></td>\n<td style=\"border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">/s/ Darin Sadow<font style=\"font-family: Times New Roman, Times, Serif\"> </font></font></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">its general partner</font></td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">Darin Sadow, Authorized Signatory</font></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">By:</font></td>\n<td style=\"border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">/s/ Darin Sadow<font style=\"font-family: Times New Roman, Times, Serif\"> </font></font></td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">Darin Sadow, Authorized Signatory</font></td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td></tr>\n<tr style=\"vertical-align: top\">\n<td colspan=\"2\" style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\"><b>BRIAN D. GROSSMAN</b></font></td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td colspan=\"2\" style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\"><b>CHRISTOPHER M. JAMES</b></font></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">By:</font></td>\n<td style=\"border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">/s/ Darin Sadow<font style=\"font-family: Times New Roman, Times, Serif\"> </font></font></td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">By:</font></td>\n<td style=\"border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">/s/ Darin Sadow<font style=\"font-family: Times New Roman, Times, Serif\"> </font></font></td></tr>\n<tr style=\"vertical-align: top\">\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">Darin Sadow, attorney-in-fact<u><sup>*</sup></u></font></td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\">\u00a0</td>\n<td style=\"padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt\"><font style=\"font-size: 10pt\">Darin Sadow, attorney-in-fact<u><sup>**</sup></u></font></td></tr>\n</table>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\"><b>\u00a0</b></p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\"><b><u>____________________________</u></b></p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 0\"></td><td style=\"width: 0.5in\"><u><sup>*</sup></u></td><td style=\"text-align: left\">Darin Sadow is signing on behalf of Brian Grossman as attorney-in-fact pursuant to a power of attorney\ndated August 4, 2011, and incorporated by reference herein. The power of attorney was filed as an attachment to a filing by certain\nof the Reporting Persons on Schedule 13G for K-V Pharmaceutical Company on August 5, 2011.</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<table cellpadding=\"0\" cellspacing=\"0\" style=\"font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\" width=\"100%\"><tr style=\"vertical-align: top\">\n<td style=\"width: 0\"></td><td style=\"width: 0.5in\"><u><sup>**</sup></u></td><td style=\"text-align: left\">Darin Sadow is signing on behalf of Christopher M. James as attorney-in-fact pursuant to a power of\nattorney dated August 4, 2011, and incorporated by reference herein. The power of attorney was filed as an attachment to a filing\nby certain of the Reporting Persons on Schedule 13G for K-V Pharmaceutical Company on August 5, 2011.</td></tr></table>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0</p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\"><b>\u00a0</b></p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\"><b>\u00a0</b></p>\n<!-- Field: Page; Sequence: 13; Options: Last -->\n<div style=\"margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid\"><p style=\"margin: 0pt\">\u00a0</p></div>\n<!-- Field: /Page -->\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right\"></p>\n</body>\n</html>\n</text>\n</description></filename></sequence></type></document>\n"}, "companyProfile": "MyoKardia, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of rare cardiovascular diseases. Its lead product candidate is mavacamten, an orally administered small molecule, which has completed Phase II clinical trial that is designed to reduce left ventricular contractility to potentially alleviate the functional consequences and symptoms of hypertrophic cardiomyopathy (HCM) and prevent or reverse HCM progression. The company also develops MYK-491, an orally-administered small molecule, which is in Phase I b clinical trial that is designed to restore normal contractility in the diseased dilated cardiomyopathy (DCM) heart. Its three preclinical programs include HCM-2 that is used to reduce cardiac muscle contractility to normal levels in HCM patients; DCM-2, which is used to enhance cardiac muscle contractility to normal levels in genetic DCM patients; and LUS-1 that is used to counteract a muscle disruption that results in impaired relaxation of the heart, a biomechanical defect found in specific HCM and genetic DCM patient subgroups, as well as in other less common heritable cardiomyopathies. The company has a strategic collaboration with Aventis Inc. for the research, development, and commercialization of pharmaceutical products to treat, prevent, and diagnose HCM and DCM, as well as additional indications. MyoKardia, Inc. was founded in 2012 and is headquartered in South San Francisco, California.", "stockSymbol": "MYOK", "float": "33.6M", "instOwn": "89.66%", "shortFloat": "9.61%", "sharesOutstanding": "40115401", "graphStats": {"cash": {"Q3 2018": "346,827,000", "Q2 2018": "183,865,000", "Q1 2018": "224,571,000", "Q4 2017": "227,184,000", "Q3 2017": "117,305,000", "Q2 2017": "135,594,000", "Q1 2017": "135,797,000", "Q4 2016": "77,120,000"}, "assets": {"Q3 2018": "434,154,000", "Q2 2018": "266,172,000", "Q1 2018": "282,808,000", "Q4 2017": "287,790,000", "Q3 2017": "169,763,000", "Q2 2017": "184,416,000", "Q1 2017": "201,306,000", "Q4 2016": "81,361,000"}, "net income": {"Q3 2018": "-18,413,000", "Q2 2018": "-17,820,000", "Q1 2018": "-45,952,000", "Q4 2017": "-38,557,000", "Q3 2017": "-12,837,000", "Q2 2017": "-11,547,000", "Q1 2017": "-13,152,000", "Q4 2016": "-27,411,000"}, "revenue": {"Q3 2018": "26,130,000", "Q2 2018": "23,931,000", "Q1 2018": "70,109,000", "Q4 2017": "56,409,000", "Q3 2017": "18,771,000", "Q2 2017": "17,393,000", "Q1 2017": "52,504,000", "Q4 2016": "38,139,000"}}, "accumulated deficit": "-171,088,000", "going concern": false, "companyAddress": "SOUTH SAN FRANCISCO 650-741-0900 CA 333 ALLERTON AVENUE 94080"}